Fluorescence Imaging of Virus-Host Cell Interaction and Super-Resolution Imaging of Neuronal Cytoskeleton by He, Jiang
Fluorescence Imaging of Virus-Host
Cell Interaction and Super-Resolution
Imaging of Neuronal Cytoskeleton
The Harvard community has made this
article openly available.  Please share  how
this access benefits you. Your story matters
Citation He, Jiang. 2016. Fluorescence Imaging of Virus-Host Cell Interaction
and Super-Resolution Imaging of Neuronal Cytoskeleton. Doctoral
dissertation, Harvard University, Graduate School of Arts &
Sciences.
Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:26718714
Terms of Use This article was downloaded from Harvard University’s DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at http://
nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAA
Fluorescence imaging of Virus-Host Cell Interaction and 
Super-resolution Imaging of Neuronal Cytoskeleton 
 
 
A dissertation presented 
By 
Jiang He 
to 
The Department of Molecular and Cellular Biology 
in partial fulfillment of the requirements 
for the degree of 
Doctor of Philosophy 
in the subject of 
 
Biochemistry 
 
Harvard University 
Cambridge, Massachusetts 
August, 2015 
 
 
 
 
  
 
 
 
 
 
 
© 2015 – Jiang He 
All rights reserved. 
 
iii 
 
Dissertation Advisor: Professor Xiaowei Zhuang                                         Jiang He 
Fluorescence imaging of Virus-Host Cell Interaction and Super-
resolution Imaging of Neuronal Cytoskeleton 
Abstract 
To study biological molecules, pathways and processes, fluorescence microscope has 
become an indispensable tool in modern biology. The major advantages of using fluorescence 
microscope include its ability to achieve molecule-specific visualization for targets of interest, 
and the compatibility of live cell imaging. With the advent of super-resolution imaging 
techniques, fluorescent microscope, for the first time, allows researchers to study biological 
processes on the nanometer scale. In this dissertation, I present the application of fluorescence 
imaging to characterize the role of host factors in influenza virus infection, and super-resolution 
imaging to study the developmental mechanism and prevalence of a periodic membrane skeleton 
in neurons.  
In Chapter 2 and 3, my colleagues and I studied the role of CD81 and COPI complex, 
two host factors identified in large-scale screens, for influenza infection. We found that CD81 
regulates two distinct steps during influenza infection cycle: virus uncoating during entry and 
virus budding during egress. Depleting CD81 led to a significant defect in viral uncoating and 
viral gene replication during entry, while during virus egress, CD81 depletion resulted in virions 
that failed to detach from the plasma membrane and a marked decrease in progeny virus 
production.  For COPI complexes, we found that COPI plays a direct role in viral membrane 
protein expression and assembly post-viral entry.  
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In Chapter 4 and 5, we used super-resolution imaging to study the developmental 
mechanism and prevalence of a newly discovered periodic membrane skeleton in axons, formed 
by actin, spectrin and associated molecules. We found that the periodic membrane skeleton is 
highly prevalent in different neuronal types. It forms early during neuronal development, and 
originates from regions closer to the cell body and propagates toward the distal ends of axons. 
The lattice structure further matures by recruiting additional molecular components and appears 
to be highly stable once formed. The loecn"eqpegpvtcvkqp"qh"ȕKK"urgevtkp"ku"c"mg{"fgvgtokpcpv"hqt"
the formation of this periodic membrane skeleton. In addition, we identified ankyrin B as a 
etkvkecn"oqngewnct"eqorqpgpv"hqt"vjg"rqnctk|gf"fkuvtkdwvkqp"qh"ȕKK"urgevtkp"kp"pgwtkvgu0" 
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Chapter 1: Introduction  
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1.1 Fluorescence imaging 
Biological processes are intrinsically dynamic and complex, and happen at length scales that span 
several orders of magnitude. To study biological molecules, pathways and processes in living cells, 
tissues or animals, biologists need tools to probe into these processes and light microscope has become an 
invaluable tool for modern biology. From the discovery of neurons by Ramon y Cajal a century ago[1], to 
the visualization of motor proteins walking along the cytoskeleton[2], light microscope has made 
countless significant contributions to modern biology and transformed our understanding of many 
biological questions. One attribute that makes light microscope so powerful in biology is its capability to 
visualize targets of interest specifically [3-5]. Various biological entities, including protein, DNA, and 
RNA have all been extensively characterized and studied under light microscope [3-5]. The availability of 
dyes at different spectrum not only makes it possible to visualize the target of interest specifically, but 
also permits the labeling of multiple targets simultaneously, further enabling the study of interactions 
among different biological entities [6-11]. As light is relatively non-invasive, light microscope is 
compatible with, and has been well-adapted for studying biological processes in living cells and live 
animals [3-5]. This feature gives light microscope an exceptional capability to study dynamics of various 
biological processes, making it possible to directly visualize the biological processes in real time.  
Among various light microscopes, fluorescence microscope is perhaps one of the most widely 
used techniques in modern cell biology. As the name indicates, fluorescence microscope relies on the 
detection of emitted fluorescence from targets of interest. Light excitation of fluorophores can emit 
photons characterized by a specific wavelength [3]. The unexcited non-fluorescence state is called ground 
state. After absorbing the light energy from the excitation light, the fluorophore quickly transits to an 
excited state (fluorescence state), and then returns to the ground state by shedding off the energy through 
vibrational relaxation or fluorescence excitation [3]. The wavelength of emitted light is longer than that of 
excited light. By using a filter to block the excitation light while allowing emission light to pass, it 
enables the visualization of fluorescence from targets of interest.  
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There are a large repertoire of synthetic fluorophores and genetically encoded fluorescent 
proteins, with excitation and emission spectrum spanning from UV to far red [6-11]. Synthetic 
fluorophores are usually credited for their brightness and photo-stability[11]. Quantum dots, a group of 
synthetic nano-sized particles made from semiconductor materials, is particularly well known for their 
exceptional brightness and low photo-bleaching property [12]. However, synthetic fluorophores are 
usually non-cell permeable, making it difficult to use for live cell studies [11]. Compared with synthetic 
fluorophores, fluorescent proteins are intrinsically compatible with live cell imaging [8, 10, 11]. Since the 
initial discovery and clone of green fluorescent protein (GFP) in jellyfish, many variants of fluorescent 
proteins have been developed and used in fluorescence imaging [8, 10, 11]. Because the fluorophore is 
encoded genetically, any protein of interest inside a cell can be tagged specifically by fusing its gene 
sequence with that of fluorescent proteins [8]. With modifications of labeling methods, DNA and RNA 
transcripts can be specifically labeled by fluorescent proteins as well [8, 10, 11, 13, 14].  
To date, fluorescence imaging has been wildly used in biological research for decades. Its 
capability to provide spatial, temporal and functional information makes it one of the most popular tools 
in biology, and has generated many significant insights for different biological questions. The dissertation 
presents the development and application of different fluorescence imaging techniques for the study of 
various biological questions, including virus-host cell interaction and super-resolution imaging of the 
developmental mechanism of a novel periodic membrane skeleton in axons.  
1.2 Fluorescence imaging of virus-host cell interaction 
As microscopic Trojan horses, viruses usurp host cell machinery to deliver their genome into the 
cell for initiating productive infection [15]. Viral infection is extremely dynamic and consists of multiple 
steps. The process begins with virion attachment to the cell surface, typically via low affinity electrostatic 
interactions with the glycocalyx, followed by specific binding to receptors. Receptor engagement allows 
viruses to either directly release their genome into the cell at the plasma membrane, or to enter cells 
through endocytosis. Endocytosed virus particles typically traffick through endosomal vesicles by actin- 
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and/or microtubule-dependent transport to rapidly navigate through the dense cytoplasm. Specific 
environmental cues then trigger either fusion of enveloped virus with the endosome, or membrane 
penetration by capsid proteins for non-enveloped viruses, allowing viral genetic material to be released 
into the cytoplasm [15]. For DNA viruses and a few RNA viruses, nuclear import of the viral genome 
precedes viral replication, protein expression, and assembly. For most RNA viruses however, subsequent 
steps of the infection cycle follow immediately after viral genome release (Figure 1.1) [15, 16]. After 
viral replication, protein expression, all the viral components are brought to the virus assembly site for 
successful virus egress, and subsequently start another infection cycle [15].  
Given the dynamic and multi-step nature of viral infection, many questions can benefit from 
studying viral entry and replication through imaging. To allow successful detection, viruses and relevant 
cellular components can be labeled with fluorescent probes. A number of different imaging modalities 
such as confocal, TIRF and epifluorescence microscopy have been used. Furthermore, development of 
image analysis algorithms has enabled researchers to track a large number of viral entry events in three-
dimensions with high speed and precision [17-21].   
Fluorescence imaging offers a powerful tool for studying these important events in live and fixed 
cells. For example, several viruses such as human immunodeficiency virus (HIV), vesicular stomatitis 
virus (VSV), vaccinia virus (VV), hepatitis C virus (HCV), and herpes simplex virus-1 (HSV-1) have 
been shown by live cell imaging to navigate along the cell body in an actin-dependent manner after 
attachment [22-27]. For these viruses, attachment is followed by transport along microvilli or filopodia 
toward the cell at a speed consistent with the actin retrograde flow [22, 24-27]. After viral binding to 
specific receptors, virus-induced clustering of receptors can either trigger conformational changes in the 
receptor-bound viral protein that prime viral genome release directly at the plasma membrane, or more 
commonly, transduce intracellular signaling to initiate endocytosis [15].   
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Figure 1.1. Schematic of the different viral infection pathways. Viral entry encompasses the following 
steps: virus - cell surface interactions, endocytosis, intracellular transport, genome release, and in some 
cases, nuclear import.  To begin an infection, virus particles absorb directly onto the cell surface or onto 
filopodia (a). Cell surface interactions are typically characterized by low electrostatic interactions with the 
glycocalyx prior to specific binding with cellular receptors. Virus binding to receptors may directly lead 
to genome release at the plasma membrane (b). More commonly, however, virus-receptor engagement 
induces downstream signaling events, resulting in internalization through one or more of the following 
pathways: macropinocytosis (c), clathrin-mediated endocytosis (d and e), caveolin-dependent endocytosis 
(f), or alternative, less characterized uptake pathways (g). Upon endocytosis, viruses hijack either the 
actin cytoskeleton (h) or microtubule network (i) to navigate through the dense cytoplasm. In addition to 
relying on the cytoskeleton for transport, viruses also utilize compartment-specific environmental cues, 
such as low pH or enzymatic cleavage, to trigger genome release through viral fusion for enveloped 
viruses or membrane penetration for non-enveloped viruses (j and k). For DNA viruses and a few RNA 
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Figure 1.1. (continued) viruses, genome translocation into the nucleus (l) precedes subsequent 
replication steps, while all other viruses replicate within the cytoplasm immediately after uncoating. After 
viral replication, some viruses such as HIV have the capability of mediating direct transfer of virions from 
the infected cell to another neighboring, uninfected cell (m). Figure from reference [28] 
Viruses hijack different cellular endocytotic pathways for internalization, among which clathrin-
mediated endocytosis is most commonly used. Many viruses also internalize through other pathways such 
as macropinocytosis, caveolar/raft-dependent endocytosis, and clathrin- caveolin/raft-independent 
pathways. Multicolor live cell imaging offers a powerful tool to probe the orchestrated recruitment of 
endocytic machinery during the virus internalization process. Using this technique, researchers found that 
influenza virus, reovirus, and VSV induce de novo assembly of clathrin machinery [29-32], rather than 
diffusing into nascent assembling clathrin-coated pits. HCV, Dengue virus (DenV), and VSV internalize 
cells exclusively through clathrin-mediated endocytosis [26, 29, 30, 33, 34], while Simian Virus 40 
(SV40) may enter cells through a clathrin and caveolin-independent pathways [35-37]. A number of 
viruses, including adenovirus, VV, Ebola, and influenza internalize through macropinocytosis [24, 38-44].  
The internalized viruses are usually sorted into endosomal vesicles and transported toward the 
perinuclear region along microtubules. As shown by live and fixed cell imaging studies, viruses including 
VSV and respiratory syncytial virus (RSV) undergo viral uncoating within early endosomes [30, 45, 46]. 
Many other viruses, such as influenza, Ebola, DenV, semliki forest virus (SFV), and Uukuniemi virus 
(UUKV), require trafficking from early to maturing or late endosomes before uncoating [34, 43, 47-50]. 
For delivery of viral genome into the nucleus, viruses can hijack the host cell machinery to reach its 
destination. For example, HIV-1 complexes sequentially exhibit four distinct stages of movement inside a 
cell: (1) microtubule-dependent transport, (2) actin-directed trafficking, (3) confined mobility upon 
docking at the nuclear membrane, and (4) diffusive intranuclear movement [51].   
Fluorescence imaging has substantially improved our understanding on viral infection, and has 
been used to study virtually every major step of virus infection cycle. The aforementioned examples are 
just a tip of iceberg for the insights garnered by fluorescence imaging for the study of virus-host cell 
interactions. Readers interested in this topic are referred to a comprehensive review of literature on this 
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topic [28, 52]. For the first part of this  dissertation (Chapter 2 and 3), specifically, I will present the use 
of fluorescence imaging, in combination with other biochemical assays, to study the role of host factors in 
influenza virus infection.  
1.3 Host factors in influenza virus infection  
Influenza virus is the major causal agent for flu, and has historically led to pandemic infections, 
such as the 1918 Spanish flu that killed an estimated 50 million people worldwide. It is an enveloped, 
negatively-sensed RNA virus. The virus envelope contains three viral membrane proteins: hemagglutinin 
(HA), neuraminidase (NA) and the protein channel M2. Enclosed within the viral envelope is a protein 
matrix made of M1 proteins, and a segmented genome, comprised of eight single-stranded RNAs packed 
into ribonucleoprotein complexes (vRNPs) with individual polymerase PA, PB1 and PB2 (Figure 1.2) 
[15]. 
As an obligatory pathogen that only encodes 13 viral proteins, influenza virus must hijack host 
cell machinery for productive infection. Influenza infection begins with virus binding to sialic acid on the 
plasma membrane [53], which triggers virus internalization through multiple endocytic routes including 
clathrin-mediated endocytosis and a clathrin-independent pathway [44, 54-57]. Internalized virus particles 
are first sorted into early endosomes, then low pH late endosomes, where viral fusion between the viral 
and endosomal membranes occurs to allow the release of viral genome into the cytoplasm. vRNPs are 
subsequently imported into the nucleus to initiate viral replication  [15, 28, 58, 59]. As replication 
proceeds, viral mRNAs are exported out of the nucleus for protein translation, and different viral 
components are trafficked and assembled at the plasma membrane to form progeny virions (Figure 1.2) 
[60]. 
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Figure 1.2. Influenza virus structure and virus infection cycle (Figures from reference [15]) 
To dissect the molecular and cellular mechanisms for influenza infection, it is of paramount 
importance to understand the interaction between the virus and host cell factors. In the past decade or so, 
live cell imaging has generated many important insights on influenza virology [52]. By tracking 
individual labeled-viruses during infection, for example, it has been shown that influenza enters the cell 
through three stages of active transport process: actin-dependent surfing in the cell periphery, a rapid 
microtubule-dependent unidirectional transport toward the perinuclear region, and an intermittent 
microtubule-dependent bidirectional transport before viral fusion [48]. Influenza virus is internalized 
through multiple endocytic pathways [44, 54-57], and can induce de novo assembly of clathrin machinery 
during clathrin-mediated endocytosis [56]. Inhibiting clathrin-mediated endocytosis for influenza shunts 
the virus to the alternative pathway, but does not affect overall infectivity [61]. By tracking individual 
virus trajectories that lead to successful infection, it was found that epsin 1, an adaptor protein for 
clathrin-mediated endocytosis, is recruited in synchrony with clathrin at influenza entry sites, while 
viruses that enter through the alternative pathway do not require epsin 1 [61]. Depleting epsin 1 or 
overexpressing a dominant-negative mutant only affects the clathrin-dependent entry pathway, with most 
of the virus particles routed through a clathrin-independent pathway [61].  
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After internalization, influenza virus hijacks the endocytic pathway to reach low-pH endosomes 
for successful viral uncoating. Live-cell tracking of Rab5 (early endosome marker) and Rab7 (late 
endosome marker) shows that early endosomes consist of two populations: a dynamic population that 
rapidly matures into late endosomes and a static population with much slower kinetics [62]. Interestingly, 
influenza virus and other degradative cargoes, primarily sort into the dynamic population of early 
endosomes, while recycling cargoes such as transferrin non-discriminately sorts into both populations 
[62]. The study revealed that sorting signals can come from the plasma membrane rather than beginning 
at the early endosomes. Furthermore, tracking influenza within the dynamic population revealed that viral 
fusion occurs within Rab5+ and Rab7+ endosomes [62]. Macropinocytosis has also been characterized by 
live cell imaging as an important entry pathway for influenza [44], although it remains unclear whether 
influenza virus can undergo fusion directly within macropinosomes, or whether influenza in 
macropinosomes eventually are sorted into degradative, low pH endosomal compartments for uncoating.  
To further investigate the molecular pathways for influenza virus infection, several large scale 
siRNA screens and proteomic analyses have been performed recently and successfully identified 
hundreds of candidate genes involved in influenza infection [63-68]. Between different screen studies, 
relatively low overlap was observed for the candidate genes, perhaps due to the difference of reagents and 
cells used in these studies. However, among five large scale siRNA screens, CD81 and COPI complex 
emerged as top candidates for early virus infection, with COPI complex identified in four screens [63, 64, 
66, 67], and CD81 in two screens [66, 67]. Additionally, CD81 was identified as a host cell component 
specifically incorporated into newly assembled virions through mass spectrum analysis of purified virions 
coming from infected cell  [69]. The exact role played by CD81 and COPI complex in influenza infection, 
however, has not been elucidated thus far. 
CD81 belongs to the family of tetraspanins, a family of evolutionally conserved proteins that are 
expressed in almost every cell type. There are over 32 members of tetraspanins in mammals, and they 
associate with each other and tetraspanin-interacting proteins to form tetraspanin-enriched microdomains 
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[70-72]. Like other tetraspanins, CD81 consists of three distinct domains: an extracellular domain with 
small extracellular loop and large extracellular loop; transmembrane domain and cytosolic domain. It is 
expressed on both the plasma and endosomal membranes [70, 73, 74]. Together with other tetraspanin 
family proteins, CD81 regulates many cellular processes such as cell adhesion, cell signaling, cell 
migration, and protein trafficking [70, 74-77]. Tetraspanins are known to play important roles in different 
steps of viral infection [78]. For example, CD81 functions as a co-receptor for hepatitis C virus (HCV) 
[79-82]. CD81 interacts with HCV glycoprotein E2 to prime the virus for low-pH dependent fusion 
during entry [79, 83, 84]. In addition to mediating viral entry, CD81 is also potentially involved in viral 
assembly. CD81 is one of the cell-derived components incorporated into purified influenza virus particles 
[69]. For HIV infection, CD81 and other tetraspanins have been previously identified as exit gateways for 
HIV budding, and CD81 colocalizes with HIV envelope proteins on the plasma membrane [85]. 
Relatively little is known about how CD81 regulates different steps during influenza virus infection.  
COPI proteins form complexes that coat vesicles essential for intracellular trafficking. There are 
nine different COPI complex subunits—g."ȕ3."ȕ4."h."i."Ȗ3."Ȗ4."ȗ3."cpf"ȗ4"[86-88], and multiple 
components of COP1 complex are identified as host factors required for influenza infection. Each COPI 
eqorngz"eqpvckpu"c"ukping"eqr{"qh"g."ȕ3."ȕ4."h."cpf"i"uwdwpkvu."kp"cffkvkqp"vq"qpg"qh"the following isoform 
eqodkpcvkqpu<""Ȗ31"ȗ3."Ȗ31"ȗ4."qt"Ȗ41"ȗ3."vq"hqto"c"eqcvogt"[86-88]. The coatmers are recruited to the 
vesicle membrane by activated ADP-ribosylation factor 1 (Arf1), which cycles between an activated GTP 
and inactivated GDP state [89]. Once formed, COPI coated vesicles mediate retrograde trafficking 
between Golgi apparatus and the ER, as well as between the Golgi stacks.  In addition, COPI complexes 
have been suggested to play a role in endocytic tracking, multivesicular body formation and/or membrane 
trafficking [90-95]. COPI complexes have been shown to play important roles for virus infection such as 
VSV [45]. Disruption of COPI complex through i-COPI depletion inhibits VSV virus binding and 
internalization. On the other hand, short-term Brefeldin A (BrefA) treatment, an inhibitor that prevents 
GDP to GTP exchange of ARF1, leads to a specific decrease in VSV gene expression  [45]. Influenza is a 
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different virus than VSV, it is thus unclear how COPI proteins are involved in each step of influenza virus 
infection. 
1.4 Super-resolution fluorescence microcopy 
Fluorescence microscopy has a resolution limit due to the diffraction of light. First recognized by 
Ernst Abbe in 1873, the resolution limit, or Abbe limit, defines the minimal distance between two objects 
that can be resolved by light microscopy [96]. The diffraction limit is calculated cu"Ȝ14pukpș."yjgtg"Ȝ"ku"
vjg"ycxgngpivj"qh"nkijv."p"ku"vjg"tghtcevkqp"kpfgz"qh"vjg"kocikpi"ogfkwo."cpf"ș"ku"vjg"cping"vjcv"vjg"nkijv"
converges to form a spot [96]0""pukpș"ku"cnuq"ecnngf"vjg"pwogtkecn"crgtvwtg"*PC+0Vjg"kpvgpukv{"rtqhkng"qh"c"
point of light source after passing through an object is known as point spread function (PSF). The 
resolution limit is approximately calculated as the full width at half maximum (FWHM) of the PSF [97]. 
For a fluorescence microscope equipped with an objective of ~1.4 NA, and light source at visible 
spectrum, the lateral resolution is usually around 200 nm and the axial resolution is around 500 nm. The 
resolution limit presents as a major drawback to study sub-cellular organizations and molecular 
interactions on the nanometer scale. Significant advancements have been made in fluorescence imaging to 
push the boundary of resolution limit in recent years. Super-resolution fluorescence microscopy, a class of 
newly developed light microscopy, completely shatters the resolution limit and allows the study of 
nanoscopic biological processes [98-101].  
There are two major categories of super-resolution imaging techniques: the first category relies 
on the use of patterned illumination to spatially modulate and confine a diffraction-limited fluorescent 
spot. The methods include stimulated emission depletion (STED) microscopy [102, 103], related 
RESOLFT microscopy [101], and saturated structured-illumination microscopy (SSIM) [104]. The 
second category of techniques relies on the precise localization of single molecules and reconstruction of 
measured positions from individual fluorophores. The methods include stochastic optical reconstruction 
microscopy (STORM) [105], photoactivated localization microscopy (PALM) [106], and fluorescence 
photoactivated localization microscopy (FPALM) [107]. Readers interested in a general overview of 
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super-resolution fluorescence microscopy are referred to excellent reviews [98-101]. In the following 
paragraphs, STORM, a method primarily used in this dissertation, will be described in more detail.  
STORM, PALM and fPALM are conceptually similar techniques and they all rely on the 
detection and localization of single molecules [98, 99]. A single fluorophore appears as a diffraction-
limited spot on a camera. However, the centroid position of the fluorophore can be determined with much 
higher accuracy [108, 109]. During STORM imaging, each photon can be counted as an independent 
measurement of the fluorophore’s position. The uncertainty of finding the centroid position is inversely 
tgncvgf"vq"vjg"pwodgt"qh"rjqvqp"*P+"eqnngevgf."uecnkpi"crrtqzkocvgn{"ykvj"kvu"kpxgtug"uswctg"tqqv"*\1ÁP+"
[98, 99]. Localization precision of less than one nanometer has been achieved with synthetic fluorophores 
that emit millions of photons [108]. 
A direct translation of high-precision localization information to super-resolution image, however, 
is still challenging if two fluorophores within the diffraction limit emit the photons at the same time. 
STORM overcomes this challenge by a sequential localization of photo-switchable fluorescent probes [98, 
99]. To perform STORM imaging on a biological sample, a target of interest is first labeled with photo-
switchable fluorescent probes that convert between an on (bright state) and off (dark state or another 
fluorescent state) state. Each imaging round, only a small subset of non-overlapping fluorophores are 
activated to the on state, and their localization can be accurately determined. After recording their 
positions, these fluorophores are switched to the off state, and a different subpopulation of fluorophores 
are switched to the on state. By repeating this process for many rounds, all the measured localizations can 
be superimposed to reconstruct a high-resolution image (Figure 1.3) [98, 99]. Using Alexa 647, a 
synthetic dye that emits over 5000 photons, a lateral resolution of less than 25 nm can be achieved 
through STORM [105]. 
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Figure 1.3. The principle of STORM. For a densely labeled cellular structure (green lines in the left 
image), during each imaging round, only a small subset of non-overlapping fluorophores are activated to 
the on state (blue circle in the middle image), and their localization can be accurately determined (red dot 
at the center of blue circle). After recording their positions, these fluorophores are switched to the off 
state, and a different population of fluorophores are switched to the on state. By repeating this process for 
many times, all the measured localizations can be superimposed to reconstruct a high-resolution image 
(red dotted line in the right image). Figure modified from reference [105].  
STORM is compatible with multi-color and 3D imaging. There are several approaches for multi-
color imaging: reporter-based and activator-based approach. The reporter-based approach is conceptually 
straightforward:  fluorophores with different emission spectrum are used to label targets of interest, and 
images from different color channel are constructed from the photons emitted from that specific 
fluorophore [110]. For activator-based approach, dye-pairs capable of switching between the on and off 
state are used. In each dye pair, there is a reporter fluorophore that undergoes photoswitching and an 
activator fluorophore that excites the reporter from off to on state. The color is distinguished by the 
activation wavelength used to excite the activator and shuffle its paired reporter to the on state [111].   
For 3D imaging, a cylindrical lens is inserted at the detection path before the camera to introduce 
astigmatism into the PSF [112]. With the cylindrical lens, fluorophores on the focal plane will have a 
circular PSF, while those above or below have an elliptical PSF. The degree of ellipticity is related to the 
axial position of the fluorophore. Using a single objective and Alexa 647, 3D STORM imaging with a 
lateral resolution of 25 nm and axial resolution of 50 nm has been demonstrated previously [112]. 
STORM imaging can be done in live cells. A spatial resolution of 25nm and time resolution of 
0.5 second has been achieved for 2D STORM image. For live cell 3D imaging, a frame can be imaged as 
fast as 1-2 second while maintaining a lateral resolution of ~30 nm and axial resolution of ~50 nm [113, 
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114]. The image resolution for STORM can be further improved by collecting more photons. In dual-
objective STORM, for example, two objectives collect the photons emitted from the sample sandwiched 
in between, and a lateral resolution of 7 nm and axial resolution of 15 nm has been achieved [115]. A 
separate approach uses fluorophore caging to generate photoswitchable probes with high photon yield, 
and also improves the resolution of STORM to sub-ten nanometer [116].  
1.5 Actin cytoskeleton in neurons 
Neurons are one of the most polarized cell types with their somatodendritic regions receiving 
synaptic inputs and axons propagating electrical signal output to target cells. The shape and mechanical 
properties of a neuron is critically dependent on cytoskeletal proteins; many neuronal functions are also 
supported by the cytoskeleton [117-120]. Specifically, cytoskeletal structures are essential for the 
establishment of neuronal polarity, the growth and stabilization of axons and dendrites, the trafficking of 
cargos to specific neurites, as well as the plasticity of synapses [121-126]. There are three types of 
cytoskeletal proteins in neurons: microtubules, neurofilament and actin. Each cytoskeletal protein can 
oligomerize and form a distinctive ultrastructure, and regulate many important cellular functions [127].  
Nkmg"kp"qvjgt"gwmct{qvke"egnnu."oketqvwdwngu"kp"c"pgwtqp"ctg"cuugodngf"htqo"jgvgtqfkogtu"qh"g"
cpf"ȕ"vwdwnkp"vq"hqto"c"jqnnqy"vwdwnct"uvtwevwtg"ykvj"cp"qwvgt"fkcogvgt"qh"47"po"[120]. Tubulin dimers 
exhibit two distinct states by binding with GTP or GDP, and the conversion between these two states is 
closely related to the assembly and disassembly of microtubules. Briefly, GTP-associated tubulins are 
incorporated into the fast-growing end of microtubule (plus end), while GDP-associated tubulins more 
easily dissociate from the microtubule, and they mark the minus end of microtubule [120]. In neurons, 
microtubule filaments have a more uniform orientation inside axons with the plus end extending away 
from the cell body, contrasting from the mixed orientations of microtubules in dendrites [119]. Tubulins 
inside axons also exhibit a higher rate of acetylation than that of dendrites, a post-translation modification 
that stabilizes microtubule filaments [119]. Microtubules are organized as bundled filaments inside 
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neurites and regulate many neuronal functions such as cargo transport and establishment of neuronal 
polarity [118].  
Five types of intermediate filaments (IF) exist in eukaryotic cells, including Type I, II, III, IV, 
and V IFs [120]. In neurons, the most abundant types are Type III and IV IFs, and they are generally 
named as neurofilament (NF) [127]. Like all the other IFs, NFs organize into a solid ropelike fiber, with a 
diameter of around 8-12 nm. They differ from other IFs by having an extended sidearm that projects out 
from the fiber surface. NFs are stable cytoskeletal structure and exhibit distinctive cellular distribution. 
They provide general mechanical support for the cell and help to maintain neuronal morphology [127]. 
Entangled NFs are often observed as a hallmark for many neurodegenerative diseases such as Alzheimer 
Disease (AD) and Amyotrophic Lateral Sclerosis (ALS) [127].   
Among the three type of cytoskeletal proteins, actin filament is the thinnest, with actin monomers 
oligomerizing into two strings of intertwined fibers of around 7 nm in diameter [120]. Monomeric actin is 
generally called globular actin (G-actin), whereas the polymerized form is called filamentous actin (F-
actin). Like microtubules, actin filaments also display an asymmetric orientation, with a plus end 
exhibiting fast polymerization and a minus end showing slow dynamics. Individual actin filaments often 
associate with each other to form actin bundles, such as stress fibers; or they crosslink with each other and 
form a dense meshwork beneath the cell membrane [120].  
A variety of proteins have been found to interact with actin, including actin polymerization 
factors, nucleation factors, motor proteins, actin capping protein, anchoring proteins, spectrin, etc [117]. 
Among these proteins, the distribution and general function of spectrin in neurons have been well 
characterized. Spectrin is an actin-interacting protein initially identified in red blood cells. There are two 
uwdwpkvu"hqt"urgevtkp."g"cpf"ȕ"urgevtkp0"Vyq"g"*gK"cpf"gKK+"cpf"hkxg"ȕ"uwdwpkvu"*ȕK–ȕX+"jcxg"dggp"enqpgf"
in mammals [128]0"g"cpf"ȕ"urgevtkp"cuuqekcvg"ncvgtcnn{"vq"hqto"cp"cpvkrctcnngn"jgvgtqfkogr, which are 
joined head to head to form a rod-shaped heterotetramer with a length around 200 nm [129]. In red blood 
cells, g"cpf"ȕ"urgevtkp"dkpf"ykvj"cevkp"cpf"cevkp-associated proteins to form a 2D pentagonal and 
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hexagonal structure beneath the plasma membrane (Figure 1.4) [130, 131]. This structure is further 
anchored to the plasma membrane by ankyrin through the ankyrin-binding domain of spectrin [128, 132]. 
Depleting spectrin or ankyrin leads to a significant change of membrane plasticity in red blood cells, 
indicating the actin-spectrin associated membrane skeleton is essential for providing mechanical support 
for a cell [129].  
Kp"pgwtqpu."vjg"oclqt"uwdwpkvu"qh"urgevtkp"ctg"gKK."ȕKK."ȕKKK"cpf"ȕKX"urgevtkp0"gKK"cpf"ȕKK"ctg"
expressed in many neuronal types [133, 134]."yjkng"ȕKKK"urgevtkp"ku"oqtg"gptkejgf"kp"Purkinje cells [135-
137]0"ȕKX"urgevtkp."qp"vjg"qvjgt"jcpf."ku"rtgfqokpcpvn{"hqwpf"kp axonal initial segment (AIS) regions 
[128, 138]. Together, spectrin, actin and associated molecules make up a membrane skeleton beneath the 
plasma membrane in neurons. 
 
Figure 1.4. Actin, spectrin-associated cytoskeletal structure in red blood cells. A) Electron 
microscopy of the membrane skeleton in erythrocytes. Spectrin tetrameters are cross-linked at nodes with 
actin and associated molecules to form a 2D pentagonal and hexagonal structure beneath the plasma 
membrane. B) Spectrin is attached to the plasma membrane through interaction with ankyrin and protein 
4.1. C) Short actin filament interacts with tryopomodulin at the minus end, and adducin at the plus end, 
whereas tropomyosin lies along the filament. Cevkp"cnuq"dkpfu"ykvj"vjg"P"vgtokpcn"fqockp"qh"ȕ-spectrin. 
(Figure from reference [128]).  
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Actin and actin-associated cytoskeletal proteins play crucial role in determining the shape of the 
cells, as well as in supporting many important cellular functions [117]. In neurons, actin filaments are 
particularly enriched in the growth cones, dendritic spines and presynaptic terminals [125]. Electron 
microscopy imaging has shown that actin forms a dense meshwork-like structure beneath the cell 
membrane [139]. During neuronal development, actin filaments exhibit high dynamics within the growth 
cone, spine or presynaptic terminal [125]. The retrograde flow of actin in the growth cone is essential for 
axonal growth and path finding, whereas the high actin dynamics at the tip of neurite is important for the 
establishment of neuronal polarity [122, 140, 141]. Increasing evidence also suggests important roles for 
spectrin in the maintenance of neuronal polarization, as well as the development and stabilization of 
axons [134, 142]0"gKK"cpf"ȕKK"urgevtkp"ctg"ockpn{"nqecvgf"kp"czqpu."cpf"ctg"dqvj"kpxqnxed in maintaining 
the compartmental domains of axons [133, 134]0"Okeg"ncemkpi"gkvjgt"gKK"qt"ȕKK"urgevtkp"ctg"godt{qpkecnn{"
lethal [134, 143, 144]."yjgtgcu"mpqemkpi"fqyp"gKK"qt"ȕKK"urgevtkp"ngcfu"vq"a loss of AIS without affecting 
axon specification [134]. In C elegans, spectrin participates in the mechanical sensing in sensory neurons 
[145], and provides the mechanical stability for the growing axons [142]. Axons more easily break in C 
elegans lacking spectrin [142], highlighting the crucial function of spectrin in providing mechanical 
support for neurons. Dysfunctions in actin and associated molecules have been implicated in various 
neurodegenerative diseases, such as AD, Parkinson's disease (PD), and ALS [146-148].  
Despite its importance, our understanding of actin structures in neurons---particularly in axonal 
shafts regions---is limited due to its high density in neuronal processes and the difficulty to resolve with 
conventional imaging methods. The challenge mainly lies in the fact that neurites are often sub-
micrometer in diameter but contain a high density of different types of cytoskeletal filaments, such as 
microtubules and neurofilaments [139]. Under electron microscopy, these cytoskeletal proteins entangle 
with each other, making the tracing of individual protein challenging [139]. Resolving the organization of 
actin and spectrin in the axons and dendrites requires imaging tools with both high spatial resolution and 
molecular specificity. 
18 
 
Given its impressive resolution and molecular specificity, super-resolution fluorescence 
microscopy is a powerful tool to study the ultrastructural organization of actin and associated molecules 
in axons. Using STORM, the Zhuang lab recently discovered a strikingly ordered submembrane skeleton 
in axons [149]. Three molecular components of this novel membrane skeleton, actin, spectrin and adducin 
were identified. STORM imaging of actin in cultured hippocampal neurons revealed ring-like structure of 
actin that were wrapped around axonal circumference and evenly spaced with 180-190 nm periodicity 
along the axonal shaft (Figure 1.5). This periodic structure spans the entire axon shaft starting from the 
axon initial segment. In stark contrast, dendrites appear to be dominated by long actin filaments that run 
along the dendritic shaft. Two-color STORM images of actin and the center region of spectrin tetramer 
showed highly regular, alternating patterns of actin and spectrin in axons, indicating adjacent actin rings 
are connected by spectrin tetramers (Figure 1.5). In addition, adducin also forms periodic ring-like 
structure that colocalizes with the actin rings. Given that adducin caps one end of actin filaments, this 
result suggests that the ring-like actin structures are made of capped, short actin filaments aligned along 
the circumferential direction of the axon, probably facilitated by actin-binding or actin-crosslinking 
proteins [149].  
The results described above suggest a crude structural model of the axonal submembrane 
cytoskeleton (Figure 1.5) [149]: short actin filaments, capped by adducin at one end, align into ring-like 
structures wrapping around the circumference of the axon; spectrin tetramers connect the adjacent 
actin/adducin rings along the axon, creating a quasi-one-dimensional periodic lattice structure. 
Interestingly, this periodic lattice places sodium channels into a periodic pattern along the axon initial 
segments, suggesting the ability of this submembrane cytoskeleton to organize molecular components of 
the axonal membrane, which is critical for action potential generation and propagation, as well as for 
other signaling processes in axons [149]. These observations suggest important functional roles of this 
novel cytoskeletal structure, but little is known about this new form of molecular assembly. 
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Figure 1.5. The actin, spectrin-based periodic membrane skeleton in axons. A) Two-color STORM 
kocig"qh"cevkp"*itggp+"cpf"ȕKK-spectrin C-terminus (magenta). B) Two-color STORM image of actin 
(green) and adducin (magenta). C) Two-eqnqt"UVQTO"kocig"qh"ȕKK-spectrin (green) and adducin 
(magenta). D) Two-color UVQTO"kocig"qh"uqfkwo"ejcppgnu"*itggp+"cpf"ȕKX-spectrin N-terminus 
(magenta). E) Spatial correlations between actin anf"ȕKK-spectrin C-terminus (A, black), between actin 
cpf"cffwekp"*D."dnwg+."dgvyggp"cffwekp"cpf"ȕKK-spectrin C-terminus (C, red), and between sodium 
ejcppgnu"cpf"ȕKX-spectrin N-terminus (D, green) to show the periodic distribution of these molecules 
with a periodicity of ~180–190 nm. F) A model for the periodic membrane skeleton. Actin filaments 
(green) form a ring-like structure around the circumference of the axon. Actin filaments are capped by 
adducin (blue), and adjacent actin rings are connected by spectrin tetramer (magenta) (Figure from 
reference [149]).  
1.6 Outline of chapters 
The dissertation reports the application of fluorescence imaging to study the role of host factors in 
influenza virus infection, and super-resolution imaging to the characterization of developmental 
mechanism of the periodic membrane skeleton.  
In Chapter 2, my colleagues and I examined the effect of CD81 depletion on the major steps of 
influenza infection. CD81 primarily affected virus infection at two stages: viral uncoating during entry 
and virus budding. Using single-virus tracking, CD81 was found to mark a specific endosomal population 
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and about half of the fused influenza virus particles underwent fusion within the CD81-positive 
endosomes. Depletion of CD81 resulted in a substantial defect in viral fusion and subsequent viral 
infection, without impacting virus binding, internalization or trafficking into early endosomes. During 
virus assembly, CD81 was recruited to virus budding site on the plasma membrane, and in particular, to 
specific sub-viral locations. In spherical and slightly elongated influenza virus, CD81 was localized at 
both the growing tip and the budding neck of the progeny viruses. CD81 depletion resulted in elongated 
budding virions that failed to detach from the plasma membrane and a marked decrease in progeny virus 
production. Taken together, these findings demonstrate an important dual function of CD81 in both entry 
and budding of influenza viruses.  
In Chapter 3, my colleagues and I conducted a comprehensive study to characterize the role of 
COPI complex in influenza virus infection. We found that prolonged exposure to COPI complex 
disruption through siRNA resulted in significant defects in virus internalization and trafficking to late 
endosomes. Acute inhibition of COPI complex with pharmacological compounds, however, failed to 
recapitulate the same entry defects as observed with the COPI-dgrngvgf"egnnu."dwv"fkf"tguwnv"kp"urgekÝe"
fgetgcugu"kp"xktcn"ogodtcpg"rtqvgkp"gzrtguukqp."cuugodn{"cpf"rtqigp{"xktkqp"rtqfwevkqp0"Qwt"Ýpfkpiu"
uwiiguv"vjcv"EQRK"eqorngzgu"nkmgn{"hwpevkqp"kpfktgevn{"kp"kpÞwgp|c"xktwu"gpvt{"dwv"rnc{"fktgev"tqngu"kp"
viral membrane protein expression and assembly.  
In Chapter 4, my colleagues and I focused on using super-resolution imaging to study the 
developmental mechanism of the periodic membrane skeleton. Specifically, we addressed the question of 
how the periodic membrane skeleton develops during neuronal polarization, and why it is primarily 
formed in axons instead of dendrites. We found that formation of the periodic membrane skeleton 
initiated early during neuronal development, and originated from regions closer to the cell body and 
propagated to the distal ends of axons. The lattice structure further matured by recruiting additional 
molecular components, and the matured membrane skeleton was highly stable. Multiple molecular factors 
played roles in regulating the formation of this structure. The lattice structure depended on intact 
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oketqvwdwngu0"Vjg"jkij"nqecn"eqpegpvtcvkqp"qh"ȕKK"urgevtkp"kp"czqpu"ycu"vjg"mg{"fgvgtokpkpi"hcevqt"hqt"vjg"
specific formation of the lattice structure in axons, and artificially increasing the cqpegpvtcvkqp"qh"ȕKK"
spectrin in dendrites was sufficient to induce the formation of the periodic lattice structure in dendrites. 
Tgoctmcdn{."cpm{tkp"D"ycu"korqtvcpv"hqt"vjg"rqnctk|gf"fkuvtkdwvkqp"qh"ȕKK"urgevtkp in neurites; in ankyrin 
D"mpqemqwv"okeg."ȕKK spectrin was evenly distributed in axons and dendrites, giving rise to a highly 
regular, periodic membrane skeleton in both dendrites and axons.  
As the initial discovery was made primarily in hippocampal neurons, in Chapter 5, my colleagues 
and I examined the prevalence of the periodic membrane skeleton in different neuronal types. We found 
that the periodic lattice structure is highly prevalent in different neuronal types from the central and 
periphery nervous system. The periodic skeleton predominantly existed in axons for all the neurons we 
imaged, while dendrites only contained isolated patches of the lattice structure. Moreover, we found that 
myelination does not impact the formation of this lattice structure in vitro.  
In Chapter 6, I summarize the findings presented in Chapter 2 to 5, and present a discussion on 
the future directions for these studies.  
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Chapter 2: Dual Function of CD81 in Influenza Virus Uncoating 
and Budding 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Work in this chapter was performed in collaboration with Dr. Eileen Sun, 
Miriam Bujny, and Doory Kim. Most of the results from this work are published in 
[150].  
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2.1 Introduction 
Influenza virus, the major causal agent of flu, is an enveloped, negative-sense RNA virus 
containing three viral membrane proteins: hemagglutinin (HA), neuraminidase (NA), and M2 proton 
channel. Encapsulated within the viral envelope is a layer of matrix protein (M1) and a segmented 
genome. The eight single-stranded RNAs package into viral ribonucleoprotein complexes (vRNPs), each 
attached to a RNA-dependent RNA polymerase complex with three subunits: PA, PB1, and PB2 [15].  
As an obligatory pathogen that encodes only 13 viral proteins, influenza virus must rely on host 
proteins and cellular machinery to complete its infection cycle. Influenza infection begins with virus 
binding to sialic acids on the plasma membrane [53]. Virus-receptor interaction subsequently triggers 
viral entry through multiple endocytic routes including clathrin-mediated endocytosis, a clathrin/caveolin-
independent pathway, and macropinocytosis [44, 54-57]. Upon internalization, virus particles are 
trafficked from early endosomes to maturing endosomes, where fusion between the virus and endosomal 
membranes results in release of vRNPs into the cytoplasm followed by nuclear import of the vRNPs [15, 
28, 58, 59]. As replication proceeds, viral mRNAs are exported out of the nucleus for protein translation, 
and viral components are trafficked to the plasma membrane, the site of virus assembly and progeny 
virion egress [60].  
Recently, several genome-wide siRNA screens identified host factors exploited by influenza virus 
[63-67]. CD81 emerged as a top candidate in two screens and was found to regulate early viral entry steps 
[66, 67]. CD81 belongs to the family of tetraspanins and is expressed on both plasma and endosomal 
membranes [70, 73, 74]. It associates with other tetraspanins and tetraspanin-interacting proteins to form 
tetraspanin-enriched microdomains [70-72]. Together, these proteins regulate many cellular processes 
such as cell adhesion, cell signaling, cell migration, and protein trafficking [70, 74-77]. Tetraspanins are 
known to play an important role in different steps of viral infection [78]. For example, CD81 functions as 
a co-receptor for hepatitis C virus (HCV) [79-82]. CD81 interacts with HCV glycoprotein E2 to prime the 
virus for low-pH dependent fusion during entry [79, 83, 84]. In addition to mediating viral entry, CD81 is 
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also potentially involved in viral assembly. CD81 is one of the cell-derived components incorporated into 
purified influenza virus particles [69]. It is however unknown how CD81 facilitates influenza viral entry, 
or whether CD81 plays a functional role in influenza virus assembly.   
We conducted a comprehensive study from viral entry to egress to examine the effect of CD81 
depletion on influenza infection. Upon dissecting each of the major steps in influenza infection pathway, 
we found that CD81 was required for productive viral infection and that CD81 primarily functions at two 
stages: viral fusion within endosomes and virus budding. About half of the influenza virus particles that 
fused in cells underwent fusion within CD81+ endosomes, and CD81 depletion led to a decrease in virus 
fusion and infection. CD81 was highly enriched in the virus budding zones and recruited to specific sub-
viral locations. During virus assembly, CD81 initially formed small clusters at the growing tip of 
assembling virus, and then localized at both the growing tip and budding neck of spherical or slightly 
elongated virions. CD81 depletion led to an increase in the propensity of budding virions to remain 
attached to the plasma membrane and a reduction in progeny virus production. These findings 
demonstrate a dual function of CD81 in both entry and budding of influenza viruses. 
2.2 Results 
2.2.1 CD81 is involved in both early and late stages of influenza virus infection 
To elucidate the role of CD81 in influenza virus infection, we used CD81 knockdown by siRNA 
to probe the effect on three different influenza A virus strains: influenza A/WSN/33 (H1N1), a lab-
adapted strain that mainly produces spherical virus particles; influenza A X-31, A/Aichi/68 (H3N2) which 
has a slightly elongated shape [151]; and influenza A/Udorn/72 (H3N2), which can produce long 
filamentous virus [152-155]. We screened six CD81 siRNA constructs, including several previously 
reported ones [66, 67], and found that CD81 siRNA 1 gave the highest knockdown efficiency (Figure 
2.1A, B and Figure 2.2A, B). After 48 hours, siRNA 1 yielded 80-85% CD81 knockdown (Figure 2.1C). 
Treatment with siRNA 1 specifically depleted CD81, whereas the expression levels of several known 
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not affected (Figure 2.1D). In subsequent experiments, we used siRNA 1 to deplete CD81 in A549 lung 
carcinoma cells. 
 
Figure 2.1. CD81 depletion efficiency with different siRNA constructs. A) Six different siRNA 
constructs were tested for CD81-knockdown efficiency after 48 hours of electroporation. CD81 
expression was measured by flow cytometry following staining with anti-CD81 primary antibody and 
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Figure 2.1. (continued) fluorescently labeled secondary antibody. At least 10,000 cells were measured 
for each condition. The orange, blue and magenta curves correspond to the intensity profiles measured for 
cells without addition of the primary antibody, control (non-targeting) siRNA treated cells immunostained 
for CD81, and CD81 siRNA treated cells immunostained for CD81, respectively. B) Quantitative 
summary of the measurements from (A). CD81 siRNA 1 was selected for subsequent studies. C) A549 
cells were treated with control or CD81 siRNA 1 for 48 hours. Cells were either permeabilized with 
detergent or not permeabilized to detect the total amount of CD81 in cells or the amount of CD81 on the 
cell surface, respectively. The intracellular CD81 level was then calculated by subtracting the amount of 
CD81 on the cell surface from the total amount of CD81. Based on the quantification, the cell-surface and 
intracellular CD81 fractions were ~92% and 8% in control cells, respectively. The partition is similar in 
CD81-knockdown cells (87% versus 13% for cell-surface and intracellular CD81, respectively). A two-
tailed t-test was performed in each case and the p values were provided. D) CD81 knockdown does not 
affect the expression of CD81-associating proteins. A549 cells were treated with control or CD81 siRNA 
for 48 hours. Cells were harvested for western blotting with indicated antibodies. Actin and tubulin were 
used as loading controls. 
To assay the effect of CD81 depletion on the production of infectious viral progeny, siRNA-
treated A549 cells were infected with WSN, X-31 or Udorn virus at a MOI of <0.1 for 36 hours. The 
virus titer of the supernatant was determined using plaque assays. Compared to the non-targeting control 
siRNA treated cells, the CD81-knockdown cells exhibited a substantial decrease in virus titer: ~90% 
decrease for WSN, ~75% decrease for X-31, and ~70% decrease for Udorn (Figure 2.2C). These results 
are consistent with the previously published data [66, 67], and indicate that multiple different influenza 
strains require CD81 for infection.  
Next, we proceeded to determine which stage(s) of the multi-step influenza-infection process is 
CD81-dependent. To test whether CD81 affects early infection, we infected siRNA-treated A549 cells 
and measured the expression of NP, the first viral protein expressed in influenza-infected cells [66, 67, 
156]. We assayed the fraction of cells that express NP (NP+) as well as the level of NP expression in each 
NP+ cell using flow cytometry. For all three viral strains, CD81-knockdown cells had ~50% fewer NP+ 
cells, as compared to non-targeting siRNA treated control cells (Figure 2.2D). Among the NP+ cells, the 
NP expression level was similar between control and CD81-knockdown cells (data not shown). These 
results suggest that CD81 is involved in early infection either at the step of or prior to viral protein 
expression. 
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Figure 2.2. CD81 is involved in both early and late stages of influenza virus infection. A) A549 cells 
were treated with non-targeting control siRNA, or CD81 siRNA1 for 48 hours and immunostained with 
anti-CD81 antibody. Images are maximum projections of confocal z-stacks. B) A549 cells were treated 
with control or CD81 siRNA for 48 hours. Cells were harvested for western blotting with indicated 
antibodies. Tubulin was used as a loading control. C) Influenza virus infection is impaired by CD81 
depletion. A549 cells were treated with siRNAs or mock treated for 48 hours and subsequently infected 
with X-31, WSN, or Udorn at a MOI of <0.1 for 36 hours. The viral titer in the supernatant was 
determined by plaque assays. The shaded bar indicates the infectivity measured in cells mock treated with 
a transfection solution that contains no siRNA; the hollow bars indicated the infectivity measured in cells 
treated with control, non-targeting siRNA; the black solid bars indicate the infectivity measured in cells 
treated with CD81 siRNA. D) The number of infected cells expressing viral NP is reduced by about 50% 
upon CD81- knockdown. siRNA-treated A549 cells were infected with WSN, X-31, or Udorn viruses 
with a MOI of <0.1 for 8 hours without acid bypass and the fraction of cells expressing NP was measured 
through flow cytometry. E) Viral NP expression is unaffected upon CD81 knockdown when influenza 
infection is induced by the acid-bypass treatment to eliminate the entry defect. siRNA-treated A549 cells 
were allowed to bind with WSN or X-31 virus on ice for 1 hour, treated with warm low pH PBS buffer 
(pH 4.5) for 2 minutes. After 8 hours, cells were collected and stained against NP for flow cytometry 
analysis. F) Virus titer in the supernatant is reduced by ~50% or more in CD81-knockdown cells infected 
by influenza viruses through the acid-bypass treatment. Briefly virus was allowed to bind with control or 
CD81-knockdown cells on ice for 1 hour. Unbound virus particles were washed out and low pH buffer 
was added in for 2 minutes to trigger virus fusion at the plasma membrane. At 17 hours post infection, 
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Figure 2.2. (continued) supernatant was collected and the viral titer was assayed by plaque assay. For 
figure 2.2C-F, the error bars are standard deviation derived from three independent experiments. A two-
tailed student t-test was performed for all of the numerical data, and the p value of the data is shown. A p 
value smaller than 0.05 indicates there is a statistically significant difference.  
In order to test whether CD81 directly affects viral protein expression, we next induced viral 
fusion (uncoating) at the plasma membrane through an acid-bypass treatment: treatment with a buffer of 
pH below 5, the pH value required for HA-induced membrane fusion. We then probed the expression of 
NP in these samples. The fraction of NP+ cells and the level of NP expression were similar between 
control and CD81-knockdown cells infected by the virus using the acid-bypass treatment (Figure 2.2E 
and data not shown). These results suggest that CD81 is not directly involved in the viral protein 
expression, and the inhibition of virus infection by CD81 knockdown was most likely due to inhibition of 
viral uncoating in endosomes or any step prior to uncoating. It is worth noting that this acid-bypass assay 
overcame the entry defect for the WSN and X-31 strain, but a similar acid bypass treatment did not work 
for the Udorn strain, likely because low pH causes fragmentation of filamentous influenza viruses [57]. 
To probe whether CD81 plays additional roles beyond viral uncoating, we induced influenza viral 
fusion at the plasma membrane using the acid-bypass treatment to overcome the entry defect, and 
determined the virus titer of the supernatant 17 hours post-infection. Notably, as compared to control 
siRNA treated cells, the virus titer was decreased by more than 50% in the CD81-knockdown cells 
(Figure 2.2F). This defect did not result from a decrease in viral gene expression, as the percent of viral 
protein expressing cells and the expression level at 17 hours post-infection were unaffected upon CD81 
knockdown (Figure 2.2E and data shown later). These results suggest that CD81 affects another step post 
viral gene expression. 
Taken together, the above results indicate that CD81 is important for two distinct stages of the 
influenza infection cycle: one during the early infection at or prior to viral uncoating and one during late 
infection after viral gene expression. In the following experiments, we aimed to identify the specific roles 
of CD81 in influenza virus infection. 
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2.2.2 CD81 is not involved in virus binding, internalization or trafficking to early endosomes. 
To identify the CD81-dependent entry step(s), we conducted a series of experiments to examine 
the effect of CD81 on virus binding, internalization, transport into early endosomes, and fusion. siRNA-
treated A549 cells were first incubated with fluorescently labeled X-31 virus for 30 minutes at 4 °C, a 
temperature that inhibits endocytosis. The amount of surface-bound virus was analyzed through flow 
cytometry. CD81-knockdown cells exhibited no defect in binding with influenza viruses when compared 
to control cells treated by non-targeting siRNA (Figure 2.3A). Next, influenza virus infection was allowed 
to proceed for 30 minutes at 37 °C, and the number of internalized virus particles was quantified. As 
shown in Figure 2.3B, the number of internalized viruses per cell was similar between control and CD81-
knockdown cells. Moreover, virus particles in both control and CD81-knockdown cells were delivered 
into early endosomes after internalization at 37 °C. At 20 minutes post infection, the mean fraction of 
virus particles colocalized with early endosomes (marked by EEA1) was ~50% and ~53% for control and 
CD81-knockdown cells, respectively (Figure 2.3C). These results suggest that CD81 does not affect 
trafficking of influenza virus to early endosomes.  
Additionally, we tested the effect of CD81 depletion on two other viruses: respiratory syncytial 
virus (RSV) and GFP-encoding pseudotyped murine leukaemia virus (MLV), which are known to 
undergo virus fusion in early endosomes in a pH-independent manner [157, 158]. Pseudotyped MLV 
infected cells express GFP, but cannot produce complete virions, allowing the quantification of MLV 
entry through measuring the GFP expression. For RSV, we measured the expression level of the fusion 
protein (F protein) after 24 hours of infection. As shown in Figure 2.3D, the fraction of infected cells was 
similar between control and CD81-knockdown cells with MLV and RSV infection. This data further 
corroborates the notion that CD81 does not affect virus trafficking into early endosomes.  
Taken together, the results presented above indicate that CD81 is not involved in influenza virus 
binding, internalization, or trafficking into early endosomes.  
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Figure 2.3.  CD81 is not required for virus binding, internalization or delivery into early endosomes 
A) CD81-knockdown does not affect virus binding, as measured by flow cytometry. The magenta, blue 
and orange curves correspond to the intensity profiles measured for cells without adding viruses, control 
cells after influenza virus binding, and CD81-knockdown cells after influenza virus binding, respectively. 
B) The number of virus particles internalized is not affected by CD81 knockdown. The number of 
internalized virus particles was shown in a dot plot, with the middle line representing the mean value, and 
top/bottom line representing standard deviation.  At least 40 randomly chosen cells were analyzed for 
each condition. C) The percent of virus particles colocalizing with early endosome is not affected by 
CD81 knockdown. Early endosomes were immunostained with anti-EEA1 antibody. Data was plotted 
similarly as in (B). At least 40 randomly chosen cells were analyzed for each condition. D) CD81 
depletion does not affect RSV or pseudo-typed MLV infection. siRNA-treated A549 cells were infected 
with different doses of RSV and pseudo-typed MLV virus for 24 hours. For RSV virus infection, RSV 
fusion protein expression was quantified by flow cytometry, while for pseudo-typed MLV virus, the GFP 
signal was analyzed. A two-tailed student t-test was performed for all of the numerical data, and the p 
value of the data is shown. 
2.2.3 Influenza virus particles are delivered to and fuse in CD81+ endosomes 
Next, we probed the role of CD81 in virus fusion. Influenza virus is trafficked from early 
endosomes to maturing endosomes, in which the low pH environment triggers conformational changes in 
HA that mediate viral fusion with the endosomal membrane [50, 53, 59]. In addition to being distributed 
on the plasma membrane, CD81 also showed substantial colocalization with early and maturing 
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endosomes, which are Rab5 positive (Rab5+) (Figure 2.4A) [50]. About 30-35% Rab5+ endosomes 
contained CD81 (Figure 2.4A), suggesting that CD81 is enriched in a sub-population of these endosomes. 
To probe whether influenza virus particles are delivered into CD81+ endosomes, we allowed Alexa Fluor 
647-labeled X-31 to internalize for 15 minutes and immunostained the cells for CD81. As shown in 
Figure 2.4B, a substantial fraction (~54%) of virus colocalized with CD81+ endosomes.  
 
Figure 2.4. A major fraction of viruses are trafficked to and fuse in CD81-positive endosomes. A) 
CD81 substantially colocalizes with Rab5. A549 cells were electroporated with CD81-mEmerald and 
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Figure 2.4. (continued) RFP-Rab5. At 24 hours, the cells were fixed and imaged. An enlarged image of 
the boxed region is shown on the right. Scale bar: 10 µm. B) Influenza virus particles traffick into CD81+ 
endosomes. A549 cells were cold bound with Alexa Fluor 647-labeled X-31 virus (red) on ice for 30 
minutes and then chased for 15 minutes at 37 °C. The samples were fixed and immunostained against 
CD81 (green). An enlarged image of the boxed region is shown on the right.  All of the images are 
confocal XY cross sections. Scale bar: 10 µm. C) An influenza virus particle enters and fuses within a 
CD81-positive endosome after entry. Live-cell confocal imaging of DiD-labeled X-31 added in situ to 
CD81-mEmearld expressing A549 cells maintained at 37 °C. The images were collected with a 0.5 s 
interval. C-1) Several snapshots taken at different time points with the virus indicated by the white circles. 
C-2) The fluorescence signal of the indicated DiD-labeled virus as a function of time. Note that there is a 
sudden increase of DiD signal at 515 s, which indicates a viral fusion event. D) Influenza virus can also 
fuse in a CD81-negative endosome. D-1) Several snapshots taken at different time points with the virus 
indicated by the white circles. D-2) The fluorescence signal of the indicated DiD labeled virus as a 
function of time. The virus particle fused at 422 s. E) Among 61 virus particles tracked from binding to 
fusion, 52 ± 8% enter and fuse within CD81+ endosomes whereas the remaining 48 ± 8% fuse in CD81- 
endosomes. The results are taken for four independent experiments, and the ±error indicates the standard 
deviation derived from these experiments. F) Virus fusion is impaired upon CD81 depletion. DiD-labeled 
X-31 was allowed to bind with A549 cells on ice for 30 minutes, and then chased for the indicated times 
at 37 °C. Cells were trypsinized and fixed immediately, and analyzed by flow cytometry. The increase in 
the DiD intensity versus the initial DiD intensity is plotted. The error bars are standard deviation derived 
from duplicate experiments.  
We then tracked individual influenza virus particles in living cells, a technique that has been 
previously established [28, 50, 56, 61, 159], to examine whether influenza viruses fuse in CD81+ 
endosomes. To this end, we expressed CD81-mEmerald in A549 cells. Similar to endogenous CD81, 
CD81-mEmerald was localized on both plasma and endosomal membranes and the expression of CD81-
mEmerald did not affect the fraction of endosomes that are CD81+ (data not shown). Moreover, the 
expression of CD81 also did not affect influenza viral fusion or infectivity (data not shown).  
To facilitate tracking of individual virus particles, X-31 viruses were labeled with a saturating 
amount of DiD, a lipophilic dye, such that the fluorescence emission from the DiD molecules was low 
due to a self-quenching effect between neighboring dyes. Fusion between the virus envelope and 
endosomal membrane should lead to an increase in fluorescent intensity (dequenching), due to the 
diffusion of dyes from the virus into the lipid bilayer of the endosomes [159]. We added labeled viruses to 
the CD81-mEmerald expressing cells in situ at 37 °C. The virus particles typically show restricted 
movement immediately after binding to the cell, followed by rapid and directed movement once the virus 
particles are internalized, similar to our previous observations [50, 56, 159]. We observed a proportion of 
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virus particles entering into CD81+ endosomes soon after internalization, as illustrated by the example 
shown in Figure 2.4C. These viruses remained colocalized with CD81 and eventually fused with the 
CD81+ endosomes, as reflected by the sudden increase of DiD fluorescence, presumably after the 
endosomes matured to acquire a sufficiently low pH (Figure 2.4C). Among the 61 virus particles that we 
tracked from binding to fusion, about 52 ± 8% underwent viral fusion within CD81+ endosomes (Figure 
2.4E). The remaining 48 ± 8% of virus particles fused in endosomes lacking CD81 (Figures 2.4D and 
2.4E). To confirm that the fusion events indeed occurred in endosomes, we tracked individual DiD-
labeled influenza virus particles in cells expressing RFP-Rab5. Similar to previous observations [50], 
nearly 90% of the viral fusion events occurred in Rab5+ endosomes (data not shown). 
To investigate whether CD81 affects viral fusion, we next monitored the DiD fluorescent 
intensity in control and CD81-knockdown cells that were infected with DiD-labeled X-31 virus. In these 
experiments, cells were first incubated with DiD-labeled virus at 4 °C and then the temperature was 
increased to 37 °C to initiate viral entry. At specific time points after the temperature shift, infected cells 
were collected and the DiD fluorescence from these cells was quantified with flow cytometry. As 
expected, there was a consistent increase of DiD fluorescence with time due to viral fusion (Figure 2.4F). 
Notably, compared to control cells, CD81-knockdown cells exhibited a significant reduction in viral 
fusion (Figure 2.4F), suggesting that CD81 facilitates viral fusion. Most of the remaining viral fusion 
events in CD81-knockdown cells still occurred in Rab5+ endosomes (data not shown). The reduction in 
viral fusion was, however, incomplete (Figure 2.4F), consistent with the observation that only about half 
of the virus particles fuse in CD81+ endosomes (Figure 2.4E), though the incomplete inhibition of viral 
fusion could also be in part due to the incomplete knockdown of CD81 (Figure 2.1).  
These data indicate that CD81 marks a specific population of Rab5+ endosomes that are 
responsible for half of viral fusion events. Because CD81-knockdown cells reduced viral infection (Figure 
2.2C) and exhibited a higher reduction in virus titer when infected without acid bypass than when infected 
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with acid bypass (Figures 2.2C and 2.2F), viral fusion within CD81+ endosomes likely leads to 
productive influenza infection.  
Taken together, our results indicate that half of virus particles are trafficked to and undergo viral 
fusion in CD81+ endosomes. CD81 could facilitate viral fusion by organizing endosomal membrane to 
assist viral fusion or helping virus traffick to fusion-competent endosomal compartments. 
2.2.4 CD81 is not involved in the expression or trafficking of viral proteins 
In the subsequent experiments, we aimed to determine which post-entry step(s) of the viral 
infection process are CD81 dependent. To this end, we examined the effect of CD81 on viral protein 
expression, viral protein trafficking, and the assembly and egress of progeny viruses. Our initial results in 
Figure 2.2E suggested that CD81 knockdown did not directly affect viral NP expression. This was further 
substantiated by infecting cells with various viral doses across different time points using the acid-bypass 
treatment. As shown in Figure 2.5A, the fraction of NP+ cells and NP expression level increased with the 
viral dose and infection time, while there was no significant difference between control and CD81-
knockdown cells. To further validate the finding, we measured the expression of another cytosolic viral 
protein, M1. Similar to the results on NP, CD81-knockdown cells infected by influenza viruses using the 
acid-bypass treatment did not exhibit a difference in the fraction of M1+ cells or the level of M1 protein 
expression, when compared to the control cells (Figure 2.5B). These data suggest that CD81 does not play 
a role in viral gene expression for cytosolic viral proteins.  
To determine whether CD81 affects viral membrane protein expression, we probed M2 
expression with acid bypass treatment. The fraction of M2+ cells and the M2 expression level in M2+ 
cells were similar between control and CD81-knockdown cells (Figure 2.5C). Furthermore, by only 
probing the surface M2 protein without permeabilizing the cells, we found that there was no difference in 
surface M2 protein expression level either (Figure 2.5D), indicating that CD81 knockdown also did not 
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affect the trafficking of M2 to the cell surface. Similarly, the expression and trafficking of another viral 
membrane protein, NA, were also not affected upon CD81 depletion (Figure 2.5E).  
 
Figure 2.5. CD81 depletion does not affect viral protein expression and transport. A)  CD81 
knockdown does not affect the expression of viral NP protein in cells infected by influenza viruses with 
the acid-bypass treatment. Experiments were performed similarly as in 1E) except that the expression 
levels are evaluated at different time point post infection and with different dose of viruses. The percent 
of NP-expression cells and the NP expression level in NP+ cells are plotted. B) CD81 knockdown does 
not affect the expression of viral M1 protein in cells infected by influenza viruses with the acid-bypass 
treatment. Experiments were performed similarly as in (A) except cells were immunostained for M1. The 
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Figure 2.5. (continued) percent of M1+ cells and the M1 expression level in the M1+ cells are plotted. C) 
CD81 knockdown does not affect the expression of viral M2 protein in cells infected by influenza viruses 
with the acid-bypass treatment. Experiments were performed similarly as in (A) except cells were 
immunostained for M2. The percent of M2+ cells and the M2 expression level in the M2+ cells are 
plotted. D) CD81 knockdown does not affect the amount of M2 protein trafficked to the cell surface in 
cells infected by influenza viruses with the acid-bypass treatment. Experiments were performed similarly 
as in (C) except cells were stained for M2 without permeabilization. The percent of M2+ cells and the 
surface M2 expression level in M2+ cells are plotted. E) CD81 knockdown does not affect the amount of 
NA protein trafficked to the cell surface in cells infected by influenza viruses with the acid-bypass 
treatment. The NA expression level was estimated from confocal images in control or CD81 siRNA 
treated cells infected by X-31virus. A two-tailed student t-test was performed for all of the numerical data, 
and the p value of the data is shown. 
Taken together, these data indicate that CD81 does not play a direct role in the expression of 
influenza viral proteins or the trafficking of influenza membrane proteins to the plasma membrane. 
2.2.5 CD81 is recruited to influenza virus budding sites on the plasma membrane 
Next, we probed the role of CD81 in virus assembly. To test whether CD81 is present at the viral 
assembly sites, A549 cells were infected with the three influenza strains and immunostained for CD81 
and the viral protein. Notably, with X-31 infection, CD81 was mostly localized to a site concentrated with 
multiple viral proteins (Figures 2.6A and data not shown). In contrast to uninfected cells, which showed a 
uniform distribution of CD81 on the plasma membrane, X-31-infected cells exhibited marked 
redistribution of CD81 into concentrated patches. All of the X-31 proteins that we could obtain specific 
immunofluorescence staining for, including PB1, NA and M2, were present in these patches. The CD81 
patches were formed on the plasma membrane, as confirmed by immunofluorescence of non-
permeabilized cells (data not shown). We note that there was only a modest decrease of CD81 expression 
upon viral infection (data not shown).  For Udorn-infected cells, CD81 was enriched along the budding 
virus filaments marked by PB1 (Figure 2.6B). PB1 is a good filament marker that colocalized with Udorn 
HA and M2 in the budding filamentous virions (data not shown). We have also directly observed 
colocalization between CD81 and other Udorn proteins including HA, NA and an anti-Udorn serum (data 
not shown). Remarkably, upon siRNA treatment, which depleted 80~85% of the endogenous CD81, the 
remaining CD81 was all concentrated in the budding viral filaments, whereas the cell body had little 
CD81 signal (Figures 2.6C). The average amount of CD81 per virus filament in the CD81-knockdown 
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cells was reduced by more than 60% compared to that in control cells. Although our lack of WSN 
antibodies made it difficult to perform similar immunofluorescence experiments on WSN-infected cells, 
our EM images with CD81 labeled by immunogold showed that CD81 was also recruited to the WSN 
virus budding zones (data shown later in Figure 2.8A). Taken together, these results indicate that CD81 is 
specifically recruited to the influenza virus assembly and budding sites.  
 
Figure 2.6. CD81 is recruited to the virus budding sites. A) CD81 is recruited to the virus budding 
zone in X-31 infected cells. A549 cells were infected with X-31 for 16 hours. Cells were stained with 
anti-CD81 antibody (green) and anti-PB1 antibody (red). Images are confocal XY cross-sections. Scale 
bar: 10 µm. B) CD81 is incorporated into budding filamentous virions of Udorn-infected cells. A549 cells 
were infected with Udorn virus for 16 hours, and stained with anti-CD81 antibody and anti-PB1 antibody. 
Scale bar: 10 µm. C) Remaining CD81 in CD81-knockdown cells is incorporated into budding 
filamentous viruses of Udorn infected cells. Similar to (B) except that CD81-knockdown cells were used. 
The CD81 expression level in Udorn-infected cells was calculated based on confocal images of more than 
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Figure 2.6. (continued) 100 cells, and was found to be decreased by ~88% upon CD81 depletion as 
compared to control cells. The amount of CD81 per viral filament was reduced by 63% compared to that 
in untreated cells. Scale bar: 10 µm.  
To probe which viral component may be responsible for recruiting CD81, we turned to a plasmid-
based system that expresses only specific viral envelope proteins in cells [160]. We transiently transfected 
the plasmid containing HA or NA in A549 cells and immunostained the cells with CD81 and HA or NA. 
Interestingly, HA tends to form clusters on the cell surface even when expressed alone in A549 cells and 
CD81 accumulated substantially in the HA clusters (data not shown). About 46% of HA clusters 
colocalized with CD81. In contrast, NA when expressed alone did not form clusters but was distributed 
largely uniformly across the plasma membrane and there was no appreciable correlation between the 
CD81 distribution and NA distribution (data not shown). Mock transfection with plasmid that did not 
contain HA or NA did not yield any appreciable HA or NA staining (data not shown). These results 
suggest that HA is likely responsible for recruiting CD81 to the viral budding sites. 
2.2.6 CD81 is incorporated at specific sub-viral locations and facilitates influenza virus budding 
Although we observed a ~50% or more decrease in virus titer in CD81-knockdown cells after 
acid-bypass treatment to overcome the CD81-dependent entry defects (Figure 2.2F), it remained unknown 
whether the defect in viral titer stems from a decrease in the number of budding virions assembled on the 
cell, the number of progeny virus particles released from the cell, or the specific infectivity per released 
virus particle. To distinguish between these possibilities, we first infected cells using the acid-bypass 
treatment and then quantified the number of budding virions attached to the cells using transmission 
electron microscopy. After quantifying more than 250 cell cross-sections per condition, we performed 
statistical analysis and found no statistically significant difference in the number of assembling virus 
particles per cell cross-section in the control versus CD81-knockdown cells (Figure 2.7A).  
Next, we infected cells with WSN using the acid-bypass treatment, collected the virus particles in 
the supernatant, and then quantified the amount of viral matrix protein M1 using an ELISA assay and the 
number of released virus particles positive of both M1 and HA using an imaging assay (Figure 2.7B). 
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Notably, compared to control cells treated by non-targeting siRNA, CD81-knockdown cells exhibited 50% 
or more decrease in both the amount of viral M1 and the number of M1+ and HA+ virus particles released 
into the supernatant. These results suggest that the CD81-knockdown-induced reduction in viral titer in 
cells infected by the acid-bypass treatment stems from a defect in virus release. Given that the reduction 
in viral titer (Figure 2.2F) was similar to the reduction in the amount of released viral proteins or viral 
particles (Figure 2.7B), we did not further probe the change in specific infectivity per virus particle. 
 
Figure 2.7. CD81 is enriched at specific sub-viral sites of budding virions and CD81 knockdown 
impairs virus scission. A) CD81 knockdown does not change the number of budding virions attached to 
infected cells. siRNA-treated cells were infected with WSN virus with the acid-bypass treatment for 15 
hours. Cells were directly fixed for transmission electron microscopy and the number of budding virus 
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Figure 2.7. (continued) particles per cell cross-section is quantified for over 250 sections, and presented 
in the dot plot. A two-tailed student t-test was performed and the p value is provided. B) CD81 
knockdown causes a substantial reduction in the number of released virus particles. siRNA-treated cells 
were infected with WSN virus with the acid-bypass treatment for 17 hours. The amount of viral M1 
protein in the supernatant was probed with ELISA. The number of M1 positive and HA positive virus 
particles in the supernatant was counted using immunofluorescence imaging. The error bar is standard 
deviation from three independent measurements. C) CD81 localizes at the tip of growing X-31 viruses 
during the early budding stages. Cells were infected with X-31 for 12 hours and CD81 was immunogold 
labeled for electron microscopy. An enlarged image of the area in the white box is shown in the upper 
right corner. Scale bar: 100 nm. D) CD81 mainly localizes at the tip and budding neck of the X-31 viruses 
during late budding stages. Similar to (C) except the infection time was 16 hours. Scale bar: 200 nm. E) 
Distribution of gold particles in budding X-31 viruses at 16 hour post infection. To align the virus 
particles, the length of each virus is normalized to 1, with its middle point assigned with coordinate value 
of 0. For individual gold particles on the budding virus, their coordinate values were calculated based on 
their relative distance to the middle point. Coordinates with negative values correspond to positions close 
to the plasma membrane. A total of 105 budding viruses were analyzed. F) Budding WSN viruses exhibit 
a spherical morphology with fully enclosed membrane envelope in control siRNA-treated cells. A549 
cells were infected with virus with the acid-bypass treatment for 13 hours. The region in the white box is 
magnified and shown in the upper right corner. Scale bar: 200 nm. G) Budding WSN viruses are more 
elongated in CD81 siRNA treated A549 cells. A substantial fraction of budding viruses have an open 
membrane neck connected to the plasma membrane (indicated by arrowheads).  The region in the white 
box is magnified and shown in the upper right corner. Scale bar: 200 nm. H) Budding WSN viruses are 
elongated upon CD81 depletion, as shown by the distribution of budding virus length in control or CD81-
knockdown cells.   
To examine how CD81 may facilitate release of progeny virus particles, we next probed the 
distribution of CD81 within individual budding virions using immunogold electron microscopy. In X-31-
infected cells, CD81 was readily observed in budding virions (Figure 2.7C and 2.7D). During early 
assembly stages, CD81 clusters located at the growing tip of budding virions (Figure 2.7C). Interestingly, 
when viruses grew into a mature, slightly elongated shape [151], CD81 was not only found on the 
growing tip, but also on the neck of budding virions (Figure 2.7D). The elongated morphology of X-31 
allowed us to quantitatively analyze the CD81 distribution in virions by aligning the long axis of the virus 
particles and normalizing the position of immunogold-labeled CD81 to the total length of the virus. 
Remarkably, CD81 is highly enriched at the two ends of the budding virions (Figure 2.7D and 2.7E).  
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Figure 2.8. CD81 is enriched in the budding WSN virions and CD81-knockdown impairs scission of 
the X-31 virus. A) CD81 is incorporated in budding WSN viruses. Cells were infected with WSN for 15 
hours, and CD81 was immunogold labeled for electron microscopy. An enlarged image of the area in the 
white box is shown on the upper right. Scale bar: 100 nm. B) EM image of budding X-31 virus in control 
cells. A549 cells were infected with X-31 virus with the acid-bypass treatment for 16 hours. Scale bar: 
200 nm. C) Budding X-31 viruses in CD81-knockdown cells. A549 cells were infected with X-31 virus 
with the acid-bypass treatment for 16 hours. Note that a substantial fraction of budding viruses have their 
open membrane neck connected to the plasma membrane (arrowheads). Scale bar: 200 nm. 
Similarly, we also found CD81 to be enriched in budding WSN virus particles, but the quantity of 
immunogold detected per WSN virus is substantially lower than that in X-31 viruses, which made it 
difficult to determine the CD81 distribution in these viruses (Figure 2.8A). However, the nearly perfectly 
spherical shape of the WSN virus allowed us to detect an interesting morphological defect of budding 
viruses in CD81-knockdown cells. When we examined budding virions in cells infected by WSN, we 
found that most budding WSN viruses were spherical and completely enclosed by viral envelope in 
control cells treated by non-targeting siRNA (Figure 2.7F). In stark contrast, budding WSN virus in 
CD81-knockdown cells appeared much more elongated (Figure 2.7G). The average length of budding 
virions in control and CD81-knockdown cells was ~100 nm and ~150 nm, respectively (Figure 2.7H). 
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Furthermore, many budding viruses in CD81-knockdown cells did not have a fully enclosed envelope but 
remain attached to the plasma membrane through an open membrane neck (indicated by arrowheads in 
Figure 2.7G). We performed similar experiments with the X-31 strain. Again, we consistently observed 
many budding X-31 virions with the open budding neck defect upon CD81 depletion (Figure 2.8B and 
2.8C), though characterizing whether the budding virions were further elongated was difficult due to the 
large variation of the virion length of the pleomorphic X-31. 
Taken together, the specific enrichment of CD81 at the neck of the budding virions, the defect in 
budding neck closure in CD81-knockdown cells, and the reduction in the number of released virus 
particles but not in the number of assembling virions upon CD81 knockdown suggests that CD81 plays a 
role in a late stage of the virus budding process, likely at the final scission step. CD81 may facilitate viral 
scission by directly participating in the scission process, by recruiting host or viral scission proteins, or by 
organizing the lipid domains and making it conducive to viral scission.  
2.2.7 Distribution of CD81 in budding filamentous Udorn virus
Figure 2.9: Scattered distribution of CD81 along budding filamentous Udorn virus. A) CD81 
localizes along the filament of budding Udorn viruses. A549 cells were infected with Udorn virus for 18 
hours and CD81 was immunogold labeled for electron microscopy. Shown here is a bundle of virus 
filament budding from the cell (the cell is not shown in order to magnify the virus filaments). Scale bar: 
200 nm. B) CD81 and viral PB1 proteins appear to take an alternating distribution along filamentous 
Udorn virus. A549 cells were infected with Udorn virus for 16 hours and immunostained with anti-CD81 
(green) and anti-PB1 (red) antibodies. CD81 was further probed with Alexa Fluor 405/Alexa Fluor 647-
conjugated secondary antibody while PB1 was labeled with Atto 488 conjugated antibody for two-color 
3D STORM imaging. Two example filamentous viruses were shown in B-1) and B-2). Left: xy projection 
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Figure 2.9. (continued) images. Middle) xz projection images. Right) Localization distribution of CD81 
and PB1 along the filament long axis. Scale bar: 500 nm.  
Unlike WSN and X-31 strain, Udorn virus infection typically produces filaments that can reach 2 
to 20 µm long [60, 153, 161, 162]. We visualized immunogold-labeled CD81 distribution in A549 cells 
infected by Udorn virus with electron microscopy and observed CD81 clusters in budding viral filaments. 
Notably, CD81 appeared to be distributed along the entire Udorn filament (Figure 2.9A).  
As an alternative approach, we used a super-resolution fluorescence imaging technique, 
Stochastic Optical Reconstruction Microscopy (STORM), to measure the distribution of CD81 on the 
budding filament. STORM overcomes the diffraction limit of light microscopy by sequentially activating, 
imaging and localizing individual fluorescent photoswitchable molecules at high precision, thereby 
reconstituting images from the molecular localizations with nano-meter scale resolution [163, 164]. Here, 
we used a single-objective detection geometry and photoswitchable Alexa Fluor 647 and Atto 488 dyes to 
obtain a lateral resolution of 20-30 nm and axial resolution of 50-100 nm [110, 164]. To visualize the 
localization of CD81 in filamentous Udorn, we immunostained CD81 and viral PB1, and performed two-
color 3D STORM imaging. Consistent with the results from electron microscopy (Figure 2.9A), we found 
that CD81 formed small clusters evenly distributed along the entire filament (Figure 2.9B). Adjacent 
CD81 clusters were usually separated by about 150~200 nm. Curiously, CD81 appeared to be enriched 
between clusters of viral PB1 proteins (Figure 2.9B), but the significance of this alternating pattern is 
unclear. 
2.3 Discussion 
CD81, a cellular tetraspannin protein, is critical for influenza viral infection [66, 67]. The 
infectivity of various strains of influenza viruses is strongly inhibited when cellular CD81 is depleted 
(Figure 2.2). In this work, we dissected the roles of CD81 on individual steps along the infection pathway 
from virus entry to egress. We found that CD81 plays functional roles in two separate steps of viral 
infection: viral fusion and virus budding.  
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The role of CD81 in viral entry 
The specific role of CD81 during influenza viral entry was determined using a series of 
independent assays. First, knocking down CD81 by siRNA led to ~50% decrease in the percent of 
infected cells expressing viral proteins. The defect was not due to direct regulation of viral protein 
expression by CD81, since viral protein expression remained unchanged upon CD81 knockdown when 
influenza infection was induced by the acid-bypass treatment (Figure 2.2 and Figure 2.5). These results 
suggest that CD81 mediates influenza virus entry prior to viral gene expression. Next, CD81 knockdown 
did not affect virus binding, internalization or trafficking to early endosomes (Figure 2.3), but led to a 
significant defect in viral fusion (Figure 2.4). Furthermore, single-virus tracking experiments showed that 
half of internalized virus particles were trafficked into CD81-positive endosomes and underwent viral 
fusion within these endosomes, whereas the remaining half fused in CD81-negative endosomes (Figure 
2.4). Notably, the fraction of viral fusion events occurring within CD81-positive endosomes correlated 
well with the 50% reduction in the percent of infected cells expressing viral proteins upon depletion of 
CD81, suggesting a role of CD81 in productive viral uncoating. Altogether, these results indicate that 
CD81 plays a role in influenza viral fusion. CD81 marks an endosomal route for productive virus 
uncoating process, though a parallel CD81-independent route also exists.  
Interestingly, the role of CD81 in influenza virus entry appears to differ from the role of CD81 
previously observed in HCV and HIV entry. As an essential co-receptor for HCV, CD81 is important for 
the endocytosis of HCV [80, 81, 165, 166]. Furthermore, CD81 interacts with HCV glycoprotein E2 and 
helps prime its fusogenic activity for low-pH dependent viral fusion [79, 83]. Moreover, CD81 negatively 
regulates HIV-cell fusion [167]. Incorporation of CD81 and CD81-associated tetraspanins suppresses the 
HIV-mediated cellular fusion processes [167, 168]. On the other hand, CD81 unlikely functions as a co-
receptor or attachment factor for influenza viruses because the internalization of influenza viruses into 
cells does not require CD81. Influenza viral fusion does not need to be primed by CD81 either, as acid 
treatment is sufficient to trigger viral uncoating at the plasma membrane in CD81-depleted cells. Instead, 
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our results suggest a role of CD81 in facilitating influenza virus fusion in endosomal compartments. 
Given that CD81 and CD81-associating proteins can organize membrane domains [70, 71, 73, 74], CD81 
may help organize the endosomal membrane for assisting influenza viral fusion. Alternatively, CD81 may 
play a role in trafficking influenza to fusion competent endosomal compartments. CD81 is highly 
enriched in multivesicular bodies (MVBs), an intermediate endosomal organelle on the maturation 
pathway of late endosomes and lysosomes [169]. CD81 depletion may inhibit the maturation of 
endosomes and thus compromise influenza virus fusion with endosomes.  
The role of CD81 in viral assembly 
In addition to its role in virus uncoating, CD81 also plays a functional role in a later stage of 
influenza infection post viral fusion. The requirement of CD81 in a post-fusion stage was evident from 
the finding that CD81 depletion led to a significant decrease in virus titer even when the acid-bypass 
treatment was used to induce viral uncoating at the plasma membrane, thereby eliminating entry defects 
(Figure 2.2F). The decrease did not result from a defect in expression of viral proteins or trafficking of 
viral proteins to the plasma membrane (Figure 2.5), suggesting that the perturbation likely occurred at the 
virus assembly stage. Furthermore, the average number of budding virions attached to each infected cell 
did not change upon CD81 knockdown, whereas the number of virus particles released into the 
supernatant markedly decreased (Figure 2.7A and 2.7B). These results further narrowed the involvement 
of CD81 to a relatively late stage of the budding process, likely the scission step that severs the virus 
particle from the host cells. Supporting this notion, CD81 was specifically recruited to viral budding sites 
(Figure 2.6), and among the viral proteins, HA is likely important for recruiting CD81 to the virus 
budding sites.  Interestingly, CD81 was specifically enriched at the tip and budding neck of the spherical 
and slightly elongated viruses (Figure 2.7 C-E). Upon CD81 knockdown, the budding spherical viruses 
exhibited a consistent change in morphology: the budding virions appeared substantially elongated 
compared to their counterparts in control cells and failed to detach from the plasma membrane. Many 
budding viruses did not have their budding neck closed, indicating a defect in the final scission process 
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(Figure 2.7 F-H). Taken together, our observations indicate a role of CD81 in scission process that severs 
the budding virions from the plasma membrane. CD81 could be directly participating in the scission 
process, recruiting other host or viral scission proteins for this purpose, or organizing the membrane 
domain at the budding site and making it conducive for viral scission.  
It is interesting to compare the role of CD81 in the assembly of influenza virus with that of other 
viruses. Previous studies have shown that HIV envelope proteins associate with a few tetraspanins, 
including CD81, and that HIV buds from the tetraspanin-enriched microdomains [85, 170, 171]. However, 
the exact role of CD81 in HIV egress remains unclear [168, 172-175]. One study reports that HIV 
infection is significantly impaired upon CD81 depletion or treatment with anti-CD81 antibodies [175], 
whereas two other papers report that depletion of tetraspanins does not affect the efficiency of HIV 
release whereas overexpression of tetraspanins results in decreased infectivity in released virions [168, 
173]. Tetraspanins have also been proposed to facilitate cell-to-cell transmission of HTLV-1 infection 
[78]. The role of CD81 in the egress of influenza virus appears different from these previously reported 
roles of tetraspanins in HIV and HTLV-1 infection in that CD81 positively regulate viral scission.  
It has been previously shown that influenza virus scission is dependent on viral M2 protein [176]. 
During virus budding, M2 is localized at the neck of budding viruses and mutation of its amphiphilic tail 
at the C-terminus leads to a marked defect in virus budding [176]. Interestingly, M2 is known to localize 
at the interface between lipid rafts and non-rafts region, while CD81 is partitioned into tetraspanin-
enriched microdomains, a platform that resembles lipid rafts [70]. Thus, it is possible that CD81 
facilitates the recruitment of M2 to the budding neck of the viruses. Future studies on the interaction 
between CD81 and M2 during the viral scission process would be of interest to further elucidate the 
mechanistic role of CD81. CD81 associates with tetraspanins and other tetraspanin-interacting proteins to 
form tetraspanin-enriched microdomains on cellular membranes [70, 71]. CD9, a tetraspanin that interacts 
with CD81, was previously identified in the purified virus particles [69]. Our preliminary results revealed 
that other tetraspanin family proteins were also incorporated into budding viruses (data not shown). 
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Whether and how different components within the tetraspanin-enriched microdomains cooperate with 
each other in facilitating influenza virus budding remains an interesting question for future investigations.  
2.4 Materials and methods 
Cell culture, viruses and reagents. A549 lung carcinoma cells (ATCC) were cultured in high 
glucose Dulbecco’s modified Eagle medium (DMEM; Invitrogen) containing 10% fetal bovine serum 
(Serum International), and antibiotics (ATCC; 25U/ml penicillin and 25 µg/ml streptomycin), and 
maintained in humidified, 5% CO2 environment at 37°C. For siRNA knockdown experiments, A549 cells 
were electroporated with 100 pmol siRNA constructs using program X-001 of Amaxa Lonza 
Nucleofector with Kit-T (Lonza, VVCA-1002). Experiments were performed 48 hours post 
electroporation. siGENOME non-targeting siRNA #1(Thermo Scientific) was used as a control siRNA. 
Six CD81 siRNA constructs were designed with the following sequences: CD81 siRNA 1: CACCU 
UCUAU GUAGG CAUCU A dTdT(Thermo Scientific); CD81 siRNA 2: AAGGA ACAUC AGGCA 
UGCUA A dTdT(Thermo Scientific); CD81 siRNA 3: GGAAC AUCAG GCAUG CUAATT (Qiagen); 
CD81 siRNA 4: CCUUC UAUGU AGGCA UCUATT(Qiagen); CD81 siRNA 5: GCCCA ACACC 
UUCUA UGUATT (Ambion); CD81 siRNA 6: CCACC UCAGU GCUCA AGAATT (Ambion). Note 
that CD81 siRNA 1 and CD81 siRNA 2 have been confirmed previously not to cause interferon-induced 
response [67].  For plasmid expression, 2 µg plasmids were electroporated with a similar procedure. The 
following plasmids were used in this study: CD81-mEmerald (human tetraspanin CD81 was cloned into 
the C terminal of mEmerald, with a 10 amino acid linker  between mEmerald and CD81), RFP-Rab5 (gift 
from Professor Ari Helenius, Addgene, 14437 [177]), EYFP-Rab7 [50]), pCAGGS-HA/Ud and 
pCAGGS-NA/Ud (gifts from Professor Michael Farzan, Scripps Institute, FL).  
The following viruses were used in this study: influenza virus X-31 was purchased from Charles 
River Laboratories; WSN and Udorn virus strains were gifts from Professor Robert Lamb (Northwestern 
University, Evanston, IL). Respiratory syncytial virus was purchased from Virapur. Pseudo-typed MLV 
virus was a gift from Professor Nir Hacohen (Broad Institute, Cambridge, MA). 
48 
 
The following primary antibodies were used in this study: mouse anti-CD81 antibody (BD 
Biosciences, 555675), FITC-conjugated anti-CD81 antibody (BD Bioscience,  551108), mouse anti-
EEA1 (BD Biosciences, 610457), rabbit anti-EEA1 (Cell signaling, 3288s), rabbit anti-CD82 (Santa Cruz, 
c-16, SC-1087), mouse anti-CD63 (Abcam, ab8219), rabbit anti-EWIF (Fitzgerald,  70R-13159), mouse 
anti-ITGB1 (Millipore, MAB2253), mouse anti-tubulin (Sigma, T5076), mouse anti-EGFR (BD 
bioscience,  610016), rabbit anti-actin(Abcam, ab8227), rabbit anti-CD9 (Santa Cruz, H-110, sc-9148), 
goat anti-Udorn serum (gift from Professor Robert Lamb (Northwestern University, Evanston, IL)), 
mouse anti-M1 antibody (AbD Serotec, MCA401), goat anti-M1 antibody (Abcam, ab20910), mouse 
anti-influenza virus M2 antibody [14C2] (Abcam, ab5416), mouse anti-influenza virus NP antibody 
[AA5H] (Abcam, ab20343), mouse anti-Alexa Fluor 647 (Sigma, C1117), mouse anti-RSV fusion protein 
(AbD serotec, MCA490), goat anti-influenza virus PB1 antibody (Santa Cruz, vK-20), mouse anti-
influenza virus HA antibody (Lifespan, LS-C58889), rabbit anti-influenza virus NA (gift from Professor 
Gillian Air (University of Oklahoma, Oklahoma, OK) ).  
The following secondary antibodies were used for immunofluorescence with conventional light 
microscopy or immunogold electron microscopy: Alexa Fluor 647 donkey anti-mouse (Jackson 
ImmunoResearch, 715-605-150), Cy3 donkey anti-mouse (Jackson ImmunoResearch, 715-165-150), 
Alexa Fluor 488 donkey anti-mouse (Jackson ImmunoResearch, 715-545-150), Alexa Fluor 488 donkey 
anti-rabbit (Jackson ImmunoResearch, 711-545-152), Cy3 donkey anti-rabbit (Jackson ImmunoResearch, 
711-165-152), Alexa Fluor 647 bovine anti-goat (Jackson ImmunoResearch, 805-605-180), Alexa Fluor 
488 bovine anti-goat (Jackson ImmunoResearch,805-545-180), 6 nm gold conjugated goat anti-mouse 
IgG (Jackson ImmunoResearch, 115-195-146).  
The following secondary antibodies were used for immunofluoresence with STORM: donkey 
anti-mouse (Jackson ImmunoResearch, 715-005-150) labeled with Atto 488 or Alexa Fluor 405 and 
Alexa Fluor 647, Bovine anti-goat (Jackson ImmunoResearch, 805-005-180) labeled with Atto 488 or 
Alexa Fluor 405 and Alexa Fluor 647. To label antibodies with Alexa Fluor 405 and Alexa Fluor 647, 80 
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µl antibody (1.3 mg/ml) were mixed with 10 µl 1M NaHCO3, 8 µg Alexa Fluor 405 and 1.2 µg Alexa 
Fluor 647 dissolved in DMSO for 30 minutes. To label antibodies with Atto 488, the conditions were 
similar except 1.6 µg Atto 488 was used for the labeling reaction. The mixture was then filtered through a 
NAP-5 gel filtration column (GE Healthcare) to collect labeled antibody. Atto 488 emitted about 
1100~1300 photons per switching cycle, which is significantly lower than that of Alexa Fluor 647 
(4000~5000 photons per switching cycle) [110].  
Virus infection. For virus infection, A549 cells were first inoculated with different doses of 
viruses diluted in DMEM (without serum) for 90 minutes at 37 °C. Cells were washed with PBS twice to 
remove unbound viruses, and subsequently incubated with pre-warmed full DMEM medium and 
maintained at 37 °C. For measuring the influenza virus titer (X-31, WSN, and Udorn) without using the 
acid-bypass treatment, a total of 36 hours were allowed for virus infection before collecting the 
supernatant for the plaque assay as described below. For RSV virus infection, A549 cells were infected 
with RSV for 24 hours, followed by immunostaining with anti-fusion protein (F protein) antibodies and 
analysis by flow cytometry. For pseudo-typed MLV virus infection, a 24-hour was allowed for infection 
and cells were directly fixed to assay the GFP fluorescent intensity by flow cytometry.  
To ensure equal amounts of viral entry in control and CD81 siRNA treated cells for post-entry 
studies, an acid-bypass treatment was conducted to induce viral fusion at the plasma membrane. siRNA 
treated A549 cells were allowed to bind with influenza virus at 4 ºC for one hour. After extensive washes 
with cold PBS, a pre-warmed low pH buffer (PBS, pH 4.5) was added in for two minutes. The low pH 
buffer was then neutralized with culture medium and cells were placed with pre-warmed fresh culture 
medium afterwards. For measuring the influenza virus titer (X-31 and WSN) with the acid-bypass 
treatment, a total of 17 hours were allowed for virus infection before collecting the supernatant for the 
plaque assay.  
Plaque assay. Cells were infected with influenza virus for indicated amounts of time as described 
above and supernatant was collected to assay the virus titer at the end of each time point. Serial dilutions 
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of the supernatant were used to inoculate MDCK-Texas cells (Kind gift from Robert Lamb) seeded in 6-
well plates for 90 minutes at 37ºC. After washing with PBS twice, a 3 ml agar overlay of DMEM 
containing 30% Noble agar (Affymetrix), antibiotics and 2 µg/ml acetylated trypsin (Sigma) was placed 
on cells. The plates were incubated at 37 ºC. After about two days, the agar disks were removed carefully 
and cells were immediately stained with crystal violet solution (1:1,000 V/W crystal violet, 30% ethanol 
in water) for 10 to 15 minutes, which allowed for an easy quantification of the number of plaques. Virus 
titer (PFU/mL) = number of plaques / (dilution factor × inoculation volume (mL)). For each condition, 
samples were tested with triplicates. 
Influenza virus labeling. Influenza virus X-31 was either labeled with lipophilic dye DiD 
(Invitrogen, D7757) or Alexa Fluor 647 (Invitrogen, A-20006) as previously described [159]. For the 
labeling reaction, 100 µl of the original virus stock (2 mg/ml protein concentration) was incubated with 
either 3 µl of 25mM DiD or 3 µg Alexa Fluor 647 dissolved in DMSO for two hours or one hour 
respectively with gentle vortexing in the dark at room temperature. Unincorporated dye was removed by 
buffer exchange into the Hepes 145 buffer (50mM Hepes, pH 7.4, 145mM NaCl) by using NAP-5 gel 
filtration columns (GE Healthcare). The labeled virus was aliquoted, snap-frozen in liquid nitrogen, and 
stored at -80°C. Immediately before experiments, the labeled virus was thawed and filtered through a 0.2 
µm pore size syringe filter (Supor membrane, Pall) to remove viral aggregates. Labeled viruses are 
infectious, as confirmed with standard plaque assays (data not shown). 
Virus binding assay. Control or CD81-knockdown A549 cells were allowed to bind with DiD-
labeled X-31 diluted in DMEM (without serum) for 30 minutes at 4ºC. After extensive washes with cold 
PBS to remove unbound viruses, cells were trypsinized and immediately fixed with 2% paraformaldehyde 
(PFA) for 20 minutes at room temperature. After washing PFA away with PBS, the DiD fluorescent 
intensity was measured by a flow cytometer (BD bioscience). At least 10,000 cells were quantified for 
each measurement. The data was analyzed via FlowJo. 
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Virus internalization assay. Control or CD81-knockdown A549 cells were allowed to bind with 
3×104 PFU/ml Alexa Fluor 647-labeled X-31 virus diluted in DMEM (without serum) on ice for 30 
minutes at 4ºC. After extensive washes with cold PBS to remove unbound viruses, pre-warmed full 
culture medium was added in and the virus was allowed to internalize at 37 °C for indicated amounts of 
time. At the end of each time point, cells were washed with PBS, directly fixed with 4% PFA for 20 
minutes at room temperature. In order to distinguish the surface-bound versus internalized virus particles, 
a non-permeablizing immunofluorescence in the absence of detergents was performed by using a mouse 
anti-Alexa Fluor 647 primary antibody (Sigma, C1117), followed by staining with an Alexa Fluor 555-
conjugated donkey anti-mouse secondary antibody (Invitrogen, A31570). The samples were imaged using 
a custom-built spinning disk confocal microscope. Non-internalized virus particles were stained with both 
Alexa Fluor 647 and Alexa Fluor 555, while the internalized virus particles—inaccessible to the 
antibodies—exhibited only the Alexa Fluor 647 signal. To quantify the number of particles internalized 
per cell, we used the maximum z-projection of the confocal z-stacks, and counted both the total number 
of virus particles (with Alexa Fluor647 signal) and the number of non-internalized virus particles (with 
both Alexa Fluor 647 and Alexa Fluor555 signals), and the number of internalized particles (with Alexa 
Fluor 647 but not Alexa Fluor 555 signal). A low enough number of virus particles (~15 particles) was 
internalized each cell to minimize the possibility of multiple virus particles sorting into the same vesicle. 
Statistical analysis was performed using a two-tailed student t-test.  
Western Blotting. Cell lysate samples were prepared with Laemmli sample buffer (Bio-Rad, 161-
037) and run on a 4-15% Tris-HCL polyacrylamide gel (Bio-Rad). After transferring the protein onto 
Hybond polyvinylidene difluoride membranes (GE Healthcare), the membrane was blocked with 5% 
nonfat-milk in TBS-Tween for 1 hour, followed with incubation of primary antibody overnight at 4 °C, a 
three 10 minutes wash step with TBS-Tween, and a one hour incubation of HRP-conjugated secondary 
antibody at room temperature. The signal was detected with TMA-6 (TMA-100, Lumigen) and developed 
to Kodak films. Note that CD81 and CD63 could only be detected under non-reducing conditions.  
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Flow Cytometry. For flow cytometry analysis, the procedures were similar to what was 
previously described [178].  Briefly, for measuring total protein expression level (CD81 or viral proteins), 
cells were collected and fixed with 2% PFA for 20 minutes. After washing with PBS once, cells were 
permeablized with buffer P (0.075% Saponin, 10% BSA in PBS) for 20 minutes at room temperature. 
Cells were incubated with primary antibodies diluted in buffer P (1:1,000) for 1 hour and washed with 
buffer P three times before incubating with secondary antibodies for another 45 minutes. Secondary 
antibodies were also diluted with buffer P (1: 1,000). After washing with buffer P, cells were resuspended 
with PBS and then analyzed by flow cytometry. The data was analyzed by FlowJo. Cells were gated 
based on FSC and SSC scattering, and a histogram was generated based on the fluorescence intensity 
profile. For cells that were infected with influenza virus, a second gate was set based on comparison of 
fluorescence intensity of uninfected versus infected cells. The population that falls into the second gate 
corresponds to the percent of infected cells in each sample, from which the mean fluorescence intensity 
was analyzed to infer the viral protein expression level. To probe surface protein expression, all steps 
were similar except detergent was excluded. 
Immunofluorescence. For imaging-based experiments, A549 cells seeded in Lab-Tek 8 well glass 
dishes were fixed with 4% PFA for 20 minutes at room temperature. Unless specified, fixed cells were 
permeablized with 0.1% Triton-X100 in PBS for 5 minutes, washed with PBS twice and incubated with 
blocking buffer PBSA (3% BSA in PBS, or 5% bovine serum in PBS) for 30 minutes. Cells were then 
incubated with primary antibodies diluted in PBSA (1:500) for 1 hour. Followed by three PBS washes (5 
minutes each), secondary antibodies were added for another 1 hour. Afterwards, cells were washed with 
PBS for three times again before imaging. For STORM, a post-fixation step was followed with 3% PFA 
and 0.1% glutaraldehyde (GA) in PBS for 20 minutes. For immunostaining surface protein only, 
permeablization was not performed after fixation. When antibody species conflict existed, labeled 
primary antibodies (CD81-FITC, BD Bioscience; HA-Alexa Fluor 647) were used as needed.  
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To quantify the colocalization ratio between internalized virus and cellular proteins (EEA1 and 
CD81), samples were prepared similarly as in virus internalization assay. After probing the surface-bound 
virus particles with anti-Alexa Fluor 647 antibody, cells were permeabilized with 0.1% Triton-X100 in 
PBS, and a subsequent indirect immunofluorescence was performed to stain against each protein. Images 
were acquired by confocal microscopy and at least 40~100 randomly chosen cells were analyzed 
manually for each condition. Only internalized virus particles were used to quantify the fraction of viruses 
colocalized with CD81 or EEA1. 
ELISA. Cells were infected with influenza virus with acid bypass for 17 hours and the supernatant 
was collected to assay the total amount of viral protein in the released virus particles. M1 was chosen due 
to its abundance in the virus to maximize signal. Nunc 96 well plates (eBoscience, 44-2404-21) were 
incubated with capture antibody (Goat anti-M1, Abcam, 1:1000 diluted in 0.2 M sodium 
carbonate/bicarbonate buffer, pH 9.4) at room temperature for 2 hours. After three 5 minutes wash with 
PBST (0.05% Tween in PBS), the plates were blocked with PBSA (2% BSA in PBST) for 1 hour. The 
supernatant was mixed with RIPA buffer (1:2 dilution), and added in each well for overnight incubation 
at 4 °C. The samples were washed three times with PBST, and incubated with detection antibody (Mouse 
anti-M1, AbD Serotec, 1:600 dilution in PBSA) for 1 hour at room temperature, washed three times, and 
further incubated with HRP-conjugated goat anti-Mouse antibody (Bio-Rad, 172-1011, 1:5,000) for 1 
hour. TMB substrate (Thermo Scientific, N301) was used to detect HRP activity, and the reaction was 
stopped by 0.18 M sulfuric acid before measuring the absorbance at 450 nm. The experiment was 
performed with triplicate samples from independent infections, with three measurements for each sample. 
To confirm the efficiency of detection, purified X-31 virus (Charles River laboratory) was used as a 
standard sample (data not shown).  
Quantification of the Number of Released Virions. Control and CD81 siRNA treated cells were 
infected with influenza virus by acid bypass treatment. At 17 hours post infection, supernatant was 
collected to assay for the number of released virions through immunofluorescence. Briefly, the 
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supernatant was absorbed on poly-lysine coated Lab-Tek 8 well glass dishes at 4 °C overnight. After 
washing away unbound virions with PBS twice, the sample was fixed with 4% PFA for 15 minutes, 
blocked with 3% PBSA buffer, immunostained with anti-HA and anti-M1 antibody, and then imaged by 
confocal microscopy. More than 150 randomly selected regions were imaged, and the number of particles 
positive for HA and M1 staining was quantified (with more than 600 virus particles). 
Single particle tracking. The single-particle tracking experiment has been described in detail 
previously [50, 56, 61, 159]. Briefly, A549 cells were nucleofected with CD81-mEmerald or RFP-Rab5 
plasmids 24 hours prior to single virus tracking experiments. After washing the cells with pre-warmed 
PBS twice, 2.6×104 PFU/ml DiD-labeled X-31 virus diluted in imaging buffer (9 parts DMEM without 
phenol red, 1 part pH8 Hepes buffer, supplemented with oxygen scavenge system: 0.8 mg/ml  
dihydroxybenzoic acid (PCA, Sigma, 37580), 0.5U/ml protocatechuate 3,4- dioxygenase (PCD, Sigma, 
P8279) ) was added to the cells. The objective and stage of the microscope were heated to maintain the 
temperature at 37 ºC for the cells. Image acquisition began immediately after adding DiD-labeled virus in 
situ. To obtain a simultaneous imaging of DiD-labeled virus and cellular protein, DiD was excited with a 
647 nm krypton laser (Coherent) while mEmerald and RFP was excited with a 488 nm argon ion laser 
(Coherent) and a 561 nm solid state laser (CrystaLaser) respectively. Fluorescence emissions from DiD 
and mEmerald/RFP were separated by a 630 nm long-pass dichroic, filtered with bandpass filters (705/40 
for 647 channel, 525/40 for 488 channel, and 605/70 for 561 channel) and imaged on a EMCCD camera 
(Andor) with 0.5 second exposure time. The imaging analysis was performed as described previously [56]. 
Briefly, for each image, the fluorescence signal collected from the DiD channel was convolved with a 
Gaussian spatial filter to remove background and noise. To identify the virus peaks, the algorithm 
performs recursive integration over bright regions connected to each local maximum. The centroid of 
each fluorescent peak was computed to determine the virus particle position, and the trajectories were 
obtained by reconstructing paired peaks between adjacent frames with similar proximity and intensity. 
The fluorescence intensity of DiD was plotted versus time. 
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Bulk viral fusion assay. Control or CD81-knockdown A549 cells seeded in Lab-Tek 8 well glass 
dishes were rinsed with cold PBS first, and then incubated with 2×104 PFU/ml DiD-labeled X-31 diluted 
in DMEM (without serum) for 45 minutes at 4ºC. After washing away unbound viruses with cold PBS 
twice, pre-warmed full culture medium was added in and cells were maintained at 37°C for indicated 
amounts of time. At the end of each time point, cells were trypsinized and immediately fixed with 2% 
PFA for 20 minutes. Afterwards, cells were washed and resuspended with PBS. DiD-fluorescent intensity 
was measured through a flow cytometer. At least 10,000 cells were measured for each measurement with 
duplicates for each condition. The data was analyzed with FlowJo. The normalized viral fusion extent 
(mean DiD intensity at each time point-initial mean DiD intensity)/Initial mean DiD intensity) was 
plotted.   
STORM. STORM experiments were performed as previously described on an Olympus IX71 
inverted optical microscope [113]. Three lasers were used in this study for STORM: 657 nm (RCL-300-
656; Crystalaser), 488 nm (Sapphire 460-10; Coherent) and 405 nm (CUBE 405-50C; Coherent). A high-
numerical-aperture (NA) oil-immersion objective (100X UPlanSapo, NA1.4; Olympus) was used to 
collect the fluorescence emission, which is imaged onto a back-illuminated electron-multiplying charge-
coupled device (EMCCD) camera (iXON DU-897; Andor). For two-color 3D imaging of Alexa Fluor 647 
and Atto 488, two imaging laser beams (488 nm and 657 nm) and an activation laser beam (405 nm) were 
reflected by a custom-designed polychroic mirror (z488/647/780rpc; Chroma). Fluorescence emission 
from Alexa Fluor 647 and Atto 488 were separated by a 630 nm long-pass dichroic mounted on a 
commercial beamsplitting device (3D Dual-View with a cylindrical lens, 100 cm focal length; 
Photometrics). Two bandpass filters: FF01-535/50(Semrock) and ET705/72m (Chroma) were used to 
filter for the short-wavelength and long-wavelength channel independently. In addition to the bandpass 
filters, a double-notch filter (NF01-488/647; Semrock) was added before the Dual-View (Photometrics) to 
block the two excitation laser beams. STORM imaging for each channel was performed at 60 Hz 
sequentially and each channel was imaged onto 256 × 256 pixels in the EMCCD camera (iXON DU-897). 
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STORM images were generated using similar methods as previously described [113]. The STORM 
images in the Alexa Fluor 647 and Atto 488 channels were aligned by a third-order polynomial warping 
map in three dimensions obtained from calibration images of 100-nm Tetraspeck fluorescent beads. The 
residual alignment error was ~7 nm in x-y and ~20 nm in z dimensions. To correct for the sample drift 
during imaging acquisition, we relied on the correlation function of imaging itself to correct for the lateral 
and axial drift, as previously described [164]. Since the imaging acquisition was performed sequentially 
with the longer wavelength channel first, 647 channel was drift-corrected to the last frame of the 647 nm 
acquisition while 488 channel was drift-corrected to the first frame of the 488 nm acquisition. The spatial 
resolution measured was 20~30 nm laterally and 50~60 nm axially for Alexa Fluor 647; while Atto 488 
gives a lateral resolution of 30~40 nm and axial resolution of ~100nm. 
Electron microscopy. A549 cells were infected with influenza viruses at a MOI of 2. Infection 
was allowed to proceed for a total of 15 hours before fixing with 2.5% PFA/GA in 0.1M sodium 
cacodylate buffer, pH 7.4 (Electron Microscopy Sciences, 15949) at room temperature for at least 1 hour. 
The cells were post-fixed for 30 minutes in 1% Osmium tetroxide (OsO4)/1.5% potassium ferrocyanide 
(KFeCN6), washed in water three times and incubated in 1% aqueous uranyl acetate for 30 minutes 
followed by two washes in water and subsequent dehydration in grades of alcohol (5 minutes each; 50%, 
70%, 95%, 2x 100%). Cells were removed from the dish in propyleneoxide, pelleted at 3000 rpm for 3 
minutes and infiltrated for 2 hours in a 1:1 mixture of propyleneoxide and TAAB Epon (Marivac Canada 
Inc. St. Laurent, Canada). The samples subsequently embedded in TAAB Epon and polymerized at 60 °C 
for 48 hours. Ultrathin sections (about 60 nm) were cut on a Reichert Ultracut-S microtome, transferred 
onto copper grids stained with lead citrate and examined in a TecnaiG² Spirit BioTWIN and images were 
recorded with an AMT 2k CCD camera. 
For immunogold electron microscopy, at the end of indicated time points of virus infection, cells 
were rinsed with PBS once, fixed with 4% PFA for 15 minutes, and blocked with PBSA (3% BSA in PBS) 
for 30 minutes. Primary antibodies diluted in PBSA (1:500) were incubated with cells for overnight at 4 
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ºC. After three washes with PBS, cells were treated with 6 nm gold-conjugated secondary antibodies 
(1:40) for four hours, post-fixed with 2.5% PFA/GA in 0.1 M sodium cacodylate buffer for at least one 
hour. The sample were embedded and sectioned as described above for transmission electron microscope 
imaging. 
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Chapter 3: Dissecting the Role of COPI Complexes in Influenza 
Virus Infection 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Work in this chapter was performed in collaboration with Dr. Eileen Sun. 
Most of the results from this work are published in [178]. 
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3.1 Introduction  
Influenza virus is a negative-sense stranded RNA, enveloped virus that contains eight segmented 
genomes, which encode 13 viral proteins. The influenza virion envelope is derived from the infected 
cell’s plasma membrane and contains three integral viral membrane proteins: M2 proton channel, 
hemagglutinin (HA), and neuraminidase (NA). Encapsulated within the viral envelope is a coat of matrix 
protein 1 (M1), which also forms contacts with each of the viral ribonucleoprotein complexes (vRNP). 
Each of the vRNPs consists of a strand of vRNA, which is bound to viral nucleoprotein (NP). In addition, 
each vRNP is bound to a RNA-dependent RNA polymerase complex containing three proteins: PA, PB1, 
and PB2 [15].  
Influenza A virus is the causative agent of seasonal flu, and historically has led to pandemic 
infections, such as the 1918 Spanish influenza outbreak that killed an estimated 50 million people 
worldwide [15]. At a cellular level, influenza virus infection starts with virion attachment to cell surface 
sialylated glycoproteins or glycolipids [53]. The virus particle then triggers endocytosis through clathrin-
dependent and clathrin-independent pathways [44, 54-56]. Productive entry requires the virus to traffick 
to low pH endosomes (pH ~ 5.0), at which point HA mediates fusion between the viral envelope and the 
lipid bilayer of the endosome [15, 54, 159, 179, 180]. Upon pH-mediated fusion, the vRNPs release into 
the cytoplasm and subsequently transport into the nucleus to initiate viral replication and viral protein 
translation [181]. Infected cells produce progeny virions by assembling viral proteins and vRNP 
complexes at the plasma membrane. Viral NA cleaves cell surface sialic acids, to allow assembled virions 
to bud and release from the infected cell’s membrane, and thereby initiate another infection cycle in 
neighboring uninfected cells [15]. 
As obligate pathogens encoding only 13 viral proteins, influenza hijacks host proteins and cellular 
compartments/organelles in order to harbor infection and produce progeny virus. Recently, four genome-
wide knockdown screens, one in drosophila cells and three in human cells [63, 64, 66, 67], identified host 
proteins important for influenza virus infection. One group of host dependency proteins identified in all 
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influenza screens included subunits of the COPI complex [63, 64, 66, 67]. There are nine different COPI-
complex subunits—g."ȕ3."ȕ4."h."i."Ȗ3."Ȗ4."ȗ3."cpf"ȗ40"Gcej"EQRK"eqorngz"eqpvckpu"c"ukping"eqr{"qh"g."ȕ3."
ȕ4."h."cpf"i"uwdwpkvu."kp"cffkvkqp"vq"qpg"qh"vjg"hqnnqykpi"kuqhqto"eqodkpcvkqpu<""Ȗ31"ȗ3."Ȗ31"ȗ4."qt"Ȗ41"ȗ3"
[86-88]. Together, COPI complexes form a vesicle coat that traffick contents between golgi stacks, as 
well as cargoes between the golgi apparatus and the endoplasmic reticulum (ER) [86, 88, 182]. In 
addition, several studies have reported a role for COPI complexes in the endocytic pathway, since 
perturbation of these complexes lead to defects in endosomal sorting, multivesicular body (MVB) 
formation, and/or membrane trafficking [90-95].  
Previous studies indicate that COPI may play a role in influenza virus entry. König and 
eqnngciwgu"jcxg"tgrqtvgf"vjcv"h-COPI (ARCN1)-knockdown inhibits vRNP nuclear import [67]. Given 
the roles of COPI proteins in the endocytic pathway, König and colleagues hypothesized that the block in 
vRNP nuclear import may be due to defects in endosomal trafficking. However, viral entry is a multi-step 
process and it remains unclear which step or whether any of those steps is ARCN1-dependent. 
 Recently, Cureton and colleagues reported that disruption of COPI complexes differentially 
affects Vesicular Stomatitis Virus (VSV) entry versus viral gene expression [45].  The authors used a 
temperature sensitive EJQ"egnn"nkpg"*KfnH+."yjkej"fgitcfgu"i-EQRK"cv"62üE"[95]."vq"ujqy"vjcv"i-COPI 
depletion inhibits virus binding and internalization, as well as transferrin (Tfn) uptake. However, these 
results were only recapitulated after prolonged treatment with Brefeldin A (BrefA), an inhibitor that 
prevents GDP to GTP exchange of ARF1, an essential step for membrane recruitment of COPI to the 
golgi apparatus [89]. Acute (short-term) treatment of BrefA did not lead to the same effect in viral entry 
as observed with the IdlF cells incubated at 40 üE, but did cause a specific decrease in VSV gene 
expression.   
The results from Cureton and colleagues suggest that indirect effects caused by long term 
inactivation of COPI lead to general defects in the clathrin-mediated endocytosis pathway [45]. VSV 
exclusively uses clathrin-mediated endocytosis for infection [29, 183-186]. Influenza virus, on the other 
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hand, can productively infect cells in the absence of clathrin-mediated endocytosis. Indeed, several 
reports have shown that depleting key components of the clathrin complex fails to block influenza virus 
entry and infection because alternative productive endocytic pathways such as macropinocytosis can be 
hijacked by influenza [44, 55, 56, 61]. Moreover, influenza requires lower pH compartments for viral 
fusion than VSV [54, 184, 187]. Therefore, how COPI proteins are involved in each of the steps of 
influenza virus entry and infection remains unclear.  
Here, we dissect the different steps of the influenza virus infection cycle—entry, replication, 
trafficking, and assembly—in order to identify the steps COPI proteins affect. We found that the first 
major entry block in COPI knockdown cells occurs at virus internalization. In addition, COPI-depleted 
cells also exhibited defects in early endosome to intermediate/late endosome trafficking for virus particles 
that did manage to internalize these cells. The entry block was not limited to influenza virus, but also for 
other cargoes (Tfn, EGF, and dextran) that internalize through either clathrin-mediated endocytosis or 
macropinocytosis. Given the large defect in viral entry upon siRNA silencing of COPI, we used 
pharmacological inhibitors — BrefA and Golgicide A (GCA) — to acutely disrupt the COPI complexes. 
With the inhibitor treatment, we found that COPI complexes were not directly required for influenza viral 
entry. However, disruption of functional COPI complexes directly inhibited viral membrane protein 
expression, assembly of viral components at the plasma membrane, and production of infectious progeny 
virus.   
3.2 Results 
3.2.1 COPI depletion inhibits influenza infection via an entry step at or prior to viral fusion 
To confirm previously published results showing that COPI proteins are required for influenza 
virus infection, we used siRNA to deplete one of the essential subunits of the COPI complex, h-COPI 
(ARCN1). We were able to achieve efficient ARCN1 depletion after 48 hours, as shown with western 
blotting (Figure 3.1A).  To test the effect of siRNA treatment on influenza infection, supernatant from 
influenza A/Aichi/1968 (H3N2) (X31) or influenza A/WSN/1933 (H1N1) (WSN)- infected A549 cells 
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was collected and the viral titer was measured with plaque assays. Relative to the non-targeting siRNA 
control, the viral titers of supernatant from ARCN1 knockdown cells was decreased by 78% +/- 3% for 
X31 and 90% +/- 1% for WSN infection (Figure 3.1B).  Furthermore, ARCN1 knockdown cells exhibited 
a defect in virus infection prior to viral progeny production. After 8.5 hpi with X31 or WSN, we 
quantified the fraction of NP-positive (NP+) cells with flow cytometry.  Relative to the control cells, the 
ARCN1 knockdown cells had 93% +/- 0.01% and 82% +/- 2% fewer NP+ expressing cells for X31 and 
WSN infection, respectively (Figure 3.1C). Amongst the cells that expressed NP, the NP expression level 
was similar between control and ARCN1 knockdown cells (data not shown). 
In addition, we checked for potential siRNA-mediated off-target effects: cytotoxicity and 
interferon induction. Compared to the control cells, the ARCN1 knockdown cells— after 24 and 48 hours 
siRNA treatment— exhibited ~25% decrease in cell viability (Figure 3.1D), a minor increase in 
cytotoxicity (Figure 3.1E), and a correspondingly slight decrease in cell growth (Figure 3.1F). 
Furthermore, siRNA treatment did not stimulate interferon induction [188] (Figure 3.1G). Given that the 
COPI complex is required for influenza virus infection and that the cells were largely healthy, we 
conducted experiments to dissect which steps of the influenza infection cycle COPI proteins mediate. 
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Figure 3.1. COPI depletion blocks viral infection and cells are sufficiently healthy for subsequent 
experiments. A) A yguvgtp"dnqv"rtqdkpi"h-COP1 expression in non-targeting (NT) or ARCN1 siRNA 
treated cells after 48 hours knockdown. B) Plaque assay results measuring the viral titer of released 
virions from X31 or WSN infected siRNA treated cells after 24 hours post infection (hpi). The mean viral 
titers and standard deviations from duplicate experiments. C) Normalized fraction of NP-expressing cells 
in X31 or WSN infected siRNA treated cells after 8.5 hpi. D) Calcien AM and ethidium homodimer 
staining was used to measure cell viability and cytotoxicity, respectively, in siRNA treated cells at 24 and 
48 hours after siRNA electroporation. Calcien AM is a standard indicator for cell viability: living cells 
contain esterases that can cleave the non-fluorescent, cell-permeable calcien-AM dye, resulting in a bright 
green fluorescence signal. Means represent the average of six different samples with the corresponding 
standard deviation. Results are normalized to the non-targeting control for each treatment condition. E) 
The cell-impermeable dye, ethidium homodimer, binds to nucleic acids and emits a red fluorescence in 
dead cells or cells with compromised membrane integrity. The fraction of cell death was measured by 
taking the ratio of ethidium homodimer readings from siRNA treated cells before and after saponin 
treatment. Means represent the average of six different samples with the corresponding standard deviation. 
F) Relative cell growth was measured by obtaining the ratio of ethidium homodimer fluorescence in 
permeabilized non-targeting siRNA treated and ARCN1 knockdown cells. Live siRNA treated cells were 
permeabilized with saponin, stained with ethidium homodimer, and analyzed with a Typhoon 
fluorescence scanner. The signal measured correlates with the total number of cells within each well. The 
measured fluorescence signal in the ARCN1 knockdown cells was normalized to the average fluorescence 
signal from the non-targeting control cells at 24 or 48 post siRNA treatment. G) The presence of 
intracellular dsRNA can induce an interferon anti-viral response, propagated by downstream signaling 
events such as STAT phosphorylation. Western blots were used to detect P-STAT (T{t"923+."h- COP1, 
and actin expression for cell lysates collected from non-targeting, non-targeting + 10,000 U/mL interferon 
cnrjc"*KHPg+"hqt"6"jtu"*vq"fktgevn{"uvkowncvg"kpvgthgtqp"kpfwevkqp+."cpf"CTEP3-depleted cells after 48 
hours siRNA treatment. 
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We first probed the effect of COPI depletion on viral fusion using a fluorescence dequenching 
assay. To detect viral fusion, we incorporated a saturating amount of a lipophilic dye, DiDC18(5) (DiD), 
into enveloped viruses such that the detected fluorescent signal from the virus particles becomes partially 
quenched due to intermolecular dye interaction.  For DiD-labeled viruses, pH-mediated fusion results in 
dramatic increase in fluorescent signal (de-quenching) stemming from the diffusion of DiD molecules 
from the viral envelope into the endosomal membrane [159, 189]. To measure the amount of viral fusion 
on a population level, we incubated siRNA treated cells with DiD-labeled X31 on ice, allowed the virus 
vq"kphgev"vjg"egnnu"cv"59üE"hqt"fkhhgtgpv"coqwpvu"qh"vkog."cpf"swcpvkhkgf"vjg"FkF"hnwqtguegpv"kpvgpukv{"wukpi"
a flow cytometer. As shown in Figure 3.2A, we observed an enhancement in fluorescent intensity with 
kpetgcukpi"kpewdcvkqp"vkog"cv"59üE"hqt"vjg"pqp-targeting siRNA control cells. By 60 minutes post 
infection (mpi), the control cells exhibited a 5.70 +/- 0.02 fold increase in DiD signal.  In stark contrast, 
the signal enhancement in ARCN1 knockdown cells was only 24% +/- 0.03%. In addition, we tested 
COPE, COPG1, and COPZ1 knockdown cells with the bulk DiD fusion assay to determine whether 
depletion of other COPI subunits also resulted in similar viral fusion defects. Indeed, knockdown of these 
COPI subunits also exhibited significant defects in viral fusion, albeit the effect due to COPE depletion 
appeared to be weaker (data not shown). Collectively, these results show that COPI subunit knockdown 
blocks a virus entry step(s) at or before viral fusion. 
We next tested the amount of Alexa Fluor 647-conjugated X31 (AF647-X31) virus bound to 
control and ARCN1 knockdown cells using flow cytometry.   The largest difference in binding was 
observed with the lowest virus dose tested, in which ARCN1 knockdown cells bound to 20% +/- 3% less 
virus than the non-targeting control (Figure 3.2B). We also quantified the level of  g*4.8+-linked sialic 
acids presented on the surface of the siRNA treated cells by measuring the amount of  FITC-conjugated 
elderberry lectin (SNA-FITC) bound to non-permeabilized fixed cells. We found that the ARCN1 
knockdown cells bound 17% +/- 1% less elderberry lectin than the control cells (Figure 3.2C). We 
validated the elderberry lectin binding assay with A549 cells treated with different sialidase A units 
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followed by SNA-FITC staining:  exposure to higher units of sialidase A resulted in a dose dependent 
decrease in SNA-FITC binding (Figure 3.2D). Because X31 and SNA can still bind to ARCN1-depleted 
cells, siRNA-mediated COPI complex disruption unlikely leads to a general defect in sialylation or 
presentation of glycoproteins or glycolipids at the cell surface.  Therefore, siRNA depletion of COPI 
inhibits viral infection and replication through an entry block post virus binding, but prior to or at viral 
fusion. 
 
Figure 3.2. ARCN1 knockdown cells exhibit a defect in viral entry at or prior to fusion, but not at 
binding. A) Quantification of DiD fluorescence dequenching using flow cytometry. Non-targeting and 
ARCN1 knockdown cells were cold bound with DiD-labeled X31 (DiD X31), and allowed to internalize 
hqt"fkhhgtgpv"coqwpvu"qh"vkog"cv"59üE0"Vjg"hqnf"hnwqtguegpv"ukipcn"kpetease from the DiD was monitored at 
each time point to measure the amount of viral fusion. B) Quantification of AF647-X31 binding in siRNA 
treated cells using flow cytometry. C) Binding of FITC-conjugated elderberry lectin (SNA-FITC)—a 
protein that binds to g*4.8+-linked sialic acids on glycoproteins or glycolipids—to non-targeting and 
ARCN1 siRNA treated cells with and without treatment with 0.01 U sialidase A. The data for each 
independent experiment was normalized to the non-sialidase treated, non-targeting control. Each 
condition was tested in duplicate in two independent experiments. D) Flow cytometry-based 
quantification of A549 cells treated with different sialidase A units prior to SNA-FITC staining. 
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3.2.2 siRNA knockdown of COPI abrogates the internalization of influenza, as well as other 
clathrin-mediated endocytosis or macropinocytosis cargos  
The small defects in virus binding could not explain the dramatic decrease in viral fusion in the 
COPI-depleted cells. Therefore, we subsequently tested the effect of COPI depletion on influenza virus 
internalization by quantifying the fraction of internalized AF647-X31 in the siRNA treated cells after 30 
minutes post infection (mpi). The cells were fixed, and labeled with SNA-FITC to delineate the plasma 
membrane. In addition, to confidently assign the virus particles close to the plasma membrane as being 
internalized or non-internalized, we performed non-permeabilizing immunofluorescence to stain for 
surface bound, non-internalized virus with an antibody specific for AF647 (Figure 3.3A).  The ARCN1 
knockdown cells exhibited a significant (p< 0.0001) defect in virus uptake when compared to the control 
cells. Specifically, the mean internalization fraction in non-targeting siRNA control cells and ARCN1 
knockdown cells was 0.58 and 0.19, respectively (Fig 3.3B). In addition, we report a ratio, representing 
the sum of internalized particles divided by the total number of virus particles amongst all cells. The ratio 
for the non-targeting and ARCN1 knockdown cells was 0.58 and 0.22, respectively (Figure 3.3B, top left 
corner).  
Given the substantial defect in influenza virus internalization in the ARCN1 knockdown cells, we 
tested whether other cargoes of endocytic pathways previously described as productive influenza entry 
pathways— clathrin-mediated endocytosis and macropinocytosis — were also inhibited. Tfn, EGF, and 
dextran were used as representative markers of clathrin-mediated endocytosis and macropinocytosis, 
respectively.  The cargoes were allowed to internalizg"hqt"fkhhgtgpv"coqwpvu"qh"vkog"cv"59üE."cpf"uwthceg"
bound cargoes were stripped off the cell using a low pH buffer (pH 2.5) prior to fixation and imaging. We 
applied the assay to the siRNA treated cells, and found that uptake of not only dextran, but also Tfn and 
EGF were significantly impaired (Figure 3.3C-E).  The largest defects observed in internalization were 
the earlier time points tested: 15 minutes for dextran, and 10 minutes for Tfn and EGF. EGF uptake was 
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relatively less perturbed than Tfn uptake because it has been previously shown that EGF may internalize 
through a clathrin-independent pathway at high concentrations [190-192].  
 
Figure 3.3. ARCN1 knockdown cells exhibit defective internalization of influenza and other cargoes. 
A) Representative confocal xy, yz, and xz cross section images of AF647-X31 (red) infected siRNA 
treated cells after 30 minutes post infection (mpi). The plasma membrane was labeled using SNA-FITC 
(white). Non-permeabilizing immunofluorescence with an antibody specific for AF647 (green) was also 
performed to differentiate plasma membrane-proximal particles as being non-internalized (yellow) or 
kpvgtpcnk|gf"*tgf+"*32"ȝo"uecng"dctu+0"B) The fraction of virus internalized out of the total number of virus 
particles per cell was counted. The internalized virus fraction was counted for more than 30 cells per 
siRNA treatment condition, and graphed in a form of a dot plot. Statistical analysis was performed using a 
one-sided student t-test. Furthermore, for each siRNA treatment, a ratio is presented on the top left corner, 
in which the numerator denotes the total particles internalized, and the denominator represents the total 
number of particles counted amongst all cells. C-E) Quantification of TMR-dextran, AF568-Tfn, and 
AF647-EGF uptake in non-targeting and ARCN1 siRNA treated cells from at least 18 different confocal 
z-stacks per time point. To quantify the amount of TMR-dextran, AF568-Tfn or AF647-EGF uptake of 15 
to 20 different confocal z-stacks per time point were analyzed. F) Quantification of AF647-dextran uptake 
in DMSO or EIPA treated cells. G and H) AF647-Tfn and AF647-EGF uptake in DMSO or dynasore 
treated cells. For all three experiments, at least 25 randomly selected fields of view per treatment 
condition were analyzed. 
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We validated our analysis method by quantifying the amount of cargo internalized upon treatment 
of known, well-established inhibitors for macropinocytosis and dynamin-dependent endocytosis. To 
verify our algorithm for macropinocytosis, we treated A549 cells with different concentrations of EIPA 
prior to allowing for fluid phase uptake, while for dynamin-dependent endocytosis, we treated A549 cells 
with different doses of dynasore prior to Tfn or EGF uptake [193, 194]. For all three cargoes tested, we 
observed a dose dependent decrease in measured cargo uptake with increasing concentration of inhibitor 
treatment (Figure 3.3F-H). 
Collectively, our results show that COPI depletion blocks influenza virus internalization, which in 
part contributes to the defect in viral fusion as shown in Figure 3.2A.  However, other representative 
cargoes of two different productive entry pathways for influenza—clathrin-mediated endocytosis and 
macropinocytosis [44, 54-56] —also exhibited defects in internalization in ARCN1 depleted cells.  
3.2.3 ARCN1 knockdown cells exhibit impaired endosomal trafficking upon virus internalization  
We next tested whether ARCN1 knockdown leads to any post internalization defects.  Upon 
internalization, influenza enters into Rab5+ endosomes near the cell periphery, and then sorts into Rab7+ 
endosomes towards the perinuclear region, which is late endosome/lysosome dense [50]. Upon exposure 
to pH ~5.0, the influenza envelope fuses with the endosomal membrane, releasing the vRNP into the 
cytoplasm for nuclear import [59, 195].  
To test whether ARCN1 knockdown cells exhibit any defects in trafficking to intermediate/late 
endosomes, we cold bound AF647-Z53"qpvq"ukTPC"vtgcvgf"egnnu."cpf"kpewdcvgf"vjg"ucorngu"cv"59üE"hqt"
90 minutes. The cells were then fixed, and immunostained for an intermediate/late endosome marker, 
lysobisphosphatidic acid (LBPA) [196]. We found a significant (p<0.0001) decrease in AF647-X31 
colocalization with LBPA+ vesicles, with a mean colocalization fraction for individual cells of 0.42 for 
the non-targeting control versus 0.10 for the ARCN1 knockdown cells. In addition, we report the ratio of 
the sum of colocalized particles to the total number of internalized particles amongst all analyzed cells. 
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The ratio for non-targeting and ARCN1 siRNA treated cells was 0.62 and 0.11, respectively (Figure 3.4A, 
and 3.4B, upper left corners). Regardless of the type of measurement, these findings strongly suggest that 
virus particles exhibit a defect trafficking to intermediate/late endosomes in ARCN1 siRNA treated cells.  
 
Figure 3.4. Defective endosomal trafficking of internalized influenza particles in ARCN1 depleted 
cells.  A) Representative spinning disk confocal images of non-targeting and ARCN1 siRNA treated cells 
infected with AF647-X31 for 90 minutes. The plasma membrane was stained with SNA-FITC and the 
ncvg"gpfquqogu"ygtg"koowpquvckpgf"ykvj"NDRC"*32"ȝo"uecng"dctu+0""B) The fraction of internalized 
particles that colocalize with LBPA, a late endosome marker, was counted for at least 20 cells per siRNA 
treatment. Note that the dot plot average line represents the mean colocalization fraction of the analyzed 
cells, in which each dot within the plot is the colocalized fraction from an individual cell. Statistical 
analysis was performed using a one-sided student t-test. In addition, for each siRNA treatment, a ratio is 
presented on the top left corner, in which the numerator denotes the total number of internalized particles 
colocalized with LBPA, and the denominator represents the total number of internalized virus particles 
amongst all cells. On the top left corner we report the sum of colocalized particles divided by the total 
number of internalized particles for all analyzed cells. These two values are not necessarily equal to each 
other especially in the presence of substantial cell-to-cell variation. C) Representative spinning disk 
confocal images of non-targeting and ARCN1 siRNA treated cells infected with AF647-X31 for 90 
minutes, plasma membrane stained with SNA-FITC, and immunostained with EEA1, an early endosome 
octmgt"*32"ȝo"uecng"dctu+0"D) Quantification of the internalized particles that colocalize with EEA1 at 90 
minutes post infection (mpi) was performed as in Figure 3.4B for more than 35 cells per siRNA 
treatment.  Statistical analysis was performed using a one-sided student t-test.  
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Given the large defect observed in trafficking to LBPA+ vesicles, we tested whether the ARCN1 
knockdown cells were accumulating the AF647-X31 in early endosomes. Indeed, after 90 mpi, the 
ARCN1 knockdown cells exhibited a significant (p<0.0001) increase the mean colocalization fraction, 
which was 0.24 for the ARCN1 knockdown cells and 0.07 for the non-targeting control (Figure 3.4C and 
3.4D). The sum of colocalized particles divided by the total number of internalized particles for all non-
targeting and ARCN1 siRNA treated cells was 0.1 and 0.36, respectively.   
Previous studies have reported that COPI proteins may be important for endosomal trafficking 
[90, 94]. However, it remains unclear thus far whether COPI vesicles directly mediate sorting of influenza 
between different types of endosomes. To test whether AF647-X31 trafficks within COPI vesicles, we 
transiently expressed GFP-vciigf"i-COPI (COPE-GFP) in A549 cells. Of the GFP-fusion COPI subunit 
eqpuvtwevu"vguvgf."i-COP-GFP minimized the disruption of golgi architecture. After several rounds of live 
cell imaging experiments with A549 cells expressing COPE-GFP and infected with AF647-X31, we 
found only one example of COPE-GFP colocalized with AF647-X31 out of many virus particles tracked 
(data not shown). Though this does not completely negate that COPI proteins play a specific role in 
endosomal trafficking between MVBs and late endosomes, our data suggests that the effect of COPI in 
transporting the influenza virus from early to late endosome is likely indirect. 
3.2.4 Rapid disruption of COPI vesicles with pharmacological inhibitors does not block viral entry 
The results described thus far help explain why several of the COPI subunits emerged as 
important host proteins in influenza virus infection in the siRNA genome-wide knockdown screens [64, 
66, 67]. However, efficient siRNA depletion can take a few days, thus potentially leading to the 
accumulation of siRNA mediated indirect effects due to long-term depletion of critical host proteins. In 
order to test whether we could recapitulate the observations in the siRNA treated cells, and therefore to 
determine whether there is a direct role for COPI during the influenza virus infection cycle, we conducted 
experiments using pharmacological inhibitors that rapidly disrupt COPI vesicle formation.  
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The conversion of inactive, cytosolic ADP ribosylation factor 1 (ARF1)-GDP to the activated 
ARF1-GTP form triggers its attachment to the golgi membrane, and subsequent recruitment of COPI 
complexes [86-88].  Two pharmacological inhibitors—BrefA and GCA— prevent exchange of ARF1-
GDP to ARF1-GTP via different mechanisms. BrefA binds to the protein-protein interface of ARF1 and 
several different BrefA-sensitive guanine nucleotide exchange factors (GEFs) to prevent exchange of 
GDP with GTP [89, 197]. Therefore, treatment with BrefA not only inhibits COPI membrane recruitment, 
but also other ARF1-GTP dependent vesicular trafficking processes, such as AP1-dependent trans-golgi 
network (TGN) trafficking to endosomal compartments [86, 87]. A more specific inhibitor of COPI 
complex vesicle formation is GCA, which binds to GBF1, a COPI-specific ARFGEF [198].   
We confirmed that the DMSO control treated cells exhibit a compact COPI perinuclear stain 
reminiscent of the golgi-apparatus. In stark contrast, the BrefA or GCA trecvgf"egnnu"gzjkdkv"c"fkurgtugf"ȕ-
COPI staining, indicative of the inability for COPI complex recruitment to the golgi apparatus [198] (data 
not shown).  To test whether the drug treatment also inhibits viral fusion as observed for siRNA COPI 
knockdown, we performed the viral fusion assay, as described in Figure 3.2A. Viral fusion was measured 
in A549 cells pre-treated and incubated with 32"ȝi1oN"DtghC"."32"ȝO"IEC."qt"203'"X1X"FOUQ"*cu"c"
control for the total amount of DMSO added in the BrefA or GCA treated cells) during the entire 
experiment. In contrast to the results from Figure 3.2A, we found that inhibition of COPI complex vesicle 
formation does not affect viral fusion (Figure 3.5A). 
Because internalization and transport to late endosomes comprised the two major blocks in viral 
entry for ARCN1 knockdown cells, we tested whether BrefA and GCA treatment could also recapitulate 
those same defects.  Using the same immunofluorescence-based internalization assay as described in 
Figure 3.3A and 3B, we found that the mean internalization fraction was 0.58, 0.56, and 0.57 for DMSO, 
BrefA, and GCA treated cells, respectively (Figure 3.5B). Furthermore, we tested whether inhibitor 
treatment affects trafficking to intermediate/late endosomes by measuring the fraction of internalized 
AF647-X31 within Rab7-GFP endosomes. The mean colocalization fraction between the virus and Rab7 
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in the DMSO, BrefA, and GCA treated cells was 0.74, 0.67, and 0.61, respectively (Figure 3.5C). Our 
AF647-X31 internalization and Rab7-GFP colocalization results were consistent with the viral fusion 
results: only minor differences were observed upon BrefA and GCA treatment, indicating that rapid 
disruption of COPI vesicles unlikely results in an entry defect.  
 
Figure 3.5. Pharmacological disruption of COPI complexes does not block virus entry.  A) 
Representative flow cytometry-based quantification of DiD dequenching from three independent 
experiments. DiD signal was measured at different time points post DiD-X31 infection in A549 cells 
trecvgf"ykvj"203'"X1X"FOUQ."32"ȝi1oN"DtghC."qt"32"ȝO"IEC0"Uvcpfctf"fgxkcvkqpu"tgrtgugpv"fwrnkecvg"
samples for each time point.  B) Quantification of the fraction of internalized AF647-X31 particles at 30 
mpi, upon treatment with inhibitors or DMSO using the same immunofluorescence-based internalization 
assay in Figure 3.3A. At least 17 different cells were quantified for virus internalization. Statistical 
analysis was performed using a one-way analysis of variance (ANOVA).   C) Quantification of the 
fraction of AF647-X31 particles colocalized with Rab7-GFP endosomes at 90 mpi in A549 cells treated 
ykvj"203'"X1X"FOUQ."32"ȝi1oN"DtghC."qt"32"ȝO"ICA. At least 16 different cells were quantified. On 
the top left corner, we report a ratio, representing the sum of all AF647-X31 particles colocalized Rab7 
versus the total number of internalized virus particles for all cells quantified. Statistical analysis was 
performed using a one-way ANOVA. D) Flow cytometry-based quantification of the percent of NP-
positive (NP+) cells and the NP expression levels of the NP-positive cells for A549 cells treated with 0.1% 
X1X"FOUQ."32"ȝi1oN"DtghC."qt"32"ȝO"IEC"fwtkpi"vhe entire infection with X31 (MOI ~ 1).  E) Flow 
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Figure 3.5. (continued) cytometry-based quantification of the percent of NP-positive (NP+) cells and the 
NP expression levels of the NP-positive cells for A549 cells infected with X31 (MOI ~ 1.5) and exposed 
vq"203'"X1X"FOUQ."32"ȝi1oN"DtghC"qt"32"ȝO"IEC"qpn{"fwtkpi"gpvt{0"F) Flow cytometry-based 
quantification of the percentage of NP-positive (NP+) cells and the NP expression levels of the NP-
rqukvkxg"egnnu"hqt"C76;"egnnu"kphgevgf"ykvj"Z53"*OQK"\"307+"cpf"gzrqugf"vq"203'"X1X"FOUQ."32"ȝi1oN"
DtghC."qt"32"ȝO"IEC"qpn{"chvgt";2"ork0"Kp (D-F), the bar chart represents the average from two 
independent experiments (consisting of three replicate samples for each inhibitor or DMSO treatment), 
with the corresponding SEM. 
Next, to test whether BrefA or GCA treatment affects influenza infection, we pre-treated A549 
egnnu"ykvj"203'"FOUQ"*cu"c"eqpvtqn+."32"ȝi1oN"DtghC."qt"32"ȝO"IEC"hqt"82"okpwvgu."cnnqygf"Z53"vq"
infect cells at an MOI of ~1 for nine hours, and measured NP expression with a flow cytometer. In stark 
contrast to the results from Figure 3.1C, we found that disruption of COPI complexes resulted in a 
moderate decrease in infection: relative to the DMSO control, BrefA or GCA treatment reduced the 
percent of NP-expressing cells by 21.3% +/- 7.9% or 40.6% +/- 1.3%, respectively. In addition, we found 
a moderate decrease in the NP expression level for the NP+ cells relative to the DMSO control:  31.1% 
+/- 1.2% and 35.3% +/- 3.6%, in the BrefA and GCA treated cells, respectively (Figure 3.5D).  However, 
it remains unclear whether these defects resulted from an entry or post entry exposure to BrefA or GCA. 
To assess whether exposure to BrefA or GCA during entry affects productive influenza virus 
infection, we pre-treated with the inhibitors for 60 minutes, followed by X31 infection in the presence of 
the compounds for 90 minutes. Afterwards, the compounds were removed, and the infection was 
continued for an additional 7.5 hours before processing for flow cytometry. We found that treatment of 
BrefA or GCA during entry alone did not affect the percent NP+ cells or the NP expression levels (Figure 
3.5E). However, when BrefA and GCA were added and maintained only after 90 mpi, a moderate 
decrease in NP expression was again observed (Figure 3.5F), indicating that the effects on viral gene 
expression upon BrefA or GCA treatment originate from post entry steps.  
Collectively, these results indicate that functional COPI vesicle recruitment to cellular 
membranes is not required for influenza virus internalization, endosomal trafficking, or viral fusion, but 
has a moderate effect on viral NP expression. 
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3.2.5 Rapid disruption of COPI complex function decreases viral membrane protein expression and 
progeny virus production  
To test whether COPI complex disruption inhibits viral membrane protein expression, we 
infected A549 cells with X31 (MOI ~ 1.5). At 90 mpi, we added 203'"FOUQ"*cu"c"eqpvtqn+."32"ȝi1oN"
DtghC."qt"32"ȝO"IEC"vq"vjg"xktwu"kphgevgf"egnnu0"Cv"pkpg"jrk."yg"hkzgf"vjg"egnnu."cpf"rgthqtogf"
sequential immunostaining against M2 without and with permeabilization to detect surface and total M2. 
Yg"cnuq"koowpquvckpgf"cickpuv"ȕ-COPI, and confirmed that COPI vesicle formation and concentration 
within the golgi apparatus was perturbed in both the BrefA and GCA treated cells.  By nine hpi, M2 
readily trafficked to the plasma membrane in the DMSO control cells. In stark contrast, no M2 was 
detected on the plasma membrane of BrefA treated cells, while some M2 was trafficked to the cell surface 
and some trapped within intracellular vesicles within GCA treated cells (Figure 3.6A).  
To test whether BrefA or GCA treatment also impaired plasma membrane targeting of another 
influenza membrane protein, we performed the experiment as described above, except we fixed the cells 
at a total of 12 hpi, and then immunostained for surface and total NA. In contrast to the minor M2 
trafficking defects, GCA treatment strongly inhibited NA transport to the cell surface (Figure 3.6B).  
To quantify the defect in M2 protein expression and plasma membrane transport, we performed 
the experiment as described for Figure 3.6A, except at nine hpi, we collected, fixed, immunostained for 
M2, and analyzed the samples with a flow cytometer. Immunostaining the X31 infected cells for M2 in 
the presence of detergents allowed detection of total M2 expression. When compared to the results on 
post entry effect of BrefA and GCA on NP expression in Figure 3.5F, M2 expression was more 
substantially perturbed upon treatment with BrefA or GCA, relative to the DMSO control. Furthermore, 
consistent with the immunofluorescence results from Figure 3.6A, BrefA treatment inhibited M2 plasma 
membrane transport, and only minor M2 trafficking defects were measured in GCA treated cells (Figure 
3.6C).  
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Figure 3.6. Functional COPI complex recruitment to cis-golgi is required for viral membrane 
protein expression. A) Representative spinning disk confocal xy cross-sections of X31 infected A549 
cells treated with 0.1% V/V FOUQ."32"ȝi1oN"DtghC"qt"32"ȝO"IEC."cpf"vjgp"koowpquvckpgf"vq"fgvgev"
surface M2 (left most panels, or green in the right most panels), total M2 (second left panels, or red in the 
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Figure 3.6. (continued) right most rcpgnu+."cpf"ȕ3-COPI (second right panels, or blue in the right most 
rcpgnu+"*32"ȝo"uecng"dctu+0 B) X31 infected cells were stained for surface NA (left most panels, or red in 
tkijv"rcpgnu+"cpf"vqvcn"PC"*ugeqpf"nghv"rcpgnu."qt"itggp"kp"tkijv"rcpgnu+"*32"ȝo"uecng"dctu+0 C) Flow 
cytometry-based quantification of the percent of M2-positive (M2+) cells and the M2 expression levels in 
the M2-positive cells for A549 cells infected with X31 (MOI ~ 1.5) and exposed to 0.1% V/V DMSO, 10 
ȝi1oN"DtghC."qt"32"ȝO"IEC"qpn{"chvgt";2"ork0"Koowpqhnwqtguegpeg"ycu"rgthormed either in the 
presence of saponin to detect total M2 expression, or absence of detergent to detect surface M2. The bar 
chart represents the average from two independent experiments (consisting of three replicate samples for 
each inhibitor or DMSO treatment), with the corresponding SEM. D) Quantification of the relative 
surface or total NA expression based on the acquired confocal images (error bars indicate standard 
deviation of at least 18 images per treatment condition).  
We also quantified the effect of BrefA and GCA treatment on NA expression and plasma 
membrane transport. In contrast to the M2 trafficking in Figure 3.6A and 3.6C, both BrefA and GCA 
treatment inhibited NA trafficking to the plasma membrane (Figure 3.6D). The discrepancy between M2 
and NA plasma membrane trafficking in GCA treated cells suggests that the two membrane proteins may 
exhibit different transport requirements. 
It remains unclear whether BrefA and GCA treatment leads to additional perturbations in the 
assembly of viral components at the plasma membrane. Influenza assembly is initiated by HA and NA 
recruitment to cholesterol-enriched plasma membrane domains. M1 is believed to interact with the 
cytoplasmic tails of HA and NA, and M1 interaction with vRNP facilitates the incorporation of the viral 
genomes into the budding virions [60]. The vRNPs can be detected with PB1-specific antibodies.  The 
PB1 patches are sites enriched with assembling virus particles, or budding zones. To determine whether 
functional COPI vesicle formation is essential for viral assembly, we immunostained X31 infected cells 
treated with DMSO, BrefA, or GCA with M2 (to detect infected cells) and PB1 (Figure 3.7A). We found 
that 38% of infected, DMSO-treated cells contained budding zones enriched with PB1 at 18 hpi. In stark 
contrast, only 1% and 2% of BrefA and GCA treated cells infected by X-31, respectively, had the budding 
zones (Figure 3.7B). The inability to traffick NA (and to some extend M2) to the plasma membrane in 
either the BrefA or GCA treated cells may help to explain the large defect in assembly and the failure to 
concentrate progeny virions at budding zones within infected cells.    
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Figure 3.7. Disruption of COPI complexes with inhibitors inhibits assembly of progeny virions. A) 
Representative spinning disk confocal xy cross-sections of X31 infected A549 cells treated with 0.1% 
X1X"FOUQ."32"ȝi1oN"DtghC"qt"32"ȝO"IEC."cpf"vjgp"hkzgf"cpf"koowpquvckpgf"ykvj"cpvkdqfkgu"cickpuv"
M2 (left panels, or green in the right panels) and PB1 (midfng"rcpgnu."qt"tgf"kp"vjg"tkijv"rcpgnu+"*32"ȝo"
scale bars). B) Swcpvkhkecvkqp"qh"vjg"htcevkqp"qh"kphgevgf."203'"X1X"FOUQ."32"ȝi1oN"DtghC."qt"32"ȝO"
GCA treated cells that contain budding zones at the cell periphery. The fraction on the top left corner 
represents that number of cells with the budding zone (numerator) relative to the total number of virus-
infected cells (denominator) for all cells counted. C) Viral titer of supernatant collected from X31 infected, 
203'"X1X"FOUQ."32"ȝi1oN"DtghC."qt"32"ȝO"IEC"-treated A549 cells after 18 hpi measured with 
plaque assays (Materials and Methods). The bar chart represents the SD from samples tested in 
quadruplicate. 
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To assess whether the defects in assembly was important for progeny virus production, the 
supernatant of the virus-infected cells was collected after 18 hpi and the viral titer was measured with 
standard plaque assays. We found that the presence of either BrefA or GCA reduced viral titers by about 
two orders of magnitude relative to the DMSO control (Figure 3.7C).  
In summary, the results from the pharmacological inhibitors strongly suggest that inactivation of 
COPI vesicle formation does not result in an entry defect, but does specifically inhibit viral membrane 
protein expression, plasma membrane transport, assembly, and infectious progeny virion production.  
3.3 Discussion 
As an obligate pathogen encoding 13 viral proteins, influenza virus requires host factors and 
compartments to mediate productive infection. Recently, genome-wide knockdown screens identified host 
dependency proteins important for influenza virus infection. Despite the relatively little overlap in 
identified host dependency proteins amongst the screens, all of them found subunits of the COPI 
complex, as critical host proteins in mediating productive virus infection. COPI proteins form complexes, 
which oligomerize to coat vesicles. These coated vesicles mediate retrograde trafficking between the 
golgi apparatus and the ER, as well as between the golgi stacks. Previous studies have also identified a 
role for COPI proteins in endosomal trafficking. Given that COPI proteins mediate trafficking between 
different cellular compartments both in the synthesis and endosomal trafficking pathways, it remained 
unclear which steps in the influenza virus infection cycle COPI proteins regulate.   
Identification of host dependency proteins through siRNA depletion can result from four general 
outcomes: (1) siRNA-induced cytotoxicity, (2) off-target effects (e.g. interferon-induction or siRNA 
sequence overlap with other mRNA sequences), (3) direct effects of siRNA-mediated depletion of the 
gene of interest, or (4) indirect effects mediated by long term depletion of the target of interest. We 
confirmed that within our experimental window frame, siRNA-mediated cytotoxicity did not play a 
dominant role in our studies. No difference was observed in cell viability with minor changes to 
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cytotoxicity and concomitantly cell growth. Based on the control experiments, we believe that the defects 
in influenza virus infection upon ARCN1-depletion result in either direct or indirect effects specific to 
siRNA-mediated silencing. In order to differentiate whether the COPI depletion results in direct or 
indirect effects, we used both siRNA silencing and rapid COPI vesicle disruption via BrefA or GCA 
treatment to analyze how these two methods of perturbation affect different steps in the influenza virus 
infection cycle: binding, internalization, transport into late endosomes, fusion, viral protein expression, 
trafficking, assembly, and progeny virion production. 
Previously, König and colleagues identified ARCN1, an essential subunit of the COPI complex, 
as a critical host protein for influenza virus infection [67]. Upon further analysis, the authors also 
provided evidence that ARCN1 depletion affects influenza virus entry. Because of the data suggesting a 
role for ARCN1 in mediating influenza virus entry and because ARCN1 is known to be an essential 
component of the COPI vesicle complex, we decided to focus our studies on understanding the role of 
ARCN1 on influenza virus infection, as a representative subunit for the COPI complex. After conducting 
a systematic dissection of the different entry steps, we found that ARCN1-depleted cells do exhibit a 
significant defect in viral fusion. The abrogation of viral fusion in ARCN1 depleted cells likely explains 
why König and colleagues observed a significant defect in vRNP accumulation in the nucleus when 
compared to the non-targeting control cells. Consistent with the viral fusion data, we found that ARCN1 
knockdown cells exhibited a ~66% decrease in internalization, ~76% decrease in colocalization of the 
virus with a late endosome marker, LBPA, and ~90% decrease in virus infection relative to the non-
targeting siRNA control cells.  Taken together, our results show that COPI depletion leads to defects in 
virus internalization and transport to late endosomes, and viral fusion, the latter effect is likely a 
consequence of the former two effects. 
Cureton and colleagues showed that COPI depletion also lead to defects in VSV entry, though 
there are differences in which particular steps are perturbed between the two viruses. Cureton and 
colleagues found that COPI depletion results in a decrease in viral fusion due to a ~40% decrease in VSV 
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binding and a decreased rate of VSV internalization. However, the VSV particles that do manage to 
internalize the COPI-depleted cells can still traffick to early endosomes and undergo vRNP release, 
indicating that the endosome trafficking of VSV is not perturbed.  On the other hand, our findings show 
that COPI depletion did not perturb influenza virus binding, but did inhibit virus internalization and 
transport to late endosomes. 
Treatment of cells with two pharmacological compounds—BrefA and GCA— that rapidly 
prevent the recruitment of COPI complexes to the golgi apparatus, resulted in strikingly different results 
from the siRNA experiments. Specifically, we did not observe any significant difference in influenza 
virus fusion, or colocalization with a late endosome marker when cells were treated with the DMSO, 
BrefA, or GCA. Substantiating the results from BrefA and GCA treatment, no extensive colocalization 
was observed between GFP-vciigf"i-COPI, another essential component of the COPI complex, and 
AF647-labeled influenza virus in live cells during entry. Combining the siRNA, pharmacological 
inhibitor, and live cell imaging results, we conclude that functional COPI complex vesicle formation is 
not directly required for influenza virus entry, though ARCN1 depletion leads to indirect effects that 
result in a defect in influenza virus internalization, trafficking to late endosomes, and consequently viral 
fusion.  
Functional COPI complex formation and COPI vesicles mediate trafficking between the golgi 
apparatus and ER as well as between the different golgi stacks. The golgi-derived vesicles then traffick 
contents from the golgi apparatus to other locations within the cell including late endosomes, lysosomes, 
and the plasma membrane [87, 88]. Defects in golgi vesicular trafficking over an extended period of time, 
such as during siRNA depletion, could result in improper trafficking of membrane proteins or lipids. 
Changes in protein or lipid compositions [199] at the plasma membrane and endosomes may provide an 
explanation to the significant defect observed in viral, internalization, trafficking, and fusion. The 
rqvgpvkcn"ejcpigu"kp"rtqvgkp"cpf"nkrkf"eqorqukvkqpu"ku."jqygxgt."pqv"tghngevgf"kp"vjg"coqwpv"qh"g*4.8+-
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linked sialic acids—the attachment factor for influenza— presented on the surface of cells, consistent 
with the observation that viral binding is not substantially affected by ARCN1 knockdown.  
The severely compromised uptake of general clathrin-mediated endocytosis and 
macropinocytosis cargoes in the ARCN1 knockdown cells does suggest that protein and/or lipid 
compositions at the cell surface may be altered during the course of siRNA depletion. ARCN1 
knockdown cells internalized ~60% less virus by 30 mpi relative to the non-targeting control. Other 
cargoes of clathrin-mediated endocytosis (Tfn and EGF) and macropinocytosis (dextran) also exhibited 
significant internalization defects in ARCN1 knockdown cells relative to the non-targeting siRNA treated 
cells. Consistent with our findings, Cureton and colleagues have found that only after prolonged, but not 
short exposure of COPI-disruption inhibitors, were VSV and Tfn uptake perturbed [45].  
Another phenomenon that may be related to the defect in trafficking of influenza virus to late 
endosomes is the anomalous LBPA+ late endosome staining pattern as observed in Figure 3.4A. In 
contrast to the dense perinuclear LBPA+ late endosome staining observed with the non-targeting control 
cells, we observed a reproducible dispersion of late endosomes—with no apparent aberrant changes to the 
early endosome organization— in ARCN1 knockdown cells. This observation is consistent with previous 
reports that show COPI subunit depletion alters the late endosome trafficking pattern [200]. It has also 
been found that inhibition of endosomal trafficking by blocking the uptake pathways lead to a loss of 
lysosomal acidification and perinuclear localization [201]. We also note that the shape of the ARCN1 
knockdown cells sometimes appeared different from the non-targeting control cells, though it remains 
unclear what is the underlying mechanism for the change in cell morphology. It is possible that the 
change in the spatial distribution of late endosomes and the cell morphology may also be related to the 
inhibition of viral entry. 
Together, these above results show that prolonged exposure to siRNA depletion of an essential 
COPI subunit results in an indirect effect of compromised cargo endocytosis. On the other hand, 
inhibiting COPI complex recruitment to the golgi apparatus by acute pharmacological treatment directly 
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affects viral protein expression and infectious progeny virus production. Disruption of COPI complexes 
by BrefA and GCA only had a moderate effect on NP expression. However, BrefA and GCA treatment 
inhibited M2 and NA expression, suggesting that COPI complex formation is specifically required for at 
least some membrane protein expression. The inhibition could perhaps be due to retention of proteins 
within the ER from defective trafficking between the ER and golgi apparatus. Alternatively, treatment 
may also cause re-routing of golgi contents to alternative endosomal populations rather than intended 
target sites such as the plasma membrane [202].  
We also observed that BrefA and GCA treated cells exhibited a defect in progeny virion assembly 
and production. Previous studies have found that NA, but not M2 associates with lipid rafts [60]. For 
GCA treated cells, transport of M2 to the plasma membrane was modestly affected, while both the plasma 
membrane targeting of NA and progeny virus assembly were strongly impaired. These results suggest that 
the large assembly defect in GCA treated cells may stem from inhibition of the trafficking of lipid-raft 
associated membrane proteins to the plasma membrane, which are critical for initiating virus budding and 
subsequent assembly steps.  
In summary, upon dissection of the influenza virus infection cycle with both siRNA silencing and 
pharmacological compound perturbation, we have identified which steps of influenza viral infection are 
direct or indirectly dependent on functional COPI complex formation. Long-term siRNA COPI depletion 
in cells leads to indirect effects on viral entry through defective cargo uptake and vesicular trafficking to 
late endosomes, while acute treatment with COPI complex inhibitors impaired viral membrane protein 
expression and assembly, suggesting a direct role of COPI complexes in these later steps of infection. It 
has been recently found that COPI proteins mediate many additional effects beyond the well studied 
trafficking roles within the synthesis and secretory pathways, including lipid droplet formation and lipid 
metabolism, autophagosome formation, and endocytosis of EGF and Tfn [199, 200, 203, 204], which 
could potentially be related to the observed indirect effects of COPI depletion on viral entry. Future 
studies on how COPI siRNA treatment affects protein or lipid expression, modification, and transport to 
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different cellular compartments should be helpful in understanding how COPI proteins regulate such 
diverse cellular processes, as well as how these effects may lead to the observed defects of viral infection 
in COPI-depleted cells. 
3.4 Materials and methods  
Antibodies for immunofluorescence or western blotting analysis. We used the following primary 
antibodies (vendor, catalog number, and dilution stated in parentheses) for this study: rabbit anti-coatomer 
subunit delta antibody (Abcam, ab96725, 1:1,000), mouse anti-influenza A virus nucleoprotein antibody 
[AA5H] (Abcam, ab20343, 1:1000),  mouse anti-nucleoprotein (Santa Cruz biotechnology, sc-57882, 
1:100), rabbit anti-ȕ-COPI (generously donated by James Rothman, 1:1000),  rabbit anti- COPZ1 (Sigma, 
SAB4500896, 1:1,000),  rabbit anti- Ȗ3-COP1 (generously donated by Felix Wieland, 1:10,000),  rabbit 
anti-COPE (Abcam, ab88824, 1:1,000),   mouse anti-beta actin antibody - loading control (Abcam, 
ab8227, 1:1,000), rabbit-anti phospho-STAT1 Tyr701 (Cell Signaling, 9167, 1:1,000), mouse anti-
Cy5/AF647 (Sigma, C1117, 1:1,000), mouse anti-EEA1 (BD Transduction Laboratories, 610457, 1:500),  
( mouse anti-LBPA antibody (Echelon, Z-PLBPA-50ug, 1:500), mouse anti-influenza A virus M2 protein 
antibody [14C2] (Abcam, ab5416, 1:1,000), rabbit anti-neuraminidase (kind gift of Gillian Air, 1:5000) 
and mouse anti-PB1 (Santa Cruz biotechnology, sc-17601, 1:100). We used the following secondary 
antibodies for this study: Alexa Fluor 647 donkey anti-mouse (Molecular probes, A31571, 1:1,000), 
Alexa Fluor 555 donkey anti-mouse (Molecular probes, A31570, 1:1,000), Alexa Fluor 488 donkey anti-
mouse (Molecular probes A-21202, 1:1000),  Alexa Fluor 568 donkey anti-rabbit (Molecular probes, A-
100042, 1:1,000), ECL donkey anti-rabbit IgG, HRP-Linked (GE Healthcare, NA934, 1:5,000), and ECL 
sheep anti-mouse (GE Healthcare, NXA931, 1:5,000). 
Cell culture. A549 lung carcinoma cells (ATCC) were cultured in Dulbecco's modified Eagle 
medium (DMEM; Invitrogen) supplemented with 10% fetal bovine serum (Serum International), 1 mM 
pqpguugpvkcn"cokpq"cekfu"*CVEE+."cpf"cpvkdkqvkeu"*CVEE="47"W1on"rgpkeknnkp"cpf"47"ȝi1on"uvtgrvqo{ekp+."
and maintained in humidified, 5% CO2 environment at 37°C.  
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For siRNA knockdown experiments, A549 cells were electroporated with 100 pmols of specified 
COPI siGENOME SMARTpool siRNA (Dharmacon) or AllStars Negative Control siRNA (Qiagen) 
using an Amaxa Lonza Nucleofector with kit -T (Lonza, VVCA-1002) and program X-001. Experiments 
were performed on the siRNA treated A549 cells 48 hours after electroporation. For plasmid expression, 
C76;"egnnu"ygtg"gngevtqrqtcvgf"ykvj"4"ȝi"qh"gkvjgt"COPE-GFP (Origene) or Rab7-GFP (generous gift 
from Qing Zhong [205]) plasmid using kit-T and Nucleofector program X-001. Experiments using these 
plasmids were performed within 24 hours after electroporation of these plasmids.  
LIVE/DEAD Viability/Cytotoxicity kit (Invitrogen, L-3224) was used according to vendor 
instructions to measure cell viability, death, and growth. Stimulation of the interferon response in A549 
egnnu"ycu"cejkgxgf"ykvj"32.222"W1oN"KHPg"hqt"vjtgg"jqwtu"*RDN"Dkqoedical Laboratories, 11101-1) 
prior to collecting cell lysate. 
Spinning disk confocal imaging. Spinning disk confocal z-stacks were taken with a custom built 
confocal microscope, which was previously described in detail [206]. Briefly, multi-color fluorescent 
fixed cell imaging was achieved using an Okogawa spinning disk confocal scan head attached to an 
Olympus IX-71 microscope (Olympus, Center Valley, PA) with an Olympus 60×, 1.35 NA oil-immersion 
objective. A 561 nm crystal laser, 647 nm krypton ion laser, and/or 457/488/514 nm argon laser were 
used to image the samples onto an Andor 885 electron-multiplying charge coupled device camera.  
Cargo uptake assays and data analysis.  siRNA treated A549 cells were rinsed extensively with 
PBS, and cold bound with Alexa Fluor 568-transferrin (AF568-Tfn, Invitrogen, T23365) and Alexa Fluor 
647-epidermal growth factor (AF647-GIH."Kpxkvtqigp."G57573+"hqt"52"okpwvgu"cv"6üE0"Wpdqwpf"CH78:-
Tfn and AF647-EGF was removed with extensive cold PBS washes, and incubated in warm DMEM with 
cpvkdkqvkeu"hqt"fkhhgtgpv"coqwpvu"qh"vkog"cv"59üE0"Hqt"hnwkf"rjcug"wrvcmg."ugtwo"uvctxgf"C76;"egnnu"ygtg"
incubated with 5 mg/mL TMR-dextran (Invitrogen, D-1868) in warm DMEM with antibiotics for 
difhgtgpv"coqwpvu"qh"vkog"cv"59üE0 
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At the indicated time points, surface bound cargo was removed with acid buffer (PBS, adjusted to 
rJ"408"ykvj"cegvke"cekf+"hqt"4"okpwvgu."Ýzgf"ykvj"504'"rctchqtocnfgj{fg"*RHC."Electron microscopy 
sciences), and imaged using a spinning disk confocal microscope. Confocal z-stacks were taken for each 
field of view, which contained about nine to ten cells per image.  For analyzing Tfn, EGF or dextran 
internalization, a Matlab script based on k-clustering analysis was used to threshold the images to 
differentiate the background pixels from the signal pixels. Briefly, the optimized thresholding value was 
determined for each maximum z-projection image by an iterative thresholding algorithm that found the 
maximum difference between the mean background pixels and the mean signal pixels. The mean signal 
intensity of 15 to 20 maximum z-projection images per time point was calculated and averaged.  
To test the known effect of amiloride on macropinocytosis, A549 cells were treated with different 
concentrations (specified in the figure) of 5-(N-ethyl-N-isopropyl) amiloride (EIPA) (Sigma, A3085) in 
DMEM without P/S or FBS for 60 minutes. The cells were then incubated with 0.2 mg/mL AF647-
Fgzvtcp"hqt"52"okpwvgu"cv"59üE"rtkqt"vq"nqy"rJ"RDU"ycuj."followed by PFA fixation. Additionally, 
inhibition of dynamin-dependent endocytosis was tested by treatment with different doses of dynasore 
*Ukioc."F98;5+"kp"FOGO"ykvjqwv"R1U"qt"HDU"hqt"52"okpwvgu."rtkqt"vq"eqnf"dkpfkpi"3ȝi1oN"CH869-Tfn 
or 1:1000 AF647-EGF for 30 minutes. Unbound cargo was replaced with warmed inhibitor containing 
FOGO"ykvjqwv"HDU"qt"R1U."cpf"kpewdcvgf"cv"59üE"hqt"32"okpwvgu"rtkqt"vq"nqy"rJ"RDU"ycuj."hqnnqygf"
by PFA fixation.  For dextran, Tfn, and EGF uptake experiments, images of the samples and analysis 
were performed as described in the above paragraph. 
Virus labeling. Non-specific amine-reactive labeling of virus:  50 oL of 1 mg/mL purified 
influenza A X31, A/Aichi/68 (H3N2) (Charles River Laboratories) was mixed with 47 oL 0.1 M freshly 
prepared carbonate buffer (pH ~8 to 9) and 6 og Alexa fluor 647 carboxylic acid, succinimidyl ester 
(Invitrogen, A-20106) dissolved in DMSO. The mixture was gently mixed in the dark for 60 minutes. A 
Nap5 size exclusion column (GE Healthcare) was used to separate free dyes from labeled virus using 
Hepes 145 elution buffer (50 mM Hepes pH 7.4, 145 mM NaCl). The excess AF647-labeled X31 was 
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aliquoted, snap frozen, and stored at -80ﬂC [159]. No significant difference in infectivity was observed 
between labeled and unlabeled X31 (data not shown). 
X31 membrane labeling: 100 oL of 1 mg/mL purified  X31 was mixed with 3 oL 25 mM 1,1'-
Dioctadecyl-3,3,3',3'-Tetramethylindodicarbocyanine, 4-Chlorobenzenesulfonate Salt ('DiD' solid; 
DiIC18(5) solid) (Invitrogen, D-7757) dissolved in DMSO. The mixture was gently vortexed in the dark 
for 2 hours. A Nap5 size exclusion column was used to separate free dyes from labeled virus using Hepes 
145 elution buffer. The excess DiD-labeled X31 was aliquoted, snap frozen, and stored at -80ﬂC.  Prior to 
using the DiD-labeled X31 for the experiments, the virus was filtered through a 0.2 um filter [61]. We 
confirmed with plaque assays that the DiD-labeled X31 remained infectious.  
Bulk viral fusion assay.  For the pharmacological compound-treated cells, all steps during the 
fusion assay before trypsinization—except the PBS washes—included the compounds. A549 siRNA or 
pharmacological compound-treated cells seeded in Lab-tek 8 well glass dishes were rinsed extensively 
with PBS and cold bound with 2 x 104 PFU/mL DiD-X31 for 45 minutes on ice. Unbound virus was 
removed with extensive PBS washes, and incubated with DMEM for different amounts of time at 37°C. 
Afterwards, the cells were washed once with PBS, and trypsinized. The trypsin was neutralized with PBS 
supplemented with 10% FBS and 30 mM sodium azide, and the cells were collected and placed on ice to 
prevent any further fusion. Cells were fixed with 2% PFA for 20 minutes, washed once with PBS, and 
analyzed immediately with a flow cytometer (BD Biosciences Fortessa). The data was interpreted using 
FlowJo software.  
Virus binding or Elderberry lectin binding assays. After 48 hours siRNA knockdown, A549 cells 
were washed extensively with PBS, and cold bound with different concentrations of AF647-X31 in 
DMEM for 45 minutes. Unbound virus was removed through PBS washes, and the cells were 
immediately trypsinized. The trypsin was neutralized with PBS supplemented with 10% FBS and 30 mM 
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sodium azide. Cells were collected and fixed with 2% PFA for 20 minutes, washed once with PBS, and 
analyzed immediately with a flow cytometer.  
For the elderberry lectin binding assays, siRNA treated cells were trypsinized and fixed with 2% 
PFA. The cells were then treated with or without different doses of sialidase A (Prozyme) in PBS (pH ~5) 
for one hour at 37°C. The pH was raised to ~pH 7 to stop the sialidase A reaction, and cells were stained 
with 1:1000 FITC-conjugated S. nigra (elderberry bark, SNA-FITC) lectin (Vector laboratories) for one 
hour. After three PBS washes, the samples were immediately analyzed by flow cytometry.  
Immunofluorescence for flow cytometry. siRNA or pharmacological compound-treated A549 cells 
were infected with influenza virus at 37°C for nine or 12 hours. Infected cells were trypsinized and fixed 
in 2% PFA in PBS for 20 minutes at room temperature, and washed once to remove the fixation buffer. 
The cells were permeablized in buffer P (PBS containing 10% FBS and 0.075% Saponin) for 5 minutes. 
The samples were incubated with mouse anti-influenza NP or anti-influenza M2 (1:1000 dilution in buffer 
P) for 60 minutes, washed three times with buffer P, incubated with Alexa Fluor 647 donkey anti-mouse 
(1:1000 dilution in buffer P) for 30 minutes, washed three times with buffer P, washed once with PBS, 
and analyzed by flow cytometry. 
Immunofluorescence with endosomal markers. To delineate the cell membrane, fixed A549 cells 
were first stained with SNA-FITC without permeabilization. For colocalization studies between influenza 
virus and EEA1, fixed A549 cells were blocked and permeabilized with 3% bovine serum albumin 
(Jackson laboratories) and 0.1% Triton X-100 for 30 minutes at room temperature (blocking buffer). The 
cells were incubated with mouse anti-EEA1 in blocking buffer for one hour at room temperature, rinsed 
with PBS, stained with Alexa Fluor 555 donkey anti-mouse in blocking buffer for 30 minutes, and 
washed with PBS. 
For colocalization studies between influenza virus and LBPA, fixed A549 cells were blocked and 
permeabilized with 3% bovine serum albumin (Jackson laboratories) and 0.075% (W/V) Saponin for 30 
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minutes at room temperature (blocking buffer). All subsequent wash and antibody incubations were 
performed with the blocking buffer, unless state. The sample was incubated with mouse anti-LBPA for 
one hour at room temperature, washed, stained with Alexa Fluor 555 donkey anti-mouse for 30 minutes, 
washed, and rinsed with PBS. 
All samples were imaged on a customized spinning disk confocal microscope, which is described 
briefly above and previously in more detail [206]. ImageJ software was used to visualize the fluorescent 
confocal z-stacks, and the fraction of internalized virus particles that also colocalized with the respective 
endosomal marker was counted. 
Pharmacological compounds. The following pharmacological compounds were used in this study 
with the vendor, catalog number, and concentration or dilution used in the experiments stated in 
parentheses: Dimethyl sulfoxide (DMSO) (Sigma, D2650; 1:1000), Brefeldin A (Sigma, B7651; 10 
ȝi1oN+."cpf"Iqnikekfg"C"*GOF."567:84="32"ȝO+0"Dtghgnfkp"C"cpf"Iqnikekfg"C"ygtg"dqvj"fkuuqnxgf"kp"
DMSO, and incubations were performed in DMEM supplemented with 10% fetal bovine serum, 1 mM 
non-essential amino acids, and antibiotics. The final amount of DMSO did not exceed 0.1% V/V. Specific 
incubation times for each of the experiments are described in the figures and figure legends.   
Plaque assays. We collected the supernatant from influenza-infected cells at 18 or 24 hpi. Serial 
dilutions of the virus-containing supernatant was used to inoculate a ~80% confluent monolayer of Texas-
MDCK cells (generous gift from Robert Lamb) or Vero cells (ATCC) grown in 6-well dishes for ~1.5 to 
2 hours at 37ﬂC. The cells were washed with PBS, coated with 3 mL of 30% Noble Agar (Affymetrix) in 
DMEM containing antibiotics and 2 og/mL acetylated trypsin (Sigma), and then incubated at 37ﬂC.  
Two different detection methods were used to determine the viral titer. For immuno-detection of 
infected cell colonies (fluorescent foci), the noble agar disks were removed after ~36 hpi, and the cells 
were fixed with 100% methanol for 8 to 10 minutes at -20ﬂC. The cells were rinsed with PBS, blocked 
and permeabilized with 3% BSA and 0.1% Triton X-100 in PBS for 30 minutes, immunostained against 
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NP in blocking buffer for 60 minutes, washed three times with PBS, incubated with Alexa fluor 488 
donkey anti-mouse in blocking buffer for 30 minutes, and washed three times with PBS. The fluorescent 
foci were visualized and quantified using a Typhoon fluorescent scanner (GE Healthcare).  
The second detection method to determine the viral titer was to count the number of plaques 
observed after 2.5 days post infection. To detect the plaques, the agar disks were removed and the cells 
were immediately fixed and stained with a solution containing 1:1000 V/W crystal violet with 30% 
ethanol in water. The number of plaques for each condition was counted. The viral titer was determined 
with the following equation: (number of foci or plaques)/(dilution * inoculation volume in mL). Samples 
were tested in quadruplicate.  
Western blotting. Cell lysates were diluted in Laemmeli sample buffer (Bio-rad, 161-0737) 
containing DTT to achieve the same amount of protein for all samples. The samples were loaded and ran 
on a 4-15% Tris-HCL polyacrylamide gel (Bio-rad). The separated proteins from the gel were transferred 
onto Hybond PVDF membranes (GE Healthcare), blocked with 5% non-fat milk in TBS-tween, incubated 
with the specified primary antibodies (reported in the figure legends with product information listed 
cdqxg+"hqt"qxgtpkijv"cv"6üE."ycujgf"with TBS-tween, incubated in HRP-conjugated secondary antibodies 
for 60 minutes at room temperature, washed with TBS-tween, detected with Lumigen TMA-6 (Lumigen, 
TMA-100), and exposed/developed onto high sensitivity Kodak film.    
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Chapter 4: Developmental Mechanism of the Periodic Membrane 
Skeleton in Axons 
 
 
 
 
 
 
 
 
 
 
 
 
Work in this chapter was performed in collaboration with Dr. Guisheng 
Zhong, Ruobo Zhou, Damaris Lorenzo, and Hazen Babcock. Most of the results 
from this work are published in [207].  
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4.1 Introduction  
Neurons are highly polarized cells with their somatodendritic regions receiving synaptic inputs 
and axons propagating electrical signals and sending synaptic outputs to target cells. Cytoskeletal proteins 
are important for maintaining the polarity of neurons. For example, actin and microtubules are essential 
for the growth and stabilization of axons, the trafficking of cargos to specific neurites, and the 
stabilization and plasticity of synapses [121-126]. Transient destabilization of actin at the tip of a neurite 
is sufficient to induce a dendrite to become an axon [140]. Increasing evidence also suggests an important 
role for spectrin in the maintenance of neuronal polarization, as well as the development and stabilization 
of axons [134, 142]0"gKK"cpf"ȕKK"urgevtkp"ctg"gptkejgf"kp"czqpu""[133, 134]. Spectrin is known to be 
important for providing the mechanical stability for axons [142] and protecting them from mechanical 
stress [145], for axon path finding [208], for the stabilization of presynaptic terminals [209], and for 
maintaining specific membrane domains in axons [210]0"Okeg"ncemkpi"gkvjgt"gKK"qt"ȕKK"urgevtkp"fkg"kp"vjg"
embryo, highlighting the crucial function of these proteins [134, 143, 144]. Spectrin has also been shown 
to play a role in human neurological diseases [146, 147].  
Recently, the Zhuang lab discovered a periodic submembrane lattice structure made of actin, 
spectrin and other associated molecules preferentially formed in the axons of mammalian neurons [149]. 
In this membrane skeleton, actin filaments form a ring-like structure that wraps around the circumference 
of axons. These actin rings are evenly spaced along the axon shaft with a period of ~190 nm and show a 
remarkably long-range order. Actin filaments in the rings are capped by adducin. Adjacent actin rings are 
connected by spgevtkp."nkmgn{"kp"vjg"hqto"qh"gKK-ȕKK-spectrin heterotetramers, given the observations that 
vjg"rgtkqfke"ȕKK"urgevtkp"tkpiu"cnvgtpcvg"ykvj"vjg"cevkp-adducin rings along axons and that the observed 
190 nm period matches the length of the spectrin tetramer. The ultrastructural organization of this quasi-
one-dimensional, periodic lattice structure is different from the previously observed, two-dimensional 
polygonal membrane skeletal structure found in red blood cells [129-131], whereas an erythrocyte-like 
polygonal membrane skeletal was observed in the axon terminals at the Drosophila neuromuscular 
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junction [211]. Interestingly, this periodic structure forms preferentially in axons, with the actin in 
dendrites primarily adopting the form of long filaments running along the dendrite shaft [149]. In C 
elegans vjcv"ncem"ȕ"urgevtkp"qt"ectt{"c"ȕ"urgevtkp"owvcpv."czqpu"dtgcm"oqtg"gcukn{"fwtkpi"cpkocn"
movement [142] and exhibit impaired touch sensation [145], suggesting that this structure may be 
important for the mechanical stability of axons and for sensing mechanical stimuli. This periodic lattice 
also organizes the axonal membrane by placing important membrane proteins, such as the voltage-gated 
sodium channels, into a periodic distribution [149].  
However, it is unknown how this highly regular membrane skeleton structure develops and how 
its formation is regulated. For example, it is unclear whether the periodic lattice develops during early or 
late stages of axon differentiation. Although protein factors previously identified to be important for axon 
differentiation tend to be enriched and function at the growing tips of axons [123, 124, 212, 213], it is 
unknown whether the actin-spectrin lattice also initiates at the distal ends of axons, or instead forms first 
in the proximal region near the cell body. Finally, the molecular mechanism that regulates the preferential 
formation of this periodic structure in axons remains a mystery. In this study, we addressed these 
important questions concerning the development of this newly discovered neuronal structure. We found 
that the periodic membrane skeleton initiated early during axon differentiation. The lattice structure 
originated in the axonal region adjacent to the cell body and propagated to the distal ends of axons. The 
lattice structure further matured by recruiting other components and the matured membrane skeleton was 
highly stable. The periodic structure formed preferentially in axons with long-range order, but appeared 
only in a small fraction of dendrites and they often appeared as isolated patches of periodic structures. 
Multiple molecular factors played roles in regulating the formation of this structure. The lattice structure 
fgrgpfgf"qp"kpvcev"oketqvwdwngu0"Vjg"jkij"nqecn"eqpegpvtcvkqp"qh"ȕKK"urgevtkp"kp"czqpu"ycu"vjg"mg{"
determining factor for the preferential formation of the lattice structure in axons and artificially increasing 
vjg"eqpegpvtcvkqp"qh"ȕKK"urgevtkp"kp"fgpftkvgu"ycu"uwhhkekgpv"vq"kpfweg"vjg"hqtocvkqp"qh"vjg"rgtkqfke"ncvvkeg"
uvtwevwtg"kp"fgpftkvgu0"Tgoctmcdn{"cpm{tkp"D"ycu"korqtvcpv"hqt"vjg"rqnctk|gf"fkuvtkdwvkqp"qh"ȕKK"urgevtkp 
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in neurites; in ankyrin B knoemqwv"okeg."ȕKK"urgevtkp was evenly distributed in axons and dendrites, giving 
rise to a highly regular, periodic membrane skeleton in both dendrites and axons. 
4.2 Results 
4.2.1 Early development and propagation of the periodic lattice structure in axons  
Neurons exhibit distinct developmental stages with different morphological characteristics during 
polarization [123, 212-214]. In dissociated hippocampal neuronal culture, neurons first display intense 
lamellipodial protrusive activity in stage 1, which then leads to the emergence of multiple immature 
neurites in stage 2 (~1 Day in Vitro (DIV)). In stage 3 (DIV 2-4), one of these neurites breaks the 
symmetry and extends rapidly to become an axon. The other neurites then gradually acquire dendritic 
properties in stage 4 (DIV 4-7). In stage 5 (> DIV 7), neurons continue to mature and form axon initial 
segments, dendritic spines and synapses. In order to determine the developmental course of the periodic 
membrane skeletal structure, we fixed dissociated neurons at different developmental stages, 
koowpquvckpgf"hqt"ȕKK"urgevtkp."cpf"kocigf"wukpi"uvqejcuvke"qrvkecn"tgeqpuvtwevkqp"oketqueqr{"*UVQTO+."
a super-resolution imaging method that relies on switching and localizing single molecules to acquire sub-
diffraction limit images [105-107, 112].  
To illustrate how we systematically imaged and quantified this periodic structure in axons, we 
first imaged a neuron at DIV 10. Consistent with our previous findings [149]."ȕKK"urgevtkp"cfqrvgf"c"
highly regular, periodic pattern in all regions of the axonal shaft (Figure 4.1). Both Fourier transform and 
autocorrelation analyses showed thcv"vjg"ȕKK"urgevtkp"cfqrvgf"c"rgtkqfke"fkuvtkdwvkqp"ykvj"c"rgtkqf"qh"\3;2"
nm (Figure 4.1). Similarly, actin filaments exhibited a highly periodic distribution along axon shafts (data 
not shown). Depolymerizing the actin filaments with latrunculin A (LatA) disrupted the periodic 
fkuvtkdwvkqp"qh"ȕKK"urgevtkp."cpf"mpqemkpi"fqyp"ȕKK"urgevtkp"wukpi"ujTPC"ngf"vq"c"nquu"qh"vjg"rgtkqfke"
actin distribution (data not shown). These results indicate that the periodic organizations of actin and 
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spectrin are interdependent, consistent with the model that adjacent actin rings are connected by the 
spectrin tetramers.  
 
Figure 4.1. ȕII spectrin structure in a DIV 10 neuron. C+"C"F��"��"pgwtqp"�cu"koowpquvckpgf"hqt"���"
spectrin (green) and Map2 (red) and imaged by conventional fluorescence and 3D STORM microscopy. 
STORM images of the two arrow-indicated regions along the axon are shown below. B) Histograms of 
vjg"���"u�gevtkp"nqecnk|cvkqpu"htqo"vjg"dqzgf"tgikqpu"kp"�����"kocigu0"�+"Hqwtkgt"vtcpuhqto"cpcn{ugu"qh"
vjg"���"u�gevtkp"nqecnk|cvkqpu"htqo"vjg"dqzgf"tgikqpu0"F+"Cwvqeqttgncvkqp"cpcn{ugu"qh"vjg"���"u�gevtkp"
localizations from the boxed regions. 
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Figure 4.2. Early development and propagation of the periodic lattice structure in axons. A) A DIV 
�"pg�tqp"��u"u���pg�"����"���"urge�t�p"�p���q��"�p�"�o�ig�"��"��"������"��g"u�ping"nqpi"rtqeguu"htqo"
the cell is the axon. A1, A2 and A3 are 3D STORM images taken from arrow-indicated regions from A. 
��g"�q�t�gt"�t�puhqto"�p�n�ugu"qh"��g"���"urge�rin distribution along the axon shaft are shown on the right. 
B) Similar to A) but for a DIV 6 neuron. C-��"���qeqttgn���qp"�p�n�u�u"qh"���"urge�t�p"��u�t�����qpu"qh"
DIV 2 (C) or DIV 6 (D) neurons at the proximal, middle and distal regions of axons. Shown are the 
averaged autocorrelation from multiple segments of axons for each condition. E) The average amplitude 
of autocorrelation analysis for different axonal regions of DIV 2, 4 and 6 neurons. The amplitude was 
measured as the difference between the first peak and the average of two first valleys of the 
autocorrelation curve. Error bars are standard deviation from measurements of multiple neurons (n = 7 
neurons for DIV2; n = 6 neurons for DIV4; n = 9 neurons for DIV6; from 3 independent experiments at 
each DIV). The color bar for 3D STORM image indicates the z-depth of the image, and is the same for all 
of our STORM images.  
96 
 
Pgzv."yg"swcpvkhkgf"vjg"fkuvtkdwvkqp"qh"ȕKK"urgevtkp"cv"gctnkgt"fgxgnqrogpvcn"uvcigu"kp"FKX"4."6"
and 6 neurons (Figure 4.2). Figure 4.2A shows a typical stage 3 neuron at DIV 2, with one neurite 
qwvitqykpi"vjg"qvjgtu"cpf"dgeqokpi"cp"czqp0"Kpvgtguvkpin{."vjg"rgtkqfke"rcvvgtp"qh"ȕKK"urgevtkp"jcu"
already formed in the proximal region of this axon near the cell body, as shown by both Fourier transform 
and autocorrelation analyses of the STORM image (Figure 4.2A, C). However, the periodic distribution 
did not extend far - the middle and distal parts of the same axon did not exhibit the periodic pattern 
(Figure 4.2A, C). Similar results were observed for other stage 3 neurons that we imaged. As neurons 
eqpvkpwgf"vq"ocvwtg."vjg"rgtkqfke"ȕKK"urgevtkp"fkuvtkdwvkqp"gzvgpfgf"vq"oqtg"fkuvcn"tgikqpu"qh"czqpu0"D{"
FKX"8."vjg"rgtkqfke"ȕKK"urgevtkp"fkuvtkdwvkqp"gzvgpfgf"hqt"pgctn{"vjg"gpvktg"ngpivj"qh"vjg"axon, except for 
the very distal region (Figure 4.2B, D). Using the autocorrelation amplitude at the first peak (~190 nm) to 
swcpvkh{"vjg"fgitgg"qh"rgtkqfkekv{"hqt"vjg"ȕKK"urgevtkp"fkuvtkdwvkqpu."yg"hqwpf"vjcv"vjg"rgtkqfkekv{"fgitcfgf"
quickly along axons in DIV 2 neurons, but gradually extended to the distal end of the axon in later 
developmental stages until the structure eventually occupied nearly the entire axon (Figure 4.2E). Taken 
together, these results demonstrate that the periodic membrane skeleton forms early during development, 
originates in proximal axon regions close to the cell body, and propagates toward the distal end of the 
axon.   
60404"Vjg"uvtwevwtcn"qticpk|cvkqp"qh"ȕKK"urgevtkp"kp"fgpftkvgu 
The periodic membrane skeleton was initially discovered in axons [149]. To test whether the 
lattice structure could be extended to other neurites, we examined the distribution of ȕKK"urgevtkp in 
dendrites of neurons at different developmental stages. DIV2, 5, 10 and 14 neurons were immunostained 
for ȕKK"urgevtkp and ȕKK"urgevtkp in the dendrites were imaged by STORM. As shown in Figure 4.3, during 
early developmental stages (DIV2 and DIV5), ȕKK"urgevtkp is largely irregular in dendrites, in contrast to 
the high periodic distribution in axons of the same neurons (Figure 4.3A and 4.3B). As neurons mature, 
however, ȕKK"urgevtkp adopted a periodic form in a small fraction of dendrites during later developmental 
stages (DIV14) (Figure 4.3 C-E). In these dendrites, kuqncvgf"rcvejgu"qh"rgtkqfke"ȕKK"urgevtkp"rcvvgtpu"
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could be readily observed (Figure 4.3E). However, unlike in axons, these patches did not form a cohesive 
lattice structure with a long-range order. Quantitatively, the average autocorrelation analysis showed 
much smaller amplitudes in dendrites than those in axons (Figure 4.3G), indicating a much poorer 
regularity of the structure in dendrites. Similar results were obserYHGIRUȕ,,,VSHFWULQ)LJXUH4.3F, H), an 
LVRIRUPRIȕVSHFWULQWKDWLVHQULFKHGLQGHQGULWHVLQVWHDGRID[RQV[135-137]. Recently, D’Este and 
colleagues used SiR-Actin, a newly developed fluorescent probe, to label actin, and studied the periodic 
structure in live neurons using STED imaging. Consistent with our findings, they also found that the 
lattice structure could be identified in all axons but only in a small fraction (~25%) of dendrites [215].  
 
Figure 4.3�"�������������"��"���������"���"���"����"���������"A-B) DIV 2 and DIV 5 neurons were 
immunostained with ȕII spectrin, and both axonal and dendritic processes were imaged by 3D STORM. 
The reconstructed neuron image, 3D STORM images of axon and dendrite from indicated regions 
(arrows), and autocorrelation analyses are shown. C-E) DIV 14 neurons were immunostained with ȕII 
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Figure 4.3. (continued) spectrin and a dendritic marker Map2, and the ȕII spectrin was imaged by 3D 
STORM. The conventional images, 3D STORM images of axons and dendrites from indicated regions 
(arrows), and autocorrelation analyses are shown. F) DIV 14 neurons were immunostained with ȕIII 
spectrin. The conventional image, STORM images of ȕIII spectrin from two indicated dendritic regions, 
and autocorrelation analyses are shown. ȕIII spectrin only stains for dendrites and we did not observe 
detectable ȕIII spectrin in axons. G) Average autocorrelation analyses of ȕII spectrin in axons and 
dendrites of neurons at DIV 5, DIV 10 and DIV 14 (n =14 neurons for DIV5; n = 11 neurons for DIV 10; 
n = 16 neurons for DIV14; from at least 3 independent experiments at each DIV). H) Average 
autocorrelation analysis of ȕIII spectrin of DIV 14 neurons (n = 12 neurons, from 4 independent 
experiments).  
4.2.3 Actin dependence during the early developmental phase of the periodic membrane skeleton 
Ukoknct"vq"vjg"ncvvkeg"uvtwevwtg"kp"ocvwtg"czqpu."vjg"rgtkqfke"rcvvgtp"qh"ȕKK"urgevtkp"fgrgpfgf"qp"
actin during early development. Treatment of neurons with actin-depolymerizing drugs, cytochalasin D 
*E{vqF+"qt"NcvC."fkutwrvgf"vjg"rgtkqfkekv{"qh"ȕKK"urgevtkp"kp"FKX"5"pgwtqpu"*Hkiwtg"4.4 A-E). The effect 
of actin-fgrqn{ogtk|kpi"ftwiu"ugv"kp"swkemn{"ykvj"vjg"rgtkqfke"ȕKK"urgevtkp"fkuvtkdwvkqp"uwduvcpvkcnn{"
disrupted after several minutes of LatA treatment (Figure 4.4F and 4.4G), consistent with the drug acting 
directly on the lattice structure. These results indicate that actin is involved in the lattice structure during 
early neuronal development. The form of actin, however, appeared to be different during the early 
developmental stages as compared to that in mature axons. We have previously shown that the periodic 
pattern of actin was not directly observed in the STORM images during DIV 1-4. In DIV 5, the periodic 
actin pattern begins to appear in some neurons, and become robustly observed in neurons at DIV 7 [149]. 
Similar results were observed here (data not shown). One possible interpretation is that actin existed in a 
less stable form during the early developmental stages and was not preserved by our sample treatment 
(fixation and extraction) prior to imaging. Consistent with the notion that actin filaments in the lattice 
uvtwevwtg"ygtg"nguu"uvcdng"fwtkpi"gctn{"fgxgnqrogpvcn"uvcigu."vjg"rgtkqfke"uvtwevwtg"qh"ȕKK"urgevtkp"ycu"
more quickly disrupted by LatA treatment during early development than in older neurons (Figure 4.4G). 
We also observed a relatively slow developmental time course for the periodic pattern of adducin, 
an actin-capping protein [216]. The periodic pattern of adducin was not observed in axons at DIV 2 or 
DIV 4 (Figure 4.5). A periodic pattern began to appear at ~DIV 6 and became obvious after DIV 7 
(Figure 4.5). The lack of adducin capping may have contributed to the lower stability of actin during early 
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development stages, although it is also possible that the lower stability of actin during the early 
development stages made it difficult to maintain the adducin pattern during cell fixation and extraction. 
Finally, it is formally possible that actin and adducin are not present in the periodic lattice structure during 
early developmental stages. However, we consider such a scenario to be less likely as it is difficult to 
imagine how spectrin tetramers themselves could self-assemble into a periodic lattice structure without 
the help of actin to crosslink multiple spectrin tetramers. 
 
Figure 4.47KHSHULRGLFVWUXFWXUHRIȕ,,VSHFWULQ depends on actin during early development. A-C) 
DIV 3 neurons were either untreated or treated with latrunculin A (LatA, 20 µM) or cytochalasin D 
���vqF."���O�"hqt"�"jqwt."cpf"uw�ug�wgpvn�"koowpquvckpgf"�kvj"���"urgevtkp"cpvk�qf�"hqt"5F"UVQTO"
imaging. Sho�p"jgtg"ctg"tgrtgugpvcvkxg"kocigu"qh"���"urgevtkp"kp"rtq�kocn"c�qpcn"tgikqpu"htqo"eqpvtqn"
(A), LatA-treated (B) and CytoD-vtgcvgf"���"pgwtqpu�"F�"Cxgtcig"cwvqeqttgncvkqp"cpcn�ugu"qh"���"urgevtkp"
from multiple axon segments of control, LatA-treated, and CytoD-treated DIV 3 neurons (n = 6 neurons 
for control; n = 7 neurons for LatA-treated; n = 7 neurons for CytoD-treated conditions; from at least 3 
independent experiments for each condition). E) The average autocorrelation amplitudes from control, 
LatA-treated, and CytoD-vtgcvgf"F��"5"pgwtqpu�"��"Cxgtcig"cwvqeqttgncvkqp"cpcn�ugu"qh"���"urgevtkp"htqo"
multiple axon segments of control and LatA-treated DIV 3 neurons at different treatment time (n > 5 
neurons from 3 independent experiments for each condition). The axon segments are taken from the 
proximal axonal regions near the cell bodies. G) DIV 3 and DIV 10 neurons were treated with 20 µM 
NcvC"hqt"kpfkecvgf"coqwpv"qh"vkog."cpf"vjg"cxgtcig"cwvqeqttgncvkqp"cornkvwfg"qh"���"urgevtkp"htqo"vjgug"
neurons are shown. Error bars are standard deviation from measurements of multiple neurons (n = 6 
neurons for DIV 3; n = 8 neurons for DIV 10; from 4 independent experiments at each DIV).   
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Together, the above results indicate that the periodic membrane skeleton continued to mature 
after formation. Consistent with this notion, the auto-FRUUHODWLRQDPSOLWXGHVRIWKHSHULRGLFȕ,,VSHFWULQ
distribution also continued to increase with time as the neuron matured (Figure 4.2E). 
 
Figure 4.5. Recruitment of adducin into the periodic lattice structure during development. A-C) 
Neurons were immunostained for adducin and imaged by 3D STORM. Shown here are representative 
images of adducin at proximal axonal regions from DIV 2, 4 and 8 neurons. D) Average autocorrelation 
analyses of adducin at proximal regions of axons near the cell body. The autocorrelation curves are 
averaged from multiple neurons (n = 5 neurons for DIV 2; n = 7 neurons for DIV 4; n = 6 neurons for 
DIV 8; from 3 independent experiments at each DIV).  
4.2.4 Assembly of axon initial segment components into the periodic membrane skeleton during late 
development stages 
As neurons further mature, axon initial segment (AIS) starts to assemble at the axonal region 
proximal to the cell body. Ankyrin G is the master regulating protein for AIS assembly, and recruits other 
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PROHFXODUFRPSRQHQWVVXFKDVȕ,9VSHFWULQDQGVRGLXPFKDQQHOVWRWKH$,6[132, 217, 218]. Next, we 
H[DPLQHGZKHWKHUȕ,9VSHFWULQDQGDQN\ULQ*ZHUHDOVR recruited to the periodic membrane skeleton and, 
if so, during which developmental stage these components were incorporated.   
 
Figure 4.6. Assembly of AIS components into the periodic lattice structure during late 
developmental stages. A, B) Neurons were immunostained with antibodies against ȕIV spectrin N-
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Figure 4.6. (continued) terminus (ȕIV spectrin (N)), ȕIV spectrin C-terminus (ȕIV spectrin (C)), ankyrin 
G spectrin-binding domain (ankyrin G (N)), or ankyrin G C-terminus (ankyrin G (C)), and imaged at 
various DIVs by 3D STORM. Representative conventional images and STORM images from the boxed 
tgikqp"cv"fkhhgtgpv"fgxgnqrogpvcn"uvcigu"ctg"ujqyp0"E+"Nghv<"Cxgtcig"cwvqeqttgncvkqp"cpcn{ugu"qh"ȕKX"
spectrin N-terminus from neurons at different developmental stages (n = 9 neurons for DIV 4; n = 12 
neurons for DIV 8; n = 16 neurons for DIV 12; at least 3 independent experiments at each DIV). Right: 
Cxgtcig"cwvqeqttgncvkqp"cpcn{ugu"qh"ȕKX"urgevtkp"P-terminus and C-terminus of DIV 12 neurons (n = 13 
neurons for N-terminus and n = 15 neurons for C-terminus, 3 independent experiments). D) Left: average 
autocorrelation analyses of ankyrin G spectrin-binding domain (near N-terminus) from neurons at 
different developmental stages (n = 12 neurons for DIV4; n = 15 neurons for DIV 8; n = 14 neurons for 
DIV 12; at least 3 independent experiments at each DIV). Right: Average autocorrelation analysis of 
ankyrin G N-terminus and C-terminus of DIV 12 neurons (n = 9 neurons for N-terminus and n = 10 
neurons for C-terminus, 3 independent experiments). E, F) A DIV 13 neuron was immunostained with 
ȕKX"cpf"ȕKK"urgevtkp"cpvkdqfkgu0"ȕKK"urgevtkp"ycu"uwdlgevgf"hqt"5F"UVQTO"kocikpi0"G+"Nghv<"eqpxgpvkqpcn"
image of ȕKK"cpf"ȕKX"urgevtkp"kp"czqp0"Tkijv<"hnwqtguegpv"kpvgpukv{"rtofile of ȕKK"cpf"ȕKX"urgevtkp"cnqpi"
the axon. F) Left: STORM image of ȕKK"urgevtkp"kp"vjg"ucog"tgikqp0"Tkijv<"cwvqeqttgncvkqp"cpcn{ugu"qh"ȕKK"
spectrin from red and green boxed-regions.  
We labeled ankyrin G using an antibody against its spectrin-binding domain near the N-terminus, 
cpf"ȕKX"urgevtkp"wukpi"cp"cpvkdqf{"cickpuv"kvu"P-vgtokpcn"fqockp0"Dqvj"cpm{tkp"I"cpf"ȕKX"urgevtkp"
signals were weak during early developmental stages, and the signals became stronger in the proximal 
region of axons at DIV 8 (data not shown+0"Pqvcdn{."vjg"gzrtguukqp"ngxgn"qh"ȕKK"urgevtkp"tgockpgf"jkij"
throughout the axons during this time (data not shown). At this time, the distributions of ankyrin G and 
ȕKX"urgevtkp"ygtg"pqv"rgtkqfke"*Hkiwtg"6.6A-D), in contrast to the highly periofke"ȕKK"urgevtkp"kp"vjg"
proximal region of axons (Figure 4.2+0"Qxgt"vkog."dqvj"cpm{tkp"I"cpf"ȕKX"urgevtkp"ukipcnu"hwtvjgt"
increased in the proximal region of axons, and by DIV 12, the N-terminal domains of both ankyrin G and 
ȕKX"urgevtkp"cfqrvgf"jkijn{"rgtiodic distributions, indicating that these molecules were incorporated into 
the periodic lattice structure (Figure 4.6A-D). Interestingly, the periodicity was substantially less 
pronounced for the C-vgtokpcn"fqockp"qh"ȕKX"urgevtkp"cpf"wpfgvgevcdng"hqt"vjg"C-terminal domain of 
ankyrin G (Figure 4.6A-D). These results suggest that the N-terminal regions of these molecules were 
tightly incorporated in the periodic lattice structure, but their C-terminal regions were likely hanging off 
from the lattice structurg"cpf"oqxkpi"tgncvkxgn{"htggn{0"Pqvcdn{."cu"cpm{tkp"I"cpf"ȕKX"urgevtkp"dgecog"
kpeqtrqtcvgf"kpvq"vjg"rgtkqfke"ncvvkeg."yg"qdugtxgf"c"fgetgcug"kp"vjg"nqecn"eqpegpvtcvkqp"qh"ȕKK"urgevtkp"cv"
the AIS (Figure 4.6 E and data not shown+0"Vjg"fgetgcug"qh"vjg"ȕKK"urectrin concentration was associated 
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�k��"c"n�uu"��"rg�k�fkek��"���"���"urge��k�"c�"���"��k���g"�.6���"u���gu�k��"��c�"cu"���"urge��k�"�cu"
k�e��r��c�gf"k���"��g"rg�k�fke"u���e���g"k�"��g"���"�g�k���"���"urge��k�"�cu"fkurncegf0" 
 
Figure 4.7. The formation of the periodic ȕIV spectrin structure in the AIS is dependent on ȕII 
spectrin. A) Neurons were infected with �II spectrin-shRNA expressing adenovirus at DIV 3, and 
subsequently stained for �II spectrin and �IV spectrin at DIV 12. �IV spectrin was subjected for STORM 
imaging. Infected neurons have a GFP signal. The conventional images of �II spectrin, GFP and �IV 
spectrin and the overlay image are shown. Efficient knockdown is demonstrated by lack of �II spectrin in 
GFP-positive process. B) STORM image of �IV spectrin from boxed region in A). C) Average 
autocorrelation analysis of �IV spectrin from �II spectrin knockdown neurons (n = 11 neurons, 3 
independent experiments). D-F) Similar to A-C) except that the virus was added at DIV 7 (n = 9 neurons, 
4 independent experiments).  
��"�gu�"��g��g�"��g"cuug��n�"��"���"urge��k�"k���"��g"rg�k�fke"u���e���g"�c�"�gn�"��"���"urge��k��"
�g"���e�gf"f���"���"urge��k�"c�"�c�k��u"���u"�uk��"c"u����-expressing adenovirus, which also 
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expressed GFP, and subsequepvn{"kocigf"ȕKX"urgevtkp"cv"FKX340"Vjg"ghhkekgpe{"qh"mpqemfqyp"ycu"
fgoqpuvtcvgf"d{"c"ncem"qh"ȕKK"urgevtkp"ukipcn"kp"xktwu-infected, GFP-positive neurons (Figure 4.7). When 
kphgevgf"d{"vjg"xktwu"cv"FKX"5."vjg"gptkejogpv"qh"ȕKX"urgevtkp"kp"vjg"CKU"tgikqp"crreared partially 
korcktgf"d{"ȕKK"urgevtkp"mpqemfqyp."vjqwij"cv"ngcuv"82'"qh"vjg"pgwtqpu"uvknn"gzjkdkvgf"gptkejogpv"qh"ȕKX"
urgevtkp"kp"CKU0"Hqt"vjgug"pgwtqpu."vjg"rgtkqfkekv{"qh"ȕKX"urgevtkp"ycu"cnuq"rctvkcnn{"fkutwrvgf"kp"vjg"ȕKK"
spectrin-depleted neurons (Figure 4.7A-E+."kpfkecvkpi"vjcv"ȕKK"urgevtkp"korqtvcpv"hqt"vjg"rgtkqfke"
cuugodn{"qh"ȕKX"urgevtkp0"Qp"vjg"qvjgt"jcpf."yjgp"pgwtqpu"ygtg"kphgevgf"ykvj"vjg"xktwu"cv"FKX"9."ȕKX"
urgevtkp"tgockpgf"rgtkqfke"gxgp"vjqwij"ȕKK"urgevtkp"ycu"fgrngvgf"*Hkiwtg"6.7 D-F). Because it takes 
several days for pre-gzkuvkpi"ȕKK"urgevtkp"oqngewngu"vq"fgitcfg"[219]."kv"ku"nkmgn{"vjcv"ȕKX"urgevtkp"ycu"
cntgcf{"kpeqtrqtcvgf"kpvq"vjg"rgtkqfke"ncvvkeg"dghqtg"vjg"gxgpvwcn"fgrngvkqp"qh"ȕKK"urgevtkp"yjgp"vjg"xktwu"
was added late.  
4.2.5 Stability of the periodic membrane skeleton  
We next probed the dynamics of the periodic lattice structure in live neurons. To this end, we 
igpgvkecnn{"hwugf"ȕKK"urgevtkp"ykvj"oOcrng5."c"tgegpvn{"fgxgnqrgf"rjqvqcevkxcvcdng"hnwqtguegpv"rtqvgkp"
[220]0"Kp"pgwtqpu"oqfgtcvgn{"gzrtguukpi"ȕKK"urgevtkp-oOcrng5."vjg"rgtkqfke"rcvvgtp"qh"ȕKK"urgevtin-
mMaple3 was readily observable in axons and the spacing of ~190 nm was identical to that observed for 
gpfqigpqwu"ȕKK"urgevtkp"kp"hkzgf"pgwtqpu"*Hkiwtg"4.8A). The periodic pattern was smeared in neurons 
ykvj"jkij"gzrtguukqp"ngxgnu"qh"ȕKK"urgevtkp-mMaple3."rtguwocdn{"d{"vjg"gzeguu."htggn{"fkhhwukpi"ȕKK"
spectrin-mMaple3 molecules that were not incorporated into the lattice structure.  
Vjg"rgtkqfke"ȕKK"urgevtkp"rcvvgtp"crrgctgf"vq"dg"oquvn{"uvcvke0"Hqwtkgt"cpcn{uku"qh"vjg"rcvvgtpu"
showed that the spatial frequency (i.e. the period) of the structure did not change over the imaging time of 
several minutes (Figure 4.8B). Cross-correlation analysis of the patterns taken at different time points 
showed no phase shift of the periodic structure during the imaging time (Figure 4.8C).  
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As an alternative approach to probe the stability of the structure, we used fluorescence recovery 
chvgt"rjqvqdngcejkpi"*HTCR+0"Hqt"vjku"cpcn{uku."yg"vtcpuhgevgf"pgwtqpu"ykvj"c"���"urgevtkp-GFP fusion 
construct, bleached the GFP signal in local regions of axons, and measured the signal recovery rate. In 
neurons that exhibited moderate expression ngxgnu"qh"���"urgevtkp."yjgtg"vjg"oc�qtkv{"qh"���"urgevtkp-GFP 
molecules were incorporated into the periodic lattice structure (data not shown), the recovery rate was 
extremely slow and essentially undetectable after 30 minutes (Figure 4.8D). In contrast, the fluorescence 
tgeqxgt{"ycu"owej"hcuvgt"*97'"tgeqxgt{"kp"7"okpwvgu+"kp"pgwtqpu"yjgtg"vjg"gzrtguukqp"ngxgn"qh"���"
spectrin-�HR"ycu"jkij"cpf"vjg"oc�qtkv{"qh"���"urgevtkp-GFP molecules were not incorporated into the 
periodic structure (Figure 4.8E and data not shown). These data indicate that periodic lattice structure was 
highly stable in live neurons.   
 
Figure 4.8. The periodic lattice structure is stable in live neurons. A) 3D STORM image of �II 
spectrin-mMaple3 in live neurons at DIV 10. B) The STORM movie was segregated into four different 
time windows. Fourier transform analysis of each time window is shown. The baseline of Fourier traces is 
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Figure 4.8. (continued) shifted manually for clear visualization.  C) Cross-correlation analysis of �II 
spectrin across different time windows. The black curve is the autocorrelation of the image during 0-100 s. 
The color curves are the cross-correlation between 0-100 s and later time windows. Similar results were 
found in 6 independent experiments. D-E) FRAP analyses of �II spectrin in DIV 10 neurons. Neurons 
were transfected with �II spectrin-GFP at DIV 8. D) Representative neurons at a low �II spectrin 
expression level, where �II spectrin-GFP molecules were incorporated into the periodic structure. The 
images before photo-bleaching, 0 s post-bleaching, 1600 s post-bleaching and the fluorescence recovery 
trace is shown. E) The fluorescence recovery of representative neurons with a high �II spectrin expression 
level, where most �II spectrin-GFP molecules were not incorporated into the periodic structure. Similar 
results were found in more than 8 independent experiments.  
4.2.6 Microtubule dependence of the periodic membrane skeleton  
 
Figure 4.9. The periodic structure of ȕII spectrin relies on intact microtubules. A, B) DIV 4 neurons 
ygtg"gkvjgt"wpvtgcvgf"qt"vtgcvgf"ykvj"pqeqfc|qng"*72­O+"hqt"3"jqwt."cpf"koowpquvckpgf"ykvj"���"u�gevtkp"
antibody for 3D STORM. A reconstructed neuron image from nocodazole-treated neurons, and two 
UVQTO"kocigu"ctg"ujqyp"kp"C0"D+"Cxgtcig"cwvqeqttgncvkqp"cpcn{ugu"qh"���"u�gevtkp"htqo"ownvk�ng"
control and nocodazole-treated neurons (n = 9 neurons for control and n = 8 neurons for nocodazole-
treated conditions; from 3 independent experiments for each condition). C) Neurons were treated with 
taxol (5 nM) at DIV 3 for three days, which induces the growth of multiple axon-like processes. A 
representative STORM image of a treated neuron at DIV 6, the enlarged images of the boxed regions, and 
the autocorrelation analyses (n = 10 neurons, 4 independent experiments) are shown.  
Microtubules are essential for the establishment of neuronal polarity. Local stabilization of 
microtubules is sufficient to induce axon formation [221]. Moreover, tubulin binds to ankyrin B, a 
oqngewng"vjcv"cnuq"kpvgtcevu"ykvj"���"u�gevtkp"[222]. We thus tested whether microtubules play a role in the 
formation of the periodic membrane skeleton structure. In neurons treated with the microtubule-disrupting 
107 
 
drug nocodazole (50 µM for 1 hour)�"���"��������"�������"��"���"��������"���"�������"���������"�������"
4.9A and 4.9B). On the other hand, when microtubules were stabilized with taxol (5 nM for 3 days), a 
treatment that is known to induce multiple axon-like processes in neurons [221]�"��"�����"����"���"
spectrin exhibited a periodic pattern in all of these axon-like processes (Figure 4.9C). We also treated 
neurons with SB 216763, a drug that stabilizes microtubules and promotes axonal growth by inhibiting 
glycogen synthase kinase-3 beta (GSK-���"[223, 224]. Similarly, in neurons treated with SB-216763, we 
observed that the periodic lattice structure was formed in multiple axon-like long processes (data not 
shown).  
4.2.7 Role of Ankyrin B in the periodic membrane skeleton  
 
Figure 4.10. The ȕII spectrin structure in axons of ankyrin B KO neurons. A) Reconstructed 
image of an ankyrin B KO DIV 10 neuron. �II spectrin was subjected for 3D STORM image in both 
dendrites and axons. The STORM image of dendrites in green-boxed region is shown in Figure 4.11. The 
STORM image of axon in white-boxed region is shown in B). C) Enlarged STORM image of the boxed 
region in B). D-E) Fourier transform and autocorrelation analyses of the axon segment shown in C.  
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Given the different actin-spectrin organizations in axons and dendrites, an interesting question 
arises as to what molecular factors are critical for promoting the preferential formation of the highly 
tgiwnct."rgtkqfke"ncvvkeg"uvtwevwtg"kp"czqpu0"Cpm{tkp"D"*CPM"4+"ku"c"oqngewng"v�cv"�kpfu"vq"�KK"urgevtkp"
[129]. It is highly enriched in axons [225-227], and recently found to be potentially linked with autism 
[220, 228]. We have shown previously that ankyrin B also adopts a partially periodic pattern in axons 
albeit with a lower regularity [149], potentially due to an incomplete occupancy of the ankyrin B binding 
sites on the lattice structure and the presence of ankyrin B on intracellular membranes [129]. We thus 
asked whether ankyrin B is involved in regulating the formation of this periodic membrane skeleton in 
axons.  
 
Figure 4.11. Role of ankyrin B in the regulation of the periodic lattice structure. A-B) DIV 10 
pgwtqpu"�tqo"cpm{tkp"D"mpqemqwv"*M�+"okeg"�gtg"koowpquvckpgf"�qt"�KK"urgevtkp"cpf"c"fgpftkvke"octmgt"
�cr4."cpf"kocigf0"*C+"�qp�gpvkqpcn"kocig"q�"�KK"urgevtkp"cpf"�cr40"*D+"��"�����"q�"�KK"urgevtkp0"
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Figure 4.11. (continued) The image is taken from the green-boxed region of the neuron in Figure 4.10. 
The enlarged STORM image and autocorrelation analyses of boxed regions are shown in B1) and B2). 
Ukoknct"tguwnvu"ygtg"hqwpf"kp"6"kpfgrgpfgpv"gzrgtkogpvu0"E+"Eqpxgpvkqpcn"ȕKK"urgevtkp"kocig"htqo"yknf"
type (control) and ankyrin B KO DIV 10 neurons. The fluorescence intensity is coded by color, with red 
kpfkecvkpi"jkijgt"gzrtguukqp0"F+"Vjg"tgncvkxg"hnwqtguegpeg"kpvgpukv{"qh"ȕKK"urgevtkp"kp"fgpftkvgu"cpf"czqpu"
of wild type and ankyrin B KO neurons (n = 14 neurons for wild type and n = 13 neurons for ankyrin B 
KO; 3 independent experiments).  
To address this question, we performed STORM imaging on disassociated hippocampal neurons 
from ankyrin B knockout mice [229] at DIV 10. Similar to wild type neurons, ankyrin B knockout 
neurons still showed enrichment of MAP2 in dendrites with similar dendritic morphology, making 
dendrites easy to identify in these neurons (Figure 4.10 and 4.11+0""Vjg"rgtkqfke"rcvvgtp"qh"ȕKK"urgetrin in 
axons were not perturbed by ankyrin B deletion and appeared quantitatively similar to that observed in 
control wild type neurons (Figure 4.10+0"Uwtrtkukpin{."ȕKK"urgevtkp"cnuq"cfqrvgf"c"jkijn{"tgiwnct."rgtkqfke"
distribution in all dendrites, with the periodicity quantitatively similar to that observed in axons (Figure 
4.11A and 4.11B). This is in contrast to what we observed in wild type neurons, where only a small 
fraction of dendrites have isolated patches of the periodic structure (Figure 4.3). The actin capping protein 
adducin also adopted a periodic distribution in dendrites of ankyrin B knockout neurons, with 
swcpvkvcvkxgn{"ukoknct"rgtkqfkekv{"vq"vjcv"qh"ȕKK"urgevtkp0"Mpqemkpi"fqyp"ȕKK"urgevtkp"fkutwrvgf"vjg"rgtkqfke"
distribution of adducin, indicating that the periodic lattice structure in the dendrites of the ankyrin B 
mpqemqwv"pgwtqpu"cnuq"fgrgpfgf"qp"ȕKK"urgevtkp"*Hkiwtg"4.12). These data indicate that the formation of 
the periodic membrane skeleton does not require ankyrin B. Instead, ankyrin B is important for inhibiting 
the formation of this periodic lattice structure in dendrites.  
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Figure 4.12. Formation of the periodic lattice structure in dendrites of ankyrin B knockout neurons 
GHSHQGVRQȕ,,VSHFWULQ  A-B) Ankyrin B knockout neurons were immunostained for adducin (green) 
and MAP2 (magenta), and imaged by conventional (A) and 3D STORM (B)  microscopy. Magnified 
STORM images of adducin for arrow-indicated regions are shown in B-1) and B-2). C-D) Ankyrin B 
NQRFNRXWQHXURQVZHUHLQIHFWHGZLWKȕ,,VSHFWULQ-shRNA expressing adenovirus, and immunostained for 
adducin and MAP2, and imaged by conventional (C) and 3D STORM (D) microscopy. Infected neurons 
were marked by GFP signal expressed from the virus (not shown). Magnified STORM images of adducin 
from arrow indicated region are shown in D-1) and D-2). E) Average autocorrelation analysis of adducin 
distribution in dendrites of ankyrin B knockout neurons (n = 9 neurons, 4 independent experiments). F) 
Average autocorrelation analysis of adducin distribution in dendrites of ankyrin B knockout neurons 
WUHDWHGZLWKȕ,,VSHFWULQ-shRNA expressing adenovirus (n = 15 neurons, 3 independent experiments).  
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4.2.8 Nqecn"ȕKK"urgevtkp"eqpegpvtcvkqp"tgiwncvgu"vjg"hqtocvkqp"qh"this periodic lattice structure and 
ankyrin B regulates the polarized distribution of ȕKK"urgevtkp in neurites  
In addition to the induction of the periodic lattice structure in dendrites, we noticed that ankyrin B 
knockout also induced a dramatic redistridwvkqp"qh"ȕKK"urgevtkp"kp"pgwtkvgu0"Kp"yknf"v{rg"pgwtqpu."vjg"nqecn"
eqpegpvtcvkqp"qh"ȕKK"urgevtkp."cu"kpfkecvgf"d{"koowpqhnwqtguegpeg"kpvgpukv{."ycu"\4-fold higher in axons 
than that in dendrites (Figure 4.11C and 4.11D), consistent with previous results [133, 134]. However, the 
gzrtguukqp"ngxgn"qh"ȕKK"urgevtkp"ycu"uwduvcpvkcnn{"kpetgcugf"kp"fgpftkvgu"d{"vjg"cpm{tkp"D"mpqemqwv"vq"a 
rqkpv"vjcv"vjg"nqecn"eqpegpvtcvkqp"qh"ȕKK"urgevtkp"kp"fgpftkvgu"dgecog"kpfkuvkpiwkujcdng"htqo"vjcv"kp"czqpu."
cpf"dqvj"ygtg"eqorctcdng"vq"vjg"ȕKK"urgevtkp"eqpegpvtcvkqp"qdugtxgf"kp"yknf"v{rg"czqpu"*Figure 4.11C 
and 4.11D). We thus hypothesized that the inetgcugf"nqecn"eqpegpvtcvkqp"qh"ȕKK"urgevtkp"ecwugf"vjg"
formation of this periodic lattice structure in dendrites.  
Vq"vguv"vjku"j{rqvjguku."yg"kpetgcugf"vjg"gzrtguukqp"ngxgn"qh"ȕKK"urgevtkp"kp"cnn"pgwtkvgu"d{"
transiently transfecting neurons with a HA-tagggf"ȕKK"urgevtkp"eqpuvtwev."cpf"rgthqtogf"UVQTO"kocikpi"
qp"ȕKK"urgevtkp"kp"vtcpuhgevgf"pgwtqpu"cv"FKX"330"Cu"gzrgevgf."vjg"nqecn"eqpegpvtcvkqp"qh"ȕKK"urgevtkp"kp"
vjg"fgpftkvgu"qh"ȕKK"urgevtkp-HA expressing neurons was higher than that observed in control neurons that 
fkf"pqv"gzrtguu"ȕKK"urgevtkp-HA (Figure 4.13A-C). Remarkably, whereas a small fraction of dendrites 
from control neurons had isolated patches of periodic ȕKK"urgevtkp"*Hkiwtg"4.13D and 4.13G+."kp"ȕKK"
spectrin-JC"qxgtgzrtguukpi"pgwtqpu."ȕKK"urgevrin displayed a periodic pattern in nearly all dendritic 
processes (Figure 4.13F and 4.13G). Autocorrelation analysis showed that the periodicity in the dendrites 
of overexpressing neurons was substantially enhanced compared to the dendrites of control neurons 
(Figure 4.13H).  
Vcmgp"vqigvjgt."vjgug"fcvc"uwiiguv"vjcv"vjg"nqecn"eqpegpvtcvkqp"qh"ȕKK"urgevtkp"ku"c"mg{"fgvgtokpkpi"
factor for the preferential formation of the periodic membrane skeleton in axons and that ankyrin B was 
critical for setting the polatk|gf"fkuvtkdwvkqp"qh"ȕKK"urgevtkp"kp"czqpu"cpf"fgpftkvgu0" 
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Figure 4.13. Local ȕII spectrin concentration determines the formation of the periodic lattice 
structure. DIV 9 neurons were either mock-transfected or transfected with ȕII spectrin-HA, and 
immunostained for HA and ȕII spectrin. ȕII spectrin were subsequently imaged by 3D STORM. A-B) 
Conventional images of ȕII spectrin in dendrites of a control neuron and a ȕII spectrin-HA overexpressing 
(OE) neuron. The HA image is shown in the insets. C) The relative fluorescence intensity for ȕII spectrin 
in dendrites and axons of control and ȕII spectrin-HA overexpressing neurons (n = 10 neurons for control 
DQGQ QHXURQVIRUȕ,,VSHFWULQ-HA overexpressing conditions; from 3 independent experiments for 
each condition). D-E) STORM images of ȕII spectrin from green-boxed regions in A. F-G) STORM 
images of ȕII spectrin from green-boxed regions in B. F-1) and G-1) are enlarged images of the white-
boxed regions in F and G respectively. H) Average autocorrelation analyses of ȕII spectrin in dendrites of 
control and ȕII spectrin-+$RYHUH[SUHVVLQJQHXURQVQ QHXURQVIRUFRQWURODQGQ QHXURQVIRUȕ,,
spectrin-HA overexpressing conditions; from 3 independent experiments for each condition).  
4.3 Discussion 
Actin, spectrin and associated molecules form a periodic lattice structure with long-range order 
preferentially XQGHUQHDWKWKHD[RQDOPHPEUDQH0DQ\PROHFXODUFRPSRQHQWVLQFOXGLQJDFWLQȕ,,
VSHFWULQDGGXFLQDQN\ULQ%ȕ,9VSHFWULQ, ankyrin G and sodium channels, are present in this structure. 
We have observed this periodic membrane skeleton with STORM imaging of fixed cultured neurons 
(Figure 4.1 and 4.2) and fixed brain tissue slices [149] using actin-binding phalloidin and immunolabeling 
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of endogenously expressed proteins, as well as in live cultured neurons using fluorescent fusion proteins 
(Figure 4.8). Recently, this periodic structure has also been observed in live neurons using a cell-
permeable actin-binding dye and STED imaging [230]. Since a single actin filament can interact with 
multiple spectrin tetramers, and a single spectrin tetramer can bind to two actin filaments, one at each end 
of the symmetric tetramer [129], we reason that these crosslinking interactions are responsible for the 
formation of the lattice structure. Indeed, depolymerizing actin filaments disrupted the periodic 
distribution of ȕKK"spectrin, and knocking down of ȕKK"spectrin disrupted the periodic distribution of actin 
(data not shown). Because this lattice structure is associated with the axonal membrane, proper 
preservation of the membrane structure is essential for observing this structure. For example, a recent 
electron microscopy study of the AIS in neurons that has been subjected to detergent extraction of 
membrane before fixation did not show such periodic membrane skeleton [231]. Indeed when we applied 
the same “fixation after membrane extraction” protocol to neurons, the structure was destroyed and not 
observed in STORM images (data not shown). In this study, we investigated the developmental 
mechanism of this newly discovered axonal membrane skeleton. 
We found that this periodic membrane skeleton started to form early during axon development. In 
stage 3 neurons at DIV 2, when one neurite just broke the symmetry and became an axon (typically 
ugxgtcn"vkogu"nqpigt"vjcp"qvjgt"pgwtkvgu+."vjg"rgtkqfke"rcvvgtp"qh"ȕKK"urgevtkp"cntgcf{"gogtigf"*Hkiwre 4.2). 
It originated in the proximal axon regions near the cell bodies and gradually propagated to the distal ends 
of axons (Figure 4.2). This spatial distribution is in contrast to most previously identified signaling 
molecules involved in axon differentiation and development, which are enriched and function at the 
growing tip of axons [123, 124, 212, 213]. After its initial appearance, the lattice structure continued to 
mature with the actin filaments becoming more stable, potentially because of capping by adducin (Figures 
4.4, 4.5). Once matured, the structure appeared highly stable with little movement and extremely slow 
turnover of its molecular components was observed in live neurons (Figure 4.8). This highly stable 
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membrane skeleton may function to provide a stable mechanical swrrqtv"hqt"czqpu0"Kpfggf."fgngvkqp"qh"ȕ"
spectrin from C elegans causes axons to break when the animals move [142]. 
The emergence of this periodic lattice during early axon development and its origination in the 
proximal axon region near the cell body suggest that the periodic membrane skeleton may function as an 
independent mechanism for establishing or maintaining neuronal polarization in addition to the previously 
identified pathways that function at the distal ends of axons. However, the periodic membrane skeleton is 
not required for the initiation of axon differentiation because the periodic structure only started to form in 
stage 3, but not stage 2, a stage at which most signaling molecules for axon initiation exhibit high activity 
[212, 213]0"Oqtgqxgt."pgwtqpu"fgrngvgf"qh"ȕKK"urgevtkp"ctg"cnuq"ecrcdng"qh"hqtokpi"nqpi"czqpu"[134], 
vjqwij"vjgug"czqpu"oc{"pqv"hwnn{"hwpevkqpcn0"Kpfggf."tgoqxcn"qh"gKK"qt"ȕKK"urgevtkp"ku"godt{qpically lethal 
in mice [143, 144] and AIS, the structure important for action potential generation, fails to assemble 
rtqrgtn{""kp"pgwtqpu"vjcv"ctg"fgrngvgf"qh"ȕKK"urgevtkp"[134].   
Kpvgtguvkpin{."oqngewngu"korqtvcpv"hqt"vjg"urgekhkecvkqp"qh"CKU."cpm{tkp"I."ȕKX"urgevtkn, and 
sodium channels, were all incorporated into this periodic membrane skeleton. During the early stages of 
czqp"fgxgnqrogpv."vjg"gzrtguukqp"ngxgnu"qh"cpm{tkp"I"cpf"ȕKX"urgevtkp"ygtg"nqy"kp"vjg"rtqzkocn"czqp"
region, which was instead occupied by the perkqfke"ncvvkeg"eqortkukpi"ȕKK"urgevtkp"*Hkiwtg"4.2). Ankyrin 
I"cpf"ȕKX"urgevtkp"dgicp"vq"gptkej"kp"vjg"rtqzkocn"czqp"tgikqp"ncvgt"fwtkpi"czqp"fgxgnqrogpv."cv"\FKX":"
(data not shown), consistent with previous observations [134]0""Vjg"kpeqtrqtcvkqp"qh"cpm{tkp"I"cpf"ȕKX"
specvtkp"kpvq"vjg"rgtkqfke"ncvvkeg"ycu"qdugtxgf"gxgp"ncvgt."cv"ctqwpf"FKX"34."tgrncekpi"ȕKK"urgevtkp"htqo"
the structure in the AIS (Figure 4.6). The enrichment and periodic assembly of the AIS components 
crrgctgf"vq"fgrgpf"qp"ȕKK"urgevtkp"*Hkiwtg"6.7). Our data suggest the following developmental course for 
vjg"CKU"hqtocvkqp0"Dghqtg"vjg"CKU"ku"hqtogf."cevkp"cpf"ȕKK"urgevtkp"hqto"c"eqjgukxg"rgtkqfke"ncvvkeg"
structure that covers the entire axonal shaft including the proximal axonal region. The AIS then forms by 
vjg"gptkejogpv"qh"cpm{tkp"I"cpf"ȕKX"urgevtkp"kp"vjg"rtqzkocn"czqpcn"tgikqp"cpf"vjg"tgrncegogpv"qh"ȕKK"
urgevtkp"d{"ȕKX"urgevtkp"kp"vjg"rgtkqfke"ogodtcpg"umgngvqp0"Rqvgpvkcnn{."cpm{tkp"I."vjg"ocuvgt"tgiwncvqt"
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of AIS that recruits other AIS components [132, 217, 218], is first enriched in the proximal axon region. 
Cpm{tkp"I"vjgp"tgetwkvu"ȕKX"urgevtkp"vq"vjg"ucog"tgikqp"cpf"ecwugu"kv"vq"dg"kpeqtrqtcvgf"kp"vjg"rgtkqfke"
ncvvkeg0"ȕKX"urgevtkp"kp"vwtp"cpejors ankyrin G into a periodic pattern as well. As an adaptor, ankyrin G 
then places sodium channels into a periodic distribution pattern in the AIS.  
Finally, we addressed the question why the cohesive, periodic lattice structure preferentially 
formed in axons, with a small fraction of dendrites showed isolated patches of periodic structure with 
much less regularity (Figure 4.3). We found multiple molecular factors participate in this regulation. The 
periodic lattice structure depended on intact microtubules. Treatment with a microtubule-depolymerizing 
drug disrupts the structure in axons, whereas treatment with microtubule-stabilizing drugs induces the 
formation of the lattice structure in multiple neurites (Figure 4.9). Importantly, we found that the local 
eqpegpvtcvkqp"qh"ȕKK"urgevtkp"ku"a determining factor for the formation of the lattice structure. The local 
concentration oh"ȕKK"urgevtkp"ku"\4"vkogu"jkijgt"kp"czqpu"vjcp"kp"fgpftkvgu"*Hkiwtg"4.11). Remarkably, 
kpetgcukpi"vjg"fgpftkvke"eqpegpvtcvkqp"qh"ȕKK"urgevtkp"d{"qxgt-expression induced the formation of the 
periodic lattice structure in all dendrites (Figure 4.13). Interestingly, ankyrin B was critical for 
ockpvckpkpi"vjg"rqnctk|gf"fkuvtkdwvkqp"qh"ȕKK"urgevtkp0"Mpqemkpi"qwv"cpm{tkp"D"ngf"vq"cp"gxgp"fkuvtkdwvkqp"
qh"ȕKK"urgevtkp"kp"fgpftkvgu"cpf"czqpu"cpf"vjg"hqtocvkqp"qh"c"jkijn{"tgiwnct"cpf"eqjgukxg"rgtkqfke"ncvvkeg"
structure in all dendrites (Figure 4.11+0"Eqpukuvgpv"ykvj"vjg"pqvkqp"vjcv"vjg"kpetgcugf"eqpegpvtcvkqp"qh"ȕKK"
spectrin in dendrites is responsible for inducing the formation of the periodic lattice structure in dendrites, 
mpqemkpi"fqyp"ȕKK"urgevtkp"htqo"cpm{tkp"D knockout neurons disrupted the lattice structure (Figure 4.12). 
Vjgug"tguwnvu"kpfkecvg"vjcv"cpm{tkp"D"ku"etkvkecn"hqt"guvcdnkujkpi"c"rqnctk|gf"fkuvtkdwvkqp"qh"ȕKK"urgevtkp"kp"
pgwtkvgu"ykvj"c"jkijgt"eqpegpvtcvkqp"qh"ȕKK"urgevtkp"kp"czqpu"vjcp"kp"fgpftkvgu. which in turn promotes the 
formation of the periodic membrane skeleton in axons.  
Kv"ku"kpvgtguvkpi"vq"urgewncvg"jqy"cpm{tkp"D"oc{"guvcdnkuj"uwej"c"rqnctk|gf"fkuvtkdwvkqp"qh"ȕKK"
spectrin. The predominant form of ankyrin B during early neuronal development is a 440 kDa splice 
variant that is preferentially targeted to axons [225, 227, 232]. Given that ankyrin B specifically binds to 
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ȕKK"urgevtkp."yg"urgewncvg"vjcv"vjg"fkuvtkdwvkqp"qh"cpm{tkp"D"kp"czqpu"oc{"jgnr"guvcdnkujkpi"vjg"gptkejognt 
qh"ȕKK"urgevtkp"kp"czqpu"fwtkpi"gctn{"pgwtqpcn"fgxgnqrogpv0"Oqtgqxgt."Lorenzo and colleagues recently 
found that ankyrin B is a major cargo adaptor for dynactin and promotes axonal transport of proteins and 
organelles and that disruption of ankyrin B-dynactin interaction significantly impairs the axonal transport 
of many proteins [233]0"Kv"ku"vjwu"rquukdng"vjcv"cpm{tkp"D"oc{"cnuq"rtghgtgpvkcnn{"vtcpurqtv"ȕKK"urgevtkp"
into czqpu"kpuvgcf"qh"fgpftkvgu0"D{"ockpvckpkpi"c"rqnctk|gf"fkuvtkdwvkqp"qh"ȕKK"urgevtkp"kp"pgwtqpu."cpm{tkp"
B functions as a negative regulator for preventing the formation of the periodic membrane skeleton in 
dendrites. The exact mechanism by which ankyrin B ockpvckpu"c"rqnctk|gf"fkuvtkdwvkqp"qh"ȕKK"urgevtkp"
remains an interesting question for future investigation.  
4.4 Materials and Methods  
All experimental procedures were performed in accordance with the Guide for the Care and Use 
of Laboratory Animals of the National Institutes of Health. The protocol was approved by the Institutional 
Animal Care and Use Committee (IACUC) of Harvard University.  
Neuron culture. Primary hippocampal cultures were prepared from wild type neonatal (E18) rat 
embryos (timed pregnant SD rats from Charles River Laboratories, Wilmington, MA) or ankyrin B 
knockout mice as reported previously [229]. Hippocampi were isolated and digested with 0.05% trypsin-
EDTA (1x) (Invitrogen 25300-054) at 37oC for 15 minutes. The hippocampi were transferred to the Hib 
A solution (BrainBits HA-Ca), washed several times with the Hib A solution, and pipetted up and down 
until the tissues were mostly dissolved. The solution was then passed through a cell strainer (VWR 
21008-949) to remove the residual undissociated tissue and collected in a 50 mL conical tube. Neurons 
were spun down to the bottom of the tube, resuspended with the culture media made of 96 mL Neurobasal 
(Life Technologies 12349-015), 2 mL B-27 Supplement (Life Technologies 17504-044), 1 mL Penicillin-
Streptomycin (Life technologies 15140-122) and 1 mL Glutamax (Life technologies 35050-061), and then 
plated onto poly-L-lysine/laminin-coated 12-mm coverslips (BD bioscience BD354087) or poly-L-lysine 
coated 8-ygnn"ejcodgtu0"7"ȝO"e{vqukpg-D-arabinofuranoside (Sigma C1768) was added to the culture 
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media to inhibit the growth of glial cells three days after plating. The neurons were fed twice a week with 
freshly made culture media until use. 
Reagent. The following primary antibodies were used in this study: guinea pig anti-Map2 
antibody (Synaptic Systems, 188002); mouse anti-ȕKK"urgevtkp"cpvkdqf{"*DF"Dkquekgpegu."834785+="oqwug"
anti-ankyrin G antibody (Santa Cruz, Sc-12719, epitope mapping the spectrin-binding domain of ankyrin 
G near the N-terminal); goat anti-ankyrin G antibody (Santa Cruz, Sc-31778, epitope mapping the C 
terminal of ankyrin G); rabbit anti-adducin antibody (Abcam, ab51130); rabbit anti-HA antibody (Abcam, 
ab9110); rabbit anti-GFP antibody (Abcam, ab290); goat anti-ȕKKK"urgevtkp"*Ucpvc"Etw|."ue-9660). Rabbit 
antibodies targeting the C- or N-vgtokpwu"qh"ȕKX"urgevtkp"ygtg"mkpf"ikhvu"htqo"Ft0"Ocvv"Tcudcpf"cv"
Baylor College of Medicine.  
The following secondary antibodies were used in this study for conventional imaging: Alexa 
Fluor 647 donkey anti-mouse (Invitrogen, A31571), Alexa Fluor 555 donkey anti-mouse (Invitrogen, 
A31570), Alexa Fluor 488 donkey anti-mouse (Invitrogen, A21202), Alexa Fluor 647 donkey anti-rabbit 
(Invitrogen, A31573), Alexa Fluor 568 donkey anti-rabbit (Invitrogen, A10042), Alexa Fluor 488 donkey 
anti-rabbit (Invitrogen, A21206), Alexa Fluor 488 goat anti-guinea pig (Invitrogen, A11073), Alexa Fluor 
647 donkey anti-goat (Invitrogen, A21447), Alexa Fluor 568 donkey anti-goat (Invitrogen, A11057).  
For STORM imaging, secondary antibodies were custom-labeled with a photoswitchable reporter 
dye, Alexa Fluor 647, and an activator dye Alexa Flour 405, which facilitates the photoswitching of the 
reporter dye. Donkey anti-mouse and donkey anti-rabbit secondary antibodies (Jackson ImmunoResearch) 
were each labeled with a mixture of amine-reactive activator and reporter dyes in a one-step reaction, as 
described previously [150]. In some experiments, commercial Alexa Fluor 647 conjugated donkey anti-
mouse, anti-rabbit or anti-goat secondary antibodies were used. 
Transfection of neurons with fusion protein constructs. ȕKK"urgevtkp-IHR"cpf"ȕKK"urgevtkp-HA 
plasmids (addgene, 31070) used in this study were reported previously, with GFP inserted at the N 
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vgtokpcn"qh"ȕKK"urgevtkp."cpf"vjg"JC"vci"cv"vjg"E"vgtokpcn"qh"ȕKK"urgevtkp"tgurgevkxgn{"[134]. To make the 
ȕKK"urgevtkp-mMaple 3 construct, we replaced the HA tag sequence with the mMaple 3 sequence [220]. 
Plasmids were transfected into neurons using a calcium phosphate transfection kit from Invitrogen 
(K2780-01). The protocol for transfection was modified slightly for our neuronal cultures. Briefly, 
neurons were plated at a density of 40,000 cells/well in 12 well plates, and cultured for 6 to 10 days 
before the transfection. After changing media from original neuronal culture media to Minimum Essential 
Media (MEM, Life Technology, supplemented with 20 mM HEPEs, pH 7.15), 100 µl plasmid mixture 
was added, and neurons were incubated at 37 ºC for 20 minutes. The media was subsequently aspirated, 
and replaced with a lower pH MEM (supplemented with 20 mM HEPEs, pH 6.8) at 37 ºC for 4 minutes. 
After dissolving all calcium phosphate crystals, we added back the original neuronal culture media. 
Experiments were performed 2 or 3 days after transfection.  
Knockdown with shRNA. Vjg"ȕKK"urgevtkp"ujTPC"cfgpqxktcn"eqpuvtwev"wugf"kp"vjku"uvwf{"ycu"c"
kind gift from Dr. Matt Rasband at Baylor College of Medicine, and described previously [234]. The two 
sense sequences of shRNA are: 5’-GCATGTCACGATGTTACAA-3’ and 5’-
GGATGAAATGAAGGTGCTA-5Ó0"Hqt"cuuc{kpi"vjg"ghhgev"qh"ȕKK"urectrin knockdown on actin and 
addicin structure, neurons were infected with the virus at DIV3 and fixed for STORM imaging at around 
FKX";"qt"320"Hqt"cuuc{kpi"vjg"ghhgev"qh"ȕKK"urgevtkp"mpqemfqyp"qp"ȕKX"urgevtkp"uvtwevwtg."pgwtqpu"ygtg"
infected with the virwu"cv"FKX5"qt"FKX9."cpf"hkzgf"cv"FKX34"hqt"UVQTO"kocikpi"qh"ȕKX"urgevtkp0""
Infected neurons were marked by a GFP signal expressed from the adenoviral construct. The knockdown 
ghhkekgpe{"ycu"xcnkfcvgf"vjtqwij"koowpquvckpkpi"cickpuv"ȕKK"urgevtkp0 
Drug treatment of neurons. The following chemicals were used in this study with their 
concentration and treatment time stated: latrunculin A (Sigma, L5163, 20 µM, 1 hour or indicated time 
series), cytochalasin D (Sigma, C8273, 50µM, 1 hour), nocodazole (Sigma, M1404, 50µM, 1 hour), taxol 
(Sigma, T7402, 5nM), SB216763 (Sigma, S3442, 5µM). For taxol treatment, neurons were treated with 
the drug at DIV3 with the indicated concentration, and fixed at DIV6 for STORM imaging. For 
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SB216763 treatment, neurons were treated with the drug at DIV1 with the indicated concentration, and 
fixed at DIV5 for STORM imaging.  
Fluorescence labeling of neurons. Cultured neuron were fixed at various days in vitro (DIV). For 
imaging of actin, we used a similar method to label actin as reported previously [149, 235]. Briefly, the 
samples were simultaneously fixed and extracted for 1 min using a solution of 0.3% (v/v) glutaraldehyde 
(GA) and 0.25% (v/v) Triton X-100 in cytoskeleton buffer (CB, 10 mM MES, pH 6.1, 150 mM NaCl, 5 
mM EGTA, 5 mM glucose and 5 mM MgCl2), and then post-fixed for 15 min in 2% (v/v) GA in CB, a 
previously established protocol for maintaining actin ultrastructure [149, 235]. The GA-fixed samples 
were treated with freshly prepared 0.1% (w/v) sodium borohydride for 7 min to reduce background 
fluorescence caused by GA fixation. To label actin filaments, samples were labeled with Alexa Fluor 647 
conjugated phalloidin (Invitrogen A22287) overnight at 4 ºC or ~ 1 hour at room temperature. A 
concentration of ~0.5 µM phalloidin in PBS was used. To minimize the dissociation of phalloidin from 
actin during washing steps, actin labeling was performed after all other labeling steps (i.e. 
immunofluorescence of other molecular targets) were completed. The sample was washed 2-3 times with 
PBS and then immediately mounted for imaging.  
To test whether strong membrane extraction prior to fixation [231] disrupts the membrane 
skeleton structure, neurons were extracted with 1% Triton X-100 in PEM buffer (100 mM Pipes-KOH, 
pH 6.9, 1 mM MgCl2, and 1 mM EGTA) containing 2% polyethylene glycol, 2 µM phalloidin, and 2 µM 
taxol for 3 min at room temperature after a quick rinse with the PEM buffer containing 2 µM taxol and 
subsequently fixed with 0.2% GA in PBS for at least 20 min, as described previously [231]. Fixed 
samples were treated with freshly prepared 0.2% (w/v) sodium borohydride for 5-10 min to reduce 
background fluorescence caused by GA fixation and washed in PBS. Actin labeling was performed 
similarly as described above.  
For imaging of oqngewnct"eqorqpgpvu"pqv"kpenwfkpi"cevkp"*OCR4."ȕKK"urgevtkp."ȕKKK"urgevtkp."ȕKX"
spectrin, ankyrin G and adducin), the samples were fixed using 4% (w/v) paraformaldehyde in phosphate 
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buffered saline (PBS) for 15 min. Fixed neuron samples were then permeabilized and blocked in blocking 
buffer (3% w/v bovine serum albumin or 10% w/v donkey serum, 0.2% v/v Triton X-100 in PBS) for 1 
hour, and subsequently stained with primary antibodies in blocking buffer overnight at 4 ƕC. The samples 
were washed three times and then stained with secondary antibodies (described above) in blocking buffer 
for ~1 hour at room temperature. 
Fixed-cell STORM imaging. The imaging buffer was PBS containing 100 mM cysteamine, 5% 
glucose, 0.8 mg/mL glucose oxidase (Sigma-Cnftkej+."cpf"62"ȝi1oN"ecvcncug"*Tqejg"Crrnkgf"Uekgpeg+"
for fixed neurons. To image the samples from 12-oo"eqxgtunkru."crrtqzkocvgn{"6"ȝN"qh"kocikpi"dwhhgt"
was dropped at the center of a freshly-cleaned, #1.5 rectangular coverslip (22 mm by 60 mm), and the 
sample on the 12-mm coverslip was mounted on the rectangular coverslip and sealed with nail polish or 
Cytoseal. To image samples from 8-ygnn"ejcodgtu."622"ȝN"qh"kocikpi"dwhhgt"was added to the imaging 
chamber. 
The STORM setup was based on an Olympus IX-71 inverted optical microscope as described 
previously [236]. 405-nm (CUBE 405-50C; Coherent), 460-nm (Sapphire 460-10; Coherent), 532-nm 
(GCL-200-I; CrystaLaser), and 657-nm (RCL-300-656; CrystaLaser) lasers were introduced into the 
sample through the back focal plane of the microscope. A translation stage allowed the laser beams to be 
shifted towards the edge of the objective so that the emerging light reached the sample at incidence angles 
slightly smaller than the critical angle of the glass-water interface, thus illuminating only the fluorophores 
within a few micrometers of the coverslip surface. A T660LPXR (Chroma) was used as the dichroic 
mirror and an ET705/72M band-pass filter (Chroma) was used as the emission filter. For 3-dimensional 
(3D) STORM imaging, a cylindrical lens was inserted into the imaging path so that images of single 
molecules were elongated in x and y for molecules on the proximal and distal sides of the focal plane 
(relative to the objective), respectively [112]. 
During imaging, continuous illumination of 657-nm laser (~2 kW/cm2) was used to excite 
fluorescence from Alexa Flour 647 molecules and switched them into the dark state. Continuous 
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illumination of the 405-nm laser (when Alexa Flour 405 was used as the activator dye) or 532-nm laser 
(when Cy3 was used as the activator dye) was used to reactivate the fluorophores to the emitting state. 
The power of the activation lasers (typical range 0-1 W/cm2) was adjusted during image acquisition so 
that at any given instant, only a small, optically resolvable fraction of the fluorophores in the sample were 
in the emitting state.  
A typical STORM image was generated from a sequence of about 30,000~60,000 image frames 
at a frame rate of 60 Hz. The recorded STORM movie was analyzed according to previously described 
methods [105, 112]. The centroid positions and ellipticities of the single-molecule images provided lateral 
and axial positions of each activated fluorescent molecule, respectively [112]. Super-resolution images 
were reconstructed from the molecular coordinates by depicting each location as a 2D Gaussian peak.  
Live-cell STORM imaging. Live cell STORM experiments were performed on the same STORM 
setup as described earlier [114, 236]. Neurons were initially transfected with ȕKK"urgevtkp-mMaple 3 at 
DIV8, and imaged in an extracellular solution containing: 128mM NaCl, 5mM KCl, 2mM CaCl2, 1mM 
MgCl2, 25mM HEPES, 30mM glucose, pH 7.3) at DIV10 or DIV11. Continuous illumination of the 405 
nm laser was used to activate the mMaple 3 fluorescent protein. Continuous illumination of 561 nm laser 
was used to excite mMaple 3 and switched them to the dark state. Imaging analysis was performed as 
described above.  
FRAP analysis. FRAP experiments were performed on the same STORM setup as described 
above. Neurons were transfected with ȕKK"urgevtkp-GFP at DIV8 and then imaged at DIV10. Directly 
before FRAP experiments, neuronal culture media was replaced with an extracellular solution. After 
recording an image before photo-bleaching, a small region of the sample was bleached by shrinking the 
size of iris at the excitation light path for 10 seconds with the maximum laser power. Subsequently, the 
sample was imaged using the same power as that of pre-bleached image. The image was recorded at a 
frequency of 1 Hz. We used the unbleached regions in the image to calibrate the photo-bleaching effect 
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during the entire recording time. The fluorescence recovery fraction was measured as the fluorescence 
intensity at the bleached region at indicated time versus the original intensity before photo-bleaching. 
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Chapter 5: The Prevalence of the Periodic Membrane Skeleton in 
Different Neuronal Types  
 
 
 
 
 
 
 
 
 
 
 
 
Work in this chapter was performed in collaboration with Dr. Ruobo Zhou, Monica 
Carrasco, and Zhuhao Wu.  
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5.1 Introduction  
The aforementioned studies in Chapter 4 were mostly performed in cultured hippocampal neurons 
or hippocampal tissue slices. Hippocampal neuronal cultures are primarily comprised of pyramidal cells, 
whereas the brain contains many different types of neurons with different morphologies, properties and 
functions. It remains unknown whether the periodic submembrane cytoskeletal structure is present in 
different neuronal types and different regions of the nervous system. For example, it is unclear whether 
the periodic structure is a specific property of excitatory neurons, such as the pyramidal cells, or whether 
similar structure also exists in inhibitory neurons. Similarly, it remains to be determined whether the 
structure is only present in central neurons or whether it also exists in peripheral neurons. With the axons 
of many neuronal types myelinated in the brain, it remains unclear whether myelination has any impact 
on the formation of periodic membrane skeleton.  
In this study, we examined these important questions by super-resolution imaging of different 
types of cultured neurons. We found that the periodic membrane skeleton prevails in the axons of 
different neuronal types from central and periphery nervous system. For all the neuronal types we 
examined, the periodic membrane skeleton is preferentially formed in all axons, while a small fraction of 
dendrites also contain isolated patches of the lattice structure. Furthermore, myelination does not appear 
to impact the formation of this lattice structure in vitro.  Altogether, our results suggest that the periodic 
membrane skeleton is highly prevalent in different neuronal types.  
5.2 Results 
5.2.1 The periodic membrane skeleton is present in inhibitory neurons from the hippocampus 
To study how prevalent the periodic membrane skeleton is in different neuronal types, we 
cultured neurons from different mouse brain regions (central nervous system) or spinal cord (periphery 
nervous system), or used neurons derived from embryonic stem cells. ȕKK spectrin, a core component of 
the periodic membrane skeleton [149, 207], was immunostained and visualized by stochastic optical 
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reconstruction microscopy (STORM) [105-107, 112]. The periodic membrane skeleton was initially 
observed in hippocampal neurons [149], most of which are excitatory neurons. To test whether the 
finding can be extended to additional neuronal types, we first decided to image the distribution of ȕKK 
spectrin in inhibitory neurons from the hippocampus. Inhibitory neurons can be specifically marked by 
immunostaining of GAD65 or parvalbumin. Based on the neuronal morphology, we were able to 
distinguish the axons from dendrites. We focused on imaging axonal regions closer to the cell body, as 
these sites were where the periodic lattice structure forms earliest in excitatory neurons [207]. As shown 
in Figure 5.1, in axons of both GAD65+ and parvalbumin+ neurons, ȕKK spectrin adopts a highly periodic 
structure, with a periodicity of around 190 nm, consistent with our previous findings [149, 207]. Nearly 
all the GAD65+ and parvalbumin+ neurons have the periodic structure formed in axons at DIV10 (days in 
vitro) (Figure 5.1), indicating that the periodic structure is highly prevalent in inhibitory neurons from the 
hippocampus. As compared to the periodic distribution in axons, ȕKK spectrin is largely irregular in 
dendrites (Figure 5.1 A-2 and B-2), although a small fraction of dendrites also appeared to have isolated 
patches of the periodic structure, consistent to what we observed in excitatory neurons [207].  
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Figure 5.1. ���"u�g�vtkp"ku"qt��pk�g�"kpvq"�"�gtkq�k�"uvtw�vwtg"kp"kpjkdkvqt{"pgwtqpu"htqo"vjg"
hippocampus. A) Neurons from the hippocampus were cultured till DIV10 and immunostained with anti-
GAD65 antibody. A reconstructed image of the neuron based on GAD65 staining is shown on the left. 
Axonal and dendritic regions (arrows) were chosen for STORM imaging. 3D STORM images of ȕII 
spectrin are shown in the middle. Autocorrelation analyses of the distribution of ȕII spectrin for each 
image is shown on the right. B) Similar to A) except that the neuron was stained with parvalbumin 
antibody.  
5.2.2 The periodic membrane skeleton is present in neurons from central and periphery nervous 
system 
Next, we extended our imaging to other neuronal types from different brain regions. For the 
cortex and middle brain regions, we used immunostaining of vGlut1, GAD65 and parvalbumin to mark 
the excitatory and inhibitory neurons. Though these two brain regions contain many morphologically and 
functionally distinct neuronal types, we reasoned that our labeling strategy would still allow us to 
quantify the prevalence of the periodic structure in all neuronal types from the cortex and middle brain. A 
representative excitatory and inhibitory neuron from the cortex and middle brain are shown in Figure 5.2. 
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Similar to what we observed in hippocampal neurons, ȕKK spectrin in the axonal regions of these neurons 
exhibited a highly periodic form (Figure 5.2). We systematically quantified the degree of periodicity 
through autocorrelation analysis. As shown by the averaged autocorrelation curve from multiple 
measurements (Figure 5.2), axons of both excitatory and inhibitory neurons from the cortex and middle 
brain all had ȕKK spectrin organized into a periodic form, whereas only a small fraction of dendrites 
appeared to have the periodic structure and typically in the form of isolated patches, especially in cortical 
neurons (arrowheads in Figure 5.2A-2). Average autocorrelation analysis indicated that the degree of 
periodicity in dendrites is much worse than that in axons and in short-range. These results suggest that the 
periodic membrane skeleton might be a general structural feature for axons in the brain.  
To further test our hypothesis, we chose to image the distribution of ȕKK spectrin in a few 
morphologically and functionally distinct neuronal types from other brain regions. Specifically, in the 
cerebellum, we imaged Golgi cells, Purkinje cells, and granule cells, marked by positive metabotrophic 
glutmate receptor staining, positive calbindin staining, and negative calbindin and positive NeuN staining, 
respectively. Granules cells account for the majority of neurons in the brain and is known for its small cell 
body. Purkinje cells are large in size and have elaborate dendritic branches. Golgi cells are GABAergic 
interneurons that synapse on granule cells and parallel fibers [237]. In the pontine nuclei, we imaged 
mossy fibers, a major input to the cerebellum. Furthermore, two additional types of neurons were chosen 
because of their distinct neuronal transmitter type and function: dopamine neurons from basal ganglion 
and olfactory neurons from the olfactory bulb. For all of these neurons, we cultured them for at least 10 
days, fixed them, and immunostained with ȕKK spectrin for STORM imaging. As shown in Figure 5.3, all 
the neurons had a periodic distribution of ȕKK spectrin in their axons, and the periodicity matches with that 
of hippocampal neurons. Quantitatively, the degree of periodicity varies among different neuronal types, 
with Golgi cells and Purkinje neurons having a slightly worse periodicity. This might due to a slow 
development process for cerebellum neurons in vitro, as observed in previous studies [238, 239]. These 
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data suggest that the periodic structure is highly prevalent in morphologically and functionally distinct 
neuronal types in the central nervous system.  
  
Figure 5.2. The periodic lattice structure is present in both excitatory and inhibitory neurons from 
the cortex and middle brain. Neurons from the cortex and middle brain regions were cultured till DIV 
10 and immunostained with vGlut1 or GAD65 to label the excitatory and inhibitory neurons respectively. 
A) Left: a reconstructed image of vGlut1+ cortical neuron; middle: 3D STORM image of ȕII spectrin in 
the axonal and dendritic regions (arrows); right: autocorrelation analysis of the distribution of ȕII spectrin 
for the imaged regions. B) Similar to A) except the cortical neurons was labeled by GAD65. C) Similar to 
A) except the neuron was from the middle brain. D) Similar to A) except the neuron was from the middle 
brain and marked by GAD65.  
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Figure 5.3. The periodic structure is highly prevalent in different neuronal types from the central 
and periphery nervous system. Neurons from the central and periphery nervous system were cultured 
for at least ten days and fixed for STORM imaging. A) A reconstructed image of Golgi cell from the 
cerebellum based on immunostaining of metabotrophic glutmate receptor. 3D STORM images of ȕ,, 
spectrin and autocorrelation analyses of the distribution of ȕ,, spectrin in the axon were shown in A-1 and 
A-2. B) Similar to A) except the cell is mossy fiber from the pontine nuclei. C) Similar to A) except the 
cell is a dopamine neuron marked by tyrosine hydroxylase staining from the basal ganglion. D) Similar to 
A) except the cell is an olfactory neuron marked by OMP staining from the olfactory bulb. E) 3D 
STORM images of ȕ,, spectrin and autocorrelation analyses of the distribution of ȕ,, spectrin in the axon 
of Purkinje cells from cerebellum. F) 3D STORM images of ȕ,, spectrin and autocorrelation analyses of 
the distribution of ȕ,, spectrin in the axon of granule cells from cerebellum. G) 3D STORM images of ȕ,, 
spectrin and autocorrelation analyses of the distribution of ȕ,, spectrin in the axon of mouse embryonic 
stem cell-derived motor neurons. H) 3D STORM images of ȕ,, spectrin and autocorrelation analyses of 
the distribution of ȕ,, spectrin in the axon of human iPS cells-derived motor neurons. I) 3D STORM 
images of ȕ,, spectrin and autocorrelation analyses of the distribution of ȕ,, spectrin in the axon of DRG 
sensory neurons cultured in the explant format. J) 3D STORM images of ȕ,, spectrin and autocorrelation 
analyses of the distribution of ȕ,, spectrin in the axon of dissociated DRG sensory neurons.  
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Finally, we examined whether the periodic structure was present in periphery neurons. Two 
representative periphery neurons, motor neurons and DRG sensory neurons, were cultured, fixed and 
immunostained against ȕKK spectrin for STORM imaging. The results for DRG neurons were obtained in 
collaboration with Dr. Marc Tessier-Lavigne’s group in Rockefeller University, while the results for 
motor neurons were obtained in collaboration with Dr. Tom Maniatis’s group in Columbia University. 
Motor neurons were either generated from mouse embryonic stem cells, or from human iPS cells. DRG 
sensory neurons were cultured either in an explant format, or dissociated form. Consistent with what we 
observed in central nervous system, we found that the periodic form of ȕKK spectrin is evident for both 
motor neurons and DRG sensory neurons (Figure 5.3G-5.3J).  
Altogether, these results indicate that the periodic structure is present in neurons from both the 
central and periphery nervous system. Given that the group of selected neurons are morphologically and 
functionally different, and were dissociated from distinct locations, these results suggest that the periodic 
membrane skeleton is highly prevalent in different neuronal types.   
5.2.3 The structural organization of ȕKK spectrin in glia cells 
The high prevalence of the periodic structure in different neuronal types prompted us to wonder 
whether the lattice structure is unique to neurons, or whether other cells with long tubular neurite-like 
processes may have the periodic structure. To this end, we imaged the distribution of ȕKK spectrin in four 
different types of glia cells: microglia, oligodendrocytes, astrocytes, NG2 glia cells and Schwan cells 
[237]. All these cells have thin processes protruding from the cell body and express ȕKK spectrin. However, 
as compared to the distribution of ȕKK spectrin in neurons, we failed to detect the periodic structure in long 
range order in these glia cells (Figure 5.4). Under rare circumstances, isolated patches of periodic ȕKK 
spectrin can be observed in these processes, mostly evident in astrocytes, similar to what we observed in 
dendrites of neurons.  
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Figure 5.4. ȕ,,VSHFWULQLVODUJHO\LUUHJXODULQthe processes of different glia cells. A) Left: a microglia 
FHOOVWDLQHGZLWKPLFURJOLDPDUNHU&'EJUHHQDQGȕ,, spectrin (red); middle: 3D STORM images of 
ȕ,, spectrin in two processes from the microglia (arrows); right: autocorrelation analyses of the 
distribution of ȕ,, spectrin from the imaged regions. B) Similar to A) except an astrocyte was labeled by 
astrocyte marker GFAP (green) and ȕ,, spectrin. C) Similar to A) except a NG2+ glia cell was labeled by 
NG2 (green) and ȕ,, spectrin. D) Similar to A) except a Schwan cell was labeled by Schwan cell marker 
S100b (green) and ȕ,, spectrin.  
5.2.4 Myelination does not affect the formation of the periodic structure in cultured neurons 
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As neurons in the body are heavily myelinated, we next sought to examine whether myelination 
had any effect on the formation of this periodic membrane skeleton. A co-culture system was used to 
induce myelination on hippocampal neurons, as previously reported [240]. Briefly, hippocampal neurons 
were cultured for two weeks before seeding with glia cells from the cerebellum. After about six weeks, 
the cells were fixed, and immunostained against ȕKK spectrin, Map2 and MBP (myelination marker). 
Under conventional imaging, segments of axons wrapped by the sheath of oligodendrocytes were evident 
by the specific MBP staining (Figure 5.5A). We used STORM to image the distribution of ȕKK spectrin in 
myelinated axons as well as unmyelinated regions. As shown in Figure 5.5B, ȕKI spectrin still adapts a 
highly periodic form in myelinated regions, with a periodicity of around 180 nm. Because the axon has 
unmyelinated regions, we were able to compare the degree of periodicity between myelinated and 
unmyelinated regions on the same axon. As shown by the autocorrelation analysis (Figure 5.5C), there is 
no significant difference between the autocorrelation amplitude, indicating that myelination does not 
impact the formation of the periodic membrane skeleton, at least in our in vitro co-culture system.  
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Figure 5.5. Myelination does not affect the formation of the periodic membrane skeleton. 
Hippocampal neurons were cultured for two weeks before adding the glia cells. After co-culturing for six 
weeks, the cells were fixed and immunostaiQHGZLWKȕ,, spectrin (red), Map2 (dendritic marker, blue) and 
MBP (myelination marker, green). A) A conventional image of the myelinated axon. The green tube in 
the middle marks a myelinated axon. B) 3D STORM image of ȕ,, spectrin from A). The myelin sheath 
was shown in magenta. As shown in the image, ȕ,, spectrin adopts a highly periodic structure in the 
myelinated as well as unmyelinated regions along the axon. C) Average autocorrelation analyses of the 
distribution of ȕ,, spectrin from the MBP+ and MBP- regions from the same axon. The periodicity 
appears similar in the myelinated and unmyelinated regions. Average from at least 7 neurons.  
5.3 Discussion 
Actin, spectrin and associated molecules organize into a submembrane periodic lattice structure 
around the circumference of axons. The initial observation was primarily made in hippocampal neurons 
[149]. In this study, we extended this observation to multiple neuronal types in the central nervous system 
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and periphery nervous system. Excitatory neurons, inhibitory neurons in the hippocampus, cortex, and 
middle brain regions, granule cells, Golgi cells, Purkinje cells from cerebellum, mossy fibers from the 
pontine nuclei, dopamine neurons from basal ganglion, olfactory neurons from the olfactory bulb, mouse 
embryonic-derived motor neurons, human iPS cell-derived motor neurons, and mouse DRG sensory 
neurons, myelinated hippocampal neurons all appear to have the periodic membrane skeleton in their 
axons. These many neuronal types are morphologically and functionally different, and came from distinct 
origins. Although we couldn’t exclude the possibility that some neuronal types may not have the lattice 
structure because we didn’t image all the neuronal types in the body, given the high prevalence of the 
periodic structure, it is highly likely that the periodic membrane skeleton is a general feature for all the 
neurons. In addition to the observation of the periodic lattice structure in cultured cells, the Zhuang lab 
has also previously observed the presence of the lattice structure in the tissue slice of cortex and 
hippocampus [149]. The periodic actin-spectrin lattice structure has also been observed in the axons of 
hippocampal neurons and nodes of Ranvier of myelinated sciatic nerve by the Hell lab [215].  
Initially, the periodic membrane skeleton was only observed in axons, whereas dendrites 
predominantly contains long actin filaments and irregular distributions of ȕKK spectrin [149]. Two 
subsequent studies found that in matured neurons, the periodic structure can be observed in a small 
fraction of dendrites as well typically appearing as isolated patches [207, 215]. To systematically 
determine the distribution of ȕKK spectrin in dendrites of different neurons, we also imaged the dendritic 
distribution of ȕKK spectrin from different neuronal types in this study. For all the different neuronal types 
we imaged, we either did not detect the periodic structure in dendrites or only detected such structure in a 
small fraction of dendrites. Within these dendrites, the periodic structure didn’t exist in long-range order, 
but typically in the form of isolated patches. This is consistent to what we and the Hell lab observed in 
hippocampal neurons [207, 215]. 
The above results indicate that the polarized distribution of the periodic membrane skeleton in 
neurites might be a general feature across different neuronal types.  
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Actin is an evolutionally conserved cytoskeletal protein and essentially present in all eukaryotic 
cells. On the other hand, spectrin is a relatively late invention in evolution and only starts to appear from 
metazoans [129, 241]. An actin, spectrin-based cytoskeleton exist in neurons from C. elegans and 
Drosophila melanogaster, and was found to be important to be crucial for the mechanical stability for 
axons [142] and protecting axon from mechanical stress [145] in C. elegans, and for axon path finding 
[208], for the stabilization of presynaptic terminals [209] in the flies. However, it remains unknown 
whether actin, spectrin and associated molecules also organize into a periodic form, or whether other 
structural organization exist in neurons from these species. In this study, we found that the periodic 
membrane skeleton exists in mouse and human iPS-cell derived neurons. It will be interesting to 
determine when the periodic lattice structure evolve evolutionally in the future. 
5.4 Materials and Methods 
All experimental procedures were performed in accordance with the Guide for the Care and Use 
of Laboratory Animals of the National Institutes of Health. The protocol was approved by the Institutional 
Animal Care and Use Committee (IACUC) of Harvard University.  
Neuron culture. For culturing neurons from hippocampus, cortex, middle brain, pontine nuclei, 
cerebellum, basal ganglion, olfactory bulb, the indicated brain regions were dissociated from the brain of 
wild type neonatal (E18) rat embryos (timed pregnant SD rats from Charles River Laboratories, 
Wilmington, MA), as reported previously [229]. Briefly, the brain tissues were isolated and digested with 
0.05% trypsin-EDTA (1x) (Invitrogen 25300-054) at 37oC for 15 minutes, washed in HBSS solution 
several times, and then transferred to the culture media. After washing it once with the culture media, the 
tissues were pipetted up and down in the fresh culture media until the tissues were mostly dissolved. For 
hippocampal, cortex, middle brain, pontine nuclei, basal ganglion, cerebellum and olfactory bulb cultures, 
the neurons were resuspended with the culture media made of 96 mL Neurobasal (Life Technologies, 
12349-015), 2 mL B-27 Supplement (Life Technologies, 17504-044), 1 mL Penicillin-Streptomycin (Life 
technologies, 15140-122) and 1 mL Glutamax (Life technologies, 35050-061), and then plated onto poly-
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L-lysine/laminin-coated 18-mm coverslips (neuVitro, GG-18-pdl). The cerebellum culture could also be 
maintained in DMEM/F-12 media (Life Technologies, 11330-057) supplemented with 100 mM 
putrescine (Sigma-Aldrich, P7505), 30 nM Na2SeO3 (Sigma-Aldrich, S5261), 1.4 mM L-glutamine 
(Sigma-Aldrich, 1294808), and 10 mg/ml gentamicin (Sigma-Aldrich, G1397), and we observed modest 
increase of survival rate for Purkinje cells when cultured in this media, as reported previously [238].  
The co-culturing protocol for inducing myelination on hippocampal neuron is modified from a 
previously reported procedure [240]. Briefly, hippocampal neurons from E18 rat brains were dissociated 
and seeded as described above. Two weeks after plating, we harvested glia cells from the cerebellum of 
E18 rat by the same dissociation procedure. About 100,000 glia cells were seeded with 60,000 
hippocampal neurons on the 18-mm coverslips. The co-cultured neurons were maintained in the culture 
media: for 40 ml media, the components include 19.5 ml Neurobasal media (Life Technologies, 12349-
015), 19.5ml DMEM-high glucose media (Life Technologies, 11965-082), 400 ȝn Glutamax (Life 
technologies, 35050-061), 400 ȝn 100 mM sodium pyruvate (Life Technologies, 11360-070), 400 ȝn 
0.5mg/ml insulin (Sigma-Aldrich, I6634), 400 ȝn 100X Sato, 400 ȝn 100X T3, 800 ȝn B-27(Life 
Technologies, 17504-044), 40 ȝn 5mg/ml N-acetyl cysteine (Sigma-Aldrich, A8199), 40 ȝn 32"ȝi1on"
biotin(Sigma-Aldrich, B4639), 40 ȝn 1000X Cellgro Trace Element B(Life Technologies, MT99-175-C1). 
The neurons were fed twice a week with freshly made culture media until use. 
Reagents. The following primary antibodies were used in this study: guinea pig anti-Map2 
antibody (Synaptic Systems, 188004); mouse anti-ȕKK"urgevtkp"cpvkdqf{"*DF"Dkquekgpegu."834785+="tcddkv"
anti-adducin antibody (Abcam, ab51130); rabbit anti-GFP antibody (Abcam, ab290); guinea pig anti-
vGlut1 antibody(Synaptic Systems, 135304); rabbit anti-calbindin antibody (Swant, CB38); rabbit anti-
tyrosine hydroxylase antibody (Abcam, ab6211); rabbit anti-GAD65 antibody(Synaptic Systems, 198103); 
goat anti-parvalbumin antibody (Santa Cruz, sc-7449); rabbit anti-metabotrophic glutmate receptor 
antibody (Abcam, ab6438); rat anti-MBP antibody (Millipore, Mab386); rabbit anti-OMP antibody (Santa 
Cruz, sc-67219); goat anti-ChAT antibody (Millipore, AB144P); rabbit anti-NG2 antibody (Millipore, 
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AB5320); rabbit anti-CD11b (Novus Biologicals, NB110-89474); rabbit anti-S100b (Abcam, ab41548); 
rabbit anti-GFAP (Encor, RPCA-GFAP), rabbit anti-NeuN(Millipore, MABN140). The following 
secondary antibodies were used in this study: Alexa Fluor 647 donkey anti-mouse (Invitrogen, A31571), 
Alexa Fluor 647 donkey anti-rabbit (Invitrogen, A31573), Alexa Fluor 568 donkey anti-rabbit (Invitrogen, 
A10042), Alexa Fluor 488 donkey anti-rabbit (Invitrogen, A21206), Alexa Fluor 488 goat anti-guinea pig 
(Invitrogen, A11073), Alexa Fluor 568 donkey anti-goat (Invitrogen, A11057). For STORM imaging, 
Alexa Fluor 647 donkey anti-mouse (Invitrogen, A31571) or secondary antibodies custom-labeled with 
Alexa Fluor 647 and Alexa Fluor 405 [150] were used.  
Immunofluorescence of neurons. Cultured neuron were fixed at various days in vitro (DIV) using 
4% (w/v) paraformaldehyde in phosphate buffered saline (PBS) for 15 min. Fixed neuron samples were 
then permeabilized with 0.2% v/v Triton X-100 in PBS for 5 minutes and blocked in blocking buffer (3% 
w/v bovine serum albumin in PBS) for 1 hour, and subsequently stained with primary antibodies in 
blocking buffer overnight at 4 ƕC. The samples were washed three times and then stained with secondary 
antibodies (described above) in blocking buffer for ~1 hour at room temperature. 
STORM imaging. The STORM setup was based on an Olympus IX-71 inverted optical 
microscope as described previously [236]. 405-nm (CUBE 405-50C; Coherent), 460-nm (Sapphire 460-
10; Coherent), 532-nm (GCL-200-I; CrystaLaser), and 657-nm (RCL-300-656; CrystaLaser) lasers were 
introduced into the sample through the back focal plane of the microscope. A translation stage allowed 
the laser beams to be shifted towards the edge of the objective so that the emerging light reached the 
sample at incidence angles slightly smaller than the critical angle of the glass-water interface, thus 
illuminating only the fluorophores within a few micrometers of the coverslip surface. A T660LPXR 
(Chroma) was used as the dichroic mirror and an ET705/72M band-pass filter (Chroma) was used as the 
emission filter. For 3-dimensional (3D) STORM imaging, a cylindrical lens was inserted into the imaging 
path so that images of single molecules were elongated in x and y for molecules on the proximal and 
distal sides of the focal plane (relative to the objective), respectively [112]. 
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Before imaging, the sample was supplemented with the imaging buffer: PBS containing 100 mM 
cysteamine, 5% glucose, 0.8 mg/mL glucose oxidase (Sigma-Cnftkej+."cpf"62"ȝi1oN catalase (Roche 
Applied Science). During imaging, continuous illumination of 657-nm laser (~2 kW/cm2) was used to 
excite fluorescence from Alexa Flour 647 molecules and switched them into the dark state. Continuous 
illumination of the 405-nm laser was used to reactivate the fluorophores to the emitting state. The power 
of the activation lasers (typical range 0-1 W/cm2) was adjusted during image acquisition so that at any 
given instant, only a small, optically resolvable fraction of the fluorophores in the sample were in the 
emitting state.  
A typical STORM image was generated from a sequence of about 20,000~40,000 image frames 
at a frame rate of 60 Hz. The recorded STORM movie was analyzed according to previously described 
methods [105, 112]. The centroid positions and ellipticities of the single-molecule images provided lateral 
and axial positions of each activated fluorescent molecule, respectively [112]. Super-resolution images 
were reconstructed from the molecular coordinates by depicting each location as a 2D Gaussian peak.  
 
  
139 
 
Chapter 6: Discussion and Future Directions 
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Fluorescence imaging has become an indispensable tool to study biological processes and has 
generated many important insights in modern biology. One feature that makes fluorescence imaging so 
powerful is its ability to achieve molecule-specific visualization for targets of interest. With the 
development of many staining methods, fluorescent imaging also allows researchers to easily probe 
different biological processes in fixed or live conditions. In this dissertation, I present the use of 
conventional fluorescence imaging to study the role of host factors in influenza virus infection, as well as 
the use of super-resolution imaging to characterize the developmental mechanism of a novel periodic 
membrane skeleton.  
6.1 Host Factors in Influenza Virus Infection 
As an obligatory pathogen that only encodes 13 proteins, influenza virus must co-opt host cell 
machinery to harbor infection and to produce progeny viruses [15]. The life cycle of virus infection 
involves extensive intracellular trafficking of viral components. In order to characterize the virus-host cell 
interactions, several genome-wide siRNA screens and proteomic analyses have been performed to 
identify host factors involved in influenza virus infection [63-68]. Hundreds of candidate host factors 
have been identified, though the exact functional role for many of these host factors remains to be 
elucidated. In Chapter 2 and 3, I present the study of CD81 and COPI complex, two top candidates 
identified in multiple siRNA screens and proteomic analyses, and their role in influenza virus infection.  
In Chapter 2, my colleagues and I used siRNA to knockdown CD81 and examined the effect of 
CD81 depletion on the major steps of influenza infection. We report a dual function of CD81 in influenza 
virus infection by regulating two major steps: virus fusion during viral entry and virus budding during 
viral egress. Specifically, during viral entry, more than half of internalized virus particles were trafficked 
into a specific CD81-positive endosomal population for virus uncoating. Depleting CD81 led to a 
significant defect in viral uncoating and infection. During viral egress, CD81 was recruited to virus 
assembly site, and incorporated into individual virions at specific sub-viral locations. For spherical and 
slightly elongated influenza virus, CD81 was localized at both the growing tip and the budding neck of 
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the progeny viruses. CD81 depletion resulted in virions that failed to detach from the plasma membrane 
and a marked decrease in progeny virus production. In filamentous virus, CD81 was distributed at 
multiple sites along the viral filament. Taken together, these results demonstrate important roles of CD81 
in both entry and budding stages of the influenza infection cycle.   
In Chapter 3, my colleagues and I used siRNA and pharmacological inhibitors to dissect the 
effect of COPI depletion or disruption on influenza infection. Knocking down COPI using siRNA led to a 
significant defect for virus internalization and virus trafficking from early to intermediate/late endosomes. 
The entry block was not limited to influenza virus, but also for other cargoes (Tfn, EGF, and dextran) that 
internalize through either clathrin-mediated endocytosis or macropinocytosis. Because of the large defect 
in viral entry during prolonged siRNA treatment, we also used pharmacological inhibitors to acutely 
disrupt the COPI complexes. With the inhibitor treatment, we found that disruption of functional COPI 
complexes directly inhibited viral membrane protein expression, assembly of viral components at the 
plasma membrane, and production of infectious progeny virus.  Qwt"Ýpfkpiu"uwiiguv"vjcv"EQRK"
eqorngzgu"nkmgn{"hwpevkqp"kpfktgevn{"kp"kpÞwgp|c"xktwu"gpvt{"dwv"rnc{"fktgev"tqngu"kp"xktcn"ogodtcpg"
protein expression and assembly.  
As exemplified by these two studies, fluorescence imaging is a versatile tool that allows us to 
probe the influenza infection in either fixed or live cells. Virtually every step along the infection cycle can 
be examined by imaging-based assays [28]. Particularly, by labeling individual virions with a fluorescent 
dye and tracking the movements of viruses during viral entry, we were able to capture each step during 
viral entry from virus binding, to virus internalization, trafficking to endosomes and virus fusion [28]. 
This allowed us to study in real time how influenza viruses interact with host factors, and to examine the 
specific role of host factors during each entry step. Similarly, the assays developed for the study of post-
entry steps are mostly based on fixed cell fluorescence imaging as well. Complementary to the traditional 
biochemical approaches, these imaging-based methods not only provide detailed quantification for viral 
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replication, viral protein translation and transport, but also the spatiotemporal information on the 
functional role of host proteins during virus infection.  
Importantly, the assays presented in these two studies can be easily extended to the 
characterization of functional roles for other host factors in influenza virus infection, or more generally, 
infection cycle of other viruses. Over the past few years, many genome-wide studies have been performed 
to identify host dependency and susceptibility proteins involved in the infection cycle of different viruses 
[242]. Given that viruses exploit a variety of cellular machineries to enter cells, these assays will 
undoubtedly provide invaluable insights for dissecting the dynamic roles of these identified host proteins 
in viral entry. With the extended list of candidate proteins involved in virus infection, it should be minded 
that live cell imaging is a relatively low throughput assay. Development of high-throughput and high-
content live cell imaging methods for analyzing the large body of data will tremendously abet future work. 
On the other hand, it is important to note that viruses are generally small in size, while the 
interactions between virus and cellular factors occur at the nanometer scale [15]. Under conventional light 
microscopy, the precise localization of host or viral proteins is blurred by the diffraction limit of light. For 
instance, during viral entry, initiation of clathrin-mediated endocytosis by influenza virus leads to a highly 
specific, well-orchestrated and ordered cellular protein distribution within the clathrin-coated pit [243]. 
However, such detailed spatial orchestration information is often missing from conventional imaging. The 
recent development of super-resolution techniques that overcome the diffraction limit and provide 
nanometer-scale image resolution will open up a window for more detailed investigation of virus-cell 
interactions [98-101]. Future studies on virus and host cell interaction will undoubtedly benefit from the 
use of super-resolution imaging.  
Altogether, my studies elucidated the role of several essential host factors in the influenza life 
cycle, and would potentially offer important insights in restricting influenza spread. The exciting 
discoveries made possible by fluorescence imaging represent just the tip of iceberg of what we know 
about virus-host cell interaction. With the development of new technologies and discovery of novel 
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biological processes, future imaging studies on virus-host cell interaction will undoubtedly further enrich 
our understanding on virology and basic cellular biology. 
6.2 The periodic membrane skeleton in neurons 
In the nervous system, the information typically flows from the axons of output neurons to the 
dendrites of receiving neurons. This directional transmission of information depends critically on the 
polarization of neurons, namely the differentiation between axons and dendrites. The cytoskeleton plays 
critical roles in determining the shape and mechanical properties of the cell, as well as in supporting many 
cellular functions, including cell motility, cell division, and intracellular transport [117-120]. In neurons, 
cytoskeletal structures are essential for the establishment of neuronal polarity, the growth and stabilization 
of axons and dendrites, the trafficking of cargos to specific neurites, as well as the plasticity of synapses 
[117-120]. The Zhuang labs recently discovered a strikingly ordered submembrane cytoskeleton structure 
that is predominantly present in axons [149]. Three molecular components of this novel cytoskeleton 
structure were identified, including actin, spectrin and adducin. Actin filaments form a ring-like structure 
that wraps around the circumference of the axons. These actin rings were evenly spaced along the axon 
shafts with a highly regular periodicity, forming a quasi-one-dimensional lattice structure with a long-
range order. Actin filaments in the rings were capped by adducin and adjacent actin rings were connected 
by spectrin tetramers. The periodic lattice also organizes the axonal membrane by placing important 
membrane proteins, such as the voltage-gated sodium channels, into a periodic distribution [149].  
In Chapter 4, my colleagues and I used super-resolution imaging to study the developmental 
process of this periodic membrane skeleton, and the molecular mechanism underlying its specific 
formation in axons. We found that the periodic membrane skeleton forms early during neuronal 
development, and originates from axonal regions closer to the cell body, and propagates toward distal 
axon ends. The lattice structure continues to mature by recruiting additional molecular components during 
neuronal development, and once matured, it appears to be highly stable.  
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We found that a small fraction of dendrites also have the periodic structure during later 
developmental stages. In these dendrites, the periodic lattice structure often appeared as isolated patches 
and not throughout the entire dendrites [207]. Recently, D’Este and colleagues used SiR-Actin, a newly 
developed fluorescent probe, to label actin, and imaged the periodic structure in live neurons through 
STED imaging. Consistent with our findings, they reported that the lattice structure was identified in all 
axons but only in ~25% of the dendrites [215]. Altogether, the data suggest that the periodic membrane 
skeleton preferentially forms in axons, though a small fraction of dendrites have this lattice structure.  
We further found that the formation of this periodic membrane skeleton is regulated by the local 
eqpegpvtcvkqp"qh"ȕKK"urgevtkp."yjkej"ku"jkijgt"kp"czqpu"vjcp"kp"fgpftkvgu0"Kpetgcukpi"vjg"eqpegpvtation of 
ȕKK"urgevtkp"d{"qxgtgzrtguukqp"qt"d{ knocking down ankyrin B induces the formation of the periodic 
structure in dendrites, demonstrating that the spectrin concentration is a key determinant in the 
preferential development of this structure in axons and that ankyrin B is critical for the polarized 
fkuvtkdwvkqp"qh"ȕKK"urgevtkp"kp"pgwtkvgu0"" 
In Chapter 5, my colleagues and I studied the prevalence of this periodic membrane skeleton in 
different neuronal types. We found that this periodic structure is highly prevalent in many 
morphologically and functionally distinct neurons from the central and periphery nervous system.  On the 
other hand, glia cells do not appear to contain this periodic skeleton in long range order. Furthermore, we 
found that myelination does not impact the formation of this periodic structures in vitro.   
In red blood cells, the submembrane cytoskeleton is comprised of a large number of protein 
species in addition to actin, spectrin and adducin, including ankyrin, tropomyosin, band 4.1, dematin, 
tropomodulin [129, 222]. Although the ultrastructural organization of the axonal submembrane 
cytoskeleton is highly distinct from that of the red blood cells, the microscopic molecular interactions 
appear to be similar. It is highly likely that the periodic membrane skeleton in neurons contains many 
more molecular components. To obtain a complete picture of how the periodic membrane skeleton is 
organized in neurons, it is crucial to further determine the molecular composition of this novel structure. 
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Indeed, recent unpublished studies in the Zhuang lab have substantially expanded the molecular 
component list of this periodic lattice structure.  
As mentioned above, the lattice structure places sodium channels into a periodic pattern along the 
axon initial segments. Recent unpublished results in the Zhuang lab revealed additional, important 
membrane proteins on this structure. Together, these studies suggest the ability of this submembrane 
cytoskeleton to organize molecular components of the axonal membrane, which is critical for action 
potential generation and propagation, and other signaling pathways [149]. Additionally, mutant C. 
elegans lacking spectrin exhibits substantially lower axon stability, suggesting that the periodic lattice 
structure is essential for supporting mechanical stability of the axons [142]. Moreover, the actin-spectrin 
lattice structure appears to be in a pre-stressed state in C. elegans axons, protecting the axons from 
buckling during animal movement, and such pre-stressed state is important for mechanosensation [145]. 
These observations suggest important functional roles of this periodic membrane skeleton. In the future, it 
will be of particular interest to investigate whether dysfunction in this membrane skeletal structure has 
implications in neurological diseases.  
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